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2 
Abstract 
 
During the course of the studies outlined in this thesis, a new approach for the synthesis of 
the tropane alkaloid, (±)-physoperuvine has been developed using a highly efficient one-
pot tandem process which involved the Overman rearrangement and a ring closing 
metathesis reaction. An asymmetric one-pot tandem process has also been employed for 
the synthesis of the natural product, (+)-physoperuvine. This methodology was also 
applied to the generation of a late-stage intermediate that could be used in the synthesis of 
carbocyclic nucleosides, such as noraristeromycin. 
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In the second part of this thesis, an ether-directed Pd(II)-catalysed Overman rearrangement 
which had previously been developed by the Sutherland group was applied in conjunction 
with a cross-metathesis reaction for the stereoselective synthesis of the guanidine alkaloid, 
(+)-monanchorin in a fourteen-step synthesis. 
 
Further employment of this process provided the first synthesis of clavaminol A, C and H 
from (R)-glycidol in a rapid and efficient manner. In a similar fashion, (2S,3R)-
enantiomers were also synthesised from (S)-glycidol. In addition to this, using similar 
chemistry, an intermediate protected enone was prepared using a cross-metathesis reaction 
as the second key step in an approach towards the synthesis of an NO-inhibitor. 
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1.0 Introduction  
1.1  Claisen Rearrangement 
Over the last 100 years, the Claisen rearrangement has been widely studied and has drawn 
the attention of numerous organic chemists.1 This reaction falls under the classification of a 
[3,3]-sigmatropic shift, a well known reaction which can give good yields of 
rearrangement products, with short reaction times and can be performed under relatively 
mild conditions. The Claisen rearrangement can be defined as the thermal [3,3]-
sigmatropic reorganisation of an allyl-aryl or allyl-vinyl ethers (1, X=O) into γ,δ-
unsaturated carbonyl compound 2 by a concerted intramolecular process (Scheme 1). 
There are also nitrogen and sulfur varients of this reaction. 
 
X X[3,3]
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Scheme 1- Claisen rearrangement 
 
The first report on the Claisen rearrangement involved the conversion of O-allylated ethyl 
acetoacetate 3 into the corresponding C-allyl isomer 4 and was originally discovered by 
Ludwig Claisen in 1912 (Scheme 2).2 
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Scheme 2- The first Claisen rearrangement 
 
The Claisen rearrangement is well known for its ability to create new stereocentres in a 
controlled manner.3 In addition, the generation of a new carbonyl group and the 
stereoselective formation of carbon-carbon bonds, has made this reaction one of the most 
widely used methods in synthetic chemistry. The rearrangement is a pericyclic process, 
where bond breaking and forming occurs through a cyclic array of interacting orbitals in a 
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highly ordered transition state. This allows for the creation of stereogenic centers during 
the reaction (Scheme 3). Although asymmetric Claisen rearrangements still remain a 
challenge for organic chemists, it can be manipulated to give a diastereoselective or an 
enantioselective reaction. Diastereoselective substrates which have a stereogenic centre at 
the 1-position have been extensively studied. The 1-position in the system is found to be 
more efficient for intramolecular chirality transfer creating enantiomerically enriched 
products (Scheme 3).4 Substrates with stereogenic centers at the 1-position can be 
constructed from a chiral secondary or tertiary allylic alcohol. 
O
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R2R
X X
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R1O
X
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Scheme 3- The diastereoselective Claisen rearrangement 
1.1.1 Overman rearrangement 
The Overman rearrangement is an important method for the construction of allylic amines 
from allylic imidates and has found widespread application in organic synthesis.5 This is 
primarily due to the relative ease in which a wide variety of allylic trichloro- and 
trifluoroacetimidates can be prepared from the corresponding allylic alcohol. The Overman 
rearrangement refers to the [3,3]-sigmatropic rearrangement of allylic 
trichloroacetamidates leading to formation of C-N σ-bond. The scope of the rearrangement 
is such that primary, secondary and tertiary allylic amides are all readily accessible, thus 
providing entry into a wide variety of nitrogen-containing products including amino 
sugars, nucleotides, amino acids, peptides and various nitrogen heterocycles.6 In addition, 
the Overman rearrangement has found extensive application in the total synthesis of 
natural products. 
1.1.1.1 Thermal Overman rearrangement 
 
The thermal [3,3]-sigmatropic rearrangement of allylic trichloroacetimidates was first 
reported by Mumm and Möller.7 This reaction occurs with a negative change in enthalpy at 
elevated temperatures in excess of 140 °C, usually in aromatic solvents such as p-xylene. 
Extensive study by Overman showed that a wide variety of allylic trichloroacetimidates 5 
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readily underwent thermal rearrangement within a few hours to afford the corresponding 
allylic trichloroacetamides 6 in high yields.8,9 The mechanism of the thermal 
rearrangement occurs via a concerted pathway (Scheme 4), although the [1,3]-sigmatropic 
product can be formed via the competition of a non-concerted ionisation pathway.10 
O NH
CCl3
O NH
CCl3
R2 R2
HN
O
Cl3C
R2
R1
R1
H R1
5 6  
Scheme 4- Thermal Overman rearrangement 
 1.1.1.2 Metal catalysed Overman rearrangement 
 
Significant attention has been paid to the development of [3,3]-sigmatropic rearrangements 
using a variety of metal catalysts such as Hg(II), Pd(0), Pd(II), Ag(I), Ni(0), Ni(II), Pt(II), 
Au(I) and Al(III).11-15 Further improvements to this approach were reported by 
Overman.16,17  They demonstrated that transition metals (including Pd, Au and Pt) can 
effectively catalyse a wide range of [3,3]-sigmatropic rearrangements with a significant 
increase in reaction rate, allowing the reaction to be carried out at room temperature, under 
mild conditions and giving improved yields. 
1.1.1.2.1 Mercury(II)-catalysed Overman rearrangement 
 
In 1974, Overman reported the first metal catalysed Overman rearrangement using 
mercury(II)-salts such as mercuric trifluoroacetate and mercuric nitrate under mild 
conditions providing a new method for the 1,3-transposition of hydroxyl and amino 
functions.8 This study revealed that allylic trichloroacetimidate 7 of 2-alken-1-ols 
underwent rapid isomerisation to the corresponding allylic trichloroacetamides 9 (Scheme 
5). The results from this study allowed the use of low temperature. Further study by 
Overman has shown that the mercury(II)-catalysed process proceeds in a two step 
mechanism starting with the addition of the mercury electrophile to the double bond, which 
forms the mercurinium ion. Cleavage of the C-O bond of the unstable dihydrooxazine 8 
leads to the formation of amide 9. 
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Scheme 5- Mechanism of the Hg(II)-catalysed rearrangement 
 
In addition to the above study, Overman demonstrated that mercury(II) could successfully 
catalyse derivatives of 3-substituted primary allylic alcohols such as allylic 
trichloroacetimidate 10. This was in contrast to the thermal rearrangement and gave 
exclusively the allylic trichloroacetamide 11 in high yield (Scheme 6).9 The rearrangement 
can also take place at low temperatures (as low as –78 °C). Efforts to perform this 
rearrangement using trifluoroacetic acid were unsuccessful, giving trace amounts of the 
rearranged amide. 
 
Hg(OCOCF3)2
O CCll3
NH HN O
CCll3
1110
92%
 
       Scheme 6- Hg(II)-catalysed rearrangement of allylic trichloroacetimidate 
Overman has also reported that allylic substrates such as 12, in which alkene substitution 
allows intramolecular nucleophilic attack by the imino nitrogen at C-3, rearrange more 
successfully under mercury(II)-catalysis than imidates 13, where addition at C-2 is 
preferred (Scheme 7).8 In one case however, C-2 substituted imidate substrates bearing 
electron donating groups at C-3 such as allyl N-phenylimidates will undergo highly (E)-
selective rearrangements.18 
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Scheme 7- Scope of Hg(II)-catalysed rearrangement 
Although, the rearrangement of allylic trichloroacetimidates at room temperature can be 
achieved using a mercury(II)-catalyst, there are no examples of high yielding mercury 
catalysed rearrangements of secondary allylic trichloroacetamides. 
1.1.1.2.2 Boron(III)-catalysed aza-Claisen rearrangement 
 
The Claisen rearrangement using a boron(III)-catalyst was first reported by Schmid and co-
workers in 1973.19 They reported that BCl3 can catalyse the rearrangement of allyl aryl 
ethers 14 at low temperatures in good yields to the corresponding o- and p-allyl phenols 
15, which serve as precursors to a variety of natural products (Scheme 8). The reaction rate 
was increased significantly (1010 faster relative to thermal Claisen rearrangement), due to 
charge induction by the boron(III)-catalyst. 
 
O
BCll3
OH
90%
14 15  
Scheme 8- The first B(III)-catalysed Claisen rearrangement 
Recently, Majumdar and co-workers have developed an efficient synthetic strategy for the 
synthesis of the dibenzoazocine system 18.20 Majumdar synthesised N-allylaniline 16 
which could be subjected to an aromatic aza-Claisen rearrangement using a BF3 complex 
to afford the rearranged product 17. Compound 17 could then be utilised for an 
intramolecular Heck reaction to synthesise the dibenzoazocine derivative 18 (Scheme 9). 
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Previous studies supported these results, suggesting that the presence of an additional alkyl 
group in the para position, significantly increases the rate of the aromatic aza-Claisen 
rearrangement.21 They attempted to optimise the rearrangement process by increasing the 
reaction time and using different high boiling solvents but unfortunately these attempts 
were unsuccessful, giving undesired by-product. They also attempted to subject the tosyl-
protected substrate 19 to boron(III)- rearrangement, however no product was formed. 
H
N NH2
xxylleennee,, 7 h
65%
16 17 18
N
Tss
BF3..Ett2O
N
19
Tss
NH
20
Tss
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xx
 ∆∆
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Scheme 9- Synthesis of dibenzoazocine 18 via an aza-Claisen rearrangement 
A systematic study of the reaction was undertaken by Rzepa and co-workers to define 
optimum conditions.22 The results of this study led to higher conversions during the 
rearrangement process with a minimum loss of optical purity. Further advantages obtained 
from this study allowed the reaction to be performed at room temperature or lower (in 
direct contrast to purely thermal conditions which required high temperature of 450-470 
oC).23 In this approach, the phthaloyl derivative 21 was subjected to rearrangement using 
BF3 as the catalyst to give the corresponding 2-prenyl derivative 22 (Scheme 10).22 
Conversion of 22 in four further steps successfully gave the 2,3-disubstituted indolic 
alkaloid, tryprostatin B 23. 
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Scheme 10- Rzepa’s synthesis of tryprostatin B 
 
1.1.1.2.3 Gold-catalysed Overman rearrangement  
 
Recent reports have highlighted the use of gold(I) and gold(III)-complexes as efficient 
homogeneous catalysts in several organic transformations. These catalysts have been 
successfully applied to a series of [3,3]-sigmatropic rearrangements, such as the 
rearrangement of allenyl carbinol esters to 1,3-butadien-2-ol esters,24 and isomerisation of 
allylic acetates.25,26 However, the reactions methods were rather limited in scope, being 
successful for only a few substrates and in poor to moderate yields.12,27,28 
In 2006, Jamieson and Sutherland reported the first gold(III)-catalysis for the Overman 
rearrangement.29 In this approach, the gold(III)-catalyst was successfully employed with 
reasonable yield and selectivity using an MOM-ether directed Overman rearrangement of 
an allylic trichloroacetimidate 24 to afford the corresponding allylic trichloroacetamides 25 
and 26 (Scheme 11). 
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Scheme 11- First gold(III)-satalysis Overman rearrangement  
Previously, Istrate and Gagosz reported that the air-stable crystalline Ph3PAuNTf2 catalyst 
can be used successfully for the formation of C-C and C-O bonds.30 After this successful 
approach, their attention turned to developing a new gold(I)-catalysed rearrangement as the 
key step in the synthesis of a series of pyrroles by an initial intramolecular cyclisation of a 
substitiuted nitrogen. Pentenyl allyl tosylamide 27 was treated with Ph3PAuNTf2 under 
mild conditions and rapidly gave the expected pyrrole derivative 28 in excellent yield 
(Scheme 12).  
Ph3PAuuNTff2 (1 mooll%)
NH
Tss
N
Tss
DCM, rrtt, 5 miinn
97%
277 28  
 
Scheme 12- Au(I)-catalysed cyclisation pentenyl tosylamide 
 
Surprisingly, they have shown that allyl tosylamide 29 reacts more slowly under the same 
reaction conditions to give the rearranged pyrrole 30 in a moderate yield (Scheme 13).30 
However, when the catalyst concentration was increased and the more electrophilic (p-
F3CC6H4)3PAuNTf2 was employed, complete conversion to 30 with improved yield (80–94 
%) was achieved. 
 
Caattaallysstt
TssN N
Tss
DCM, rrtt
1 mooll% PhPAuuNTff2 == 62%
2 mooll% PhPAuuNTff2 == 80%
                 2 mooll% (p--F3CC6H4)3PAuuNTff2 == 94%
29 30
 
Scheme 13- Optimisation of the catalytic system 
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The proposed mechanism for the rearrangement of pyrrole 30 is shown in scheme 14 
 
TssN NAuuL
TssN
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Scheme 14- Rearrangement of Pyrrole  
 
Recent work by Xing and Yang has demonstrated that a gold(I)-catalyst can be employed 
for the Overman rearrangement of allylic trichloroacetimidates to allylic 
trichloroacetamides (Scheme 15).31 A number of gold(I)-catalysts in H2O were examined 
and it was discovered that optimum results were achieved when allylic trichloroactimidate 
31 was converted to the corresponding allylic trichloroacetamide 32 using AuCl. 
 
 
AuuCll (5 mmooll%)
H2O, 55 
ooC 
96%
31
O NH
CCll3
O NH
CCll3
32
 
Scheme 15- Au(I)-catalysed Overman rearrangement in H2O 
 
 
1.1.1.2.4 Palladium(II)-catalysed Overman rearrangement 
 
Palladium catalysis was first recognized by Winstein and co-workers,32 who reported that 
the palladium acetate in acetic acid was found to be considerably more efficient than 
mercury acetate in the oxidation of alkenes. Subsequently, extensive studies by Henry in 
this area demonstrated that the involvement of two equivalents of a palladium catalyst 
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allowed the oxidation of alkenes to proceed with and without exchange of the ester acyl 
group with acetic acid.33-36   
 
Palladium(II)-salts soon emerged as the most useful and effective metal catalysts for [3,3]-
sigmatropic rearrangements. This is because palladium(II) can equilibrate with the 
substrates such as allylic esters quickly at room temperature with low catalyst loading and 
in high yield, often with an increase in stereoselectivity and a decrease in the formation of 
by-products.16,37 The palladium(II)-catalysed rearrangement proceeds through a cyclisation 
induced mechanism via a stepwise pathway as shown in Scheme 16. This pathway 
involves the initial complex formation of the coordinated olefin 35 through intermolecular 
aminopalladation of the double bond (oxidative addition).10,16,17,38 Cyclisation of π-
complex 35 provides alkylpalladium intermediate 36 which, through reductive elimination, 
affords the amide product 33 and regenerates the catalyst. The driving force of this reaction 
is the irreversible amide formation, which is similar to the thermal rearrangement.  
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Scheme 16- Mechanism of Pd(II)-catalysed Overman rearrangement 
Metz and co-workers reported that a wide variety of Pd(II)-catalysts such as 
PdCl2(CH3CN)2 and PdCl2(PhCN)2 can be employed for the catalysis of the Overman 
rearrangement.18 These catalysts were found to promote the reaction with excellent yields 
of amide 38 in a few hours at room temperature as shown in Scheme 17. Unfortunately, 
whilst allylic trifluoroacetimidates were more stable than allylic trichloroacetimidates, they 
were considerably less reactive. This is due to the electron-withdrawing substituents on the 
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imidate carbon.39 In addition, the removal of the trichloroacetamide group requires harsh 
conditions and is difficult in the presence of a variety of functional groups. Whereas 
trifluoroacetamides are considered as one of the most easily cleaved amides. 
PdCll2(PhCN)2 (5 mooll%)
37
O NHNHO
CX3 CX3
THF, rrtt, 62--71%
X == Cll, F 38  
     Scheme 17- Pd(II)-catalysed rearrangement of allylic trifluoro- and trichloroacetimidates 
 
1.1.1.3 Asymmetric Overman rearrangement 
After success with Pd(II)-catalysis for allylic trichloroacetimidate rearrangements, 
Overman and Zipp focused on the research of an asymmetric variant employing a variety 
of chiral metal catalysts. They demonstrated that substrates such as secondary N-benzoyl 
benzimidates were not suitable substrates for asymmetric catalysis in cationic Pd(II)-
complexes with structure similar to 41.40 Many attempts to carry out these transformations 
were unsuccessful, giving low enantioselectivities. In addition to this, the strong 
complexation of the small, basic acetimidate nitrogen to the hard palladium centre, 
promotes competing elimination reactions and slows reaction rates.41 Consequently, new 
asymmetric Pd(II)-catalysts for the rearrangement of less strongly coordinating N-
arylimidates 39 to allylic amides 40 was successfully achieved (Scheme 18). High 
enantioselectivities was achieved with this type of substrate.42 
 
Scheme 18- Overman rearrangement using chiral catalyst 
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1.1.1.3.1 Palladium Diamine Complexes 
Initially, Overman reported the asymmetric catalysis of the rearrangement of allylic 
imidates to allylic amides using a series of cationic Pd(II)-diamine and Pd(II)-bisoxazoline 
complexes.43 The palladium diamine di-cation 44 was shown to be the first enantioselective 
catalyst proven to be more efficient than other palladium diamine complexes for this 
process. This catalyst and other cationic diamine palladium complexes were easily 
synthesised from L-proline. They were then employed in the asymmetric Overman 
rearrangement of various benzimidate substrates, e g. 42, to the corresponding amides such 
as 43, in good yield and modest enantioselectivity (Scheme 19). Unfortunately, these 
cationic palladium diamine catalysts were markedly deficient in terms of reaction rate and 
yield.  
Scheme 19- First cationic chiral catalyst for the Overman rearrangement 
Recently, Slaughter and co-workers showed that the palladium complex 47 activated with 
AgBArF4 45 can catalyse the Overman rearrangement of allylic benzimidate 42 to allylic 
amide 46, creating a new chiral centre (Scheme 20).44 Their study showed that bis(acyclic 
diaminocarbene) ligands with seven-membered chelates could support electrophilic 
reactivity at the Pd centre. Unfortunately, these ligands were limited in scope for Pd 
catalysis, due to the stringent stereoelectronic demands of the reaction.  
 Scheme 20- Asymmetric rearrangement of benzimidate using chiral Pd(II)-catalyst 
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The treatment of these cationic catalysts with other imidate substrates such as 48 which 
contain  CCl3 or CF3 groups, led to the formation of significant quantities of an undesired 
1,3-rearranged product 49 (Scheme 21).10 
OHN [11,,3] NHO
X== CF3,, CCll3
449
X
R
X
R
48
 
Scheme 21- Formation of an anti-Claisen product 
1.1.1.3.2 Cobalt Oxazoline Palladocycle (COP-Cl) Catalysts  
The cobalt oxazoline palladacycles (COP-Cl) 50 and 51 are described as one of the most 
important asymmetric catalysts for the rearrangement of allylic imidates to allylic amides 
(Figure 1). These complexes can be synthesised as a single cyclopalladated 
diastereoisomer of (S) and (R)-configuration in high yield in four steps and have recently 
emerged as highly successful chiral catalysts,45 not only for the rearrangement of N-aryl 
allylic trifluoroacetimidates, but also for the rearrangement of allylic trichloroacetimidates 
without an N-aryl protecting group. This success is based on its planar chiral sandwich 
motif, which despite its multistep synthesis has found many applications in this area of 
chemistry.46  
 
Figure 1- Cobalt oxazoline palladocycle catalysts 
Initially, (S)-COP-Cl 50 was used as a chiral catalyst for the enantioselective Overman 
rearrangement of the allylic imidate activated by AgOCOCF3 (Scheme 22).47 High 
enantioselectivities and excellent yields of benzamides 53 were obtained using Z-
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benzimidates 52 as starting materials. The corresponding E-imidates were also 
investigated, but were found to give only moderate yields. 
N O N O
Ph
R
Ph 50 (5 mmooll%)
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52 53  
Scheme 22- Activated (S)-COP-Cl rearrangement of Z-benzimidates 
In contrast to the above results reported by Kang and co-workers,47 the groups of Overman 
and Richards reported their approach for transforming prochiral allylic alcohols to allylic 
amines using E-allylic trifluoroacetimidates 54 to provide the corresponding (S)-allylic 
trifluoroacetamides 55 using (S)-COP-Cl 50 (Scheme 23).48 Interestingly, they also 
reported that (S)-COP-Cl did not require activation with silver salts. 
N O
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Scheme 23- Non-activated (S)-COP-Cl rearrangement of E-allylic imidates 
Another improvement to this approach was reported by Anderson and Overman.49 They 
found that (S)-COP-Cl 50 could catalyse the rearrangement of E-allylic 
trichloroacetimidates 56, to the allylic trichloroacetamides 57 in high yield and 
enantioselectivity (80-99% yield, 92-98% ee) (Table 1). (Z)-Allylic trichloroacetimidates 
were not found to undergo (S)-COP-Cl 50 catalysed rearrangement at a practical rate. It 
was also found that allylic trichloroacetamides of opposite absolute configuration can be 
prepared using (R)-COP-Cl 51.50 Unfortunately, this method was limited to the 
rearrangement of allylic trichloroacetimidates containing (E)-1,2-disubstituted double 
bonds whilst analogous Z-configured substrates rearrange slowly under COP-Cl catalysis. 
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Table 1- Highly enantioselective rearrangement using (S)-COP-Cl 
Although (S)-COP-Cl 50 is an excellent catalyst for these asymmetric rearrangements, its 
use was rather limited due its poor solubility in many solvents. As a consequence of this, 
Overman and co-workers have synthesised a variety of monomeric palladacycle complexes 
such as COP-hfacac 60 and COP-acac 61 to catalyse the asymmetric rearrangement 
(Scheme 24).6 These catalysts showed excellent solubility in a wide variety of solvents. 
This enhancement of solubility allowed the rearrangements to be carried out at high 
substrate concentrations and this allowed catalyst loading to be reduced to 1 mol%.    
 
Scheme 24- Highly enantioselective rearrangement of E-imidate using COP-hfacac 
1.1.1.4 Directed Overman rearrangement    
The Overman rearrangement has recently emerged as a highly successful method for 
diastereoselective synthesis. This is achieved using a directing effect of a side-chain 
functional group with a metal catalyst. A wide number of easily accessible substrates have 
a stereogenic centre close to the rearrangement site which can coordinate to the catalyst, 
resulting in a diastereoselective reaction.  
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Initially, Bellûs and Ernst reported a directed Overman rearrangement, for a stereoselective 
synthesis of 1,2-diamines starting from the corresponding chiral Boc protected allylic 
alcohol 62, which can be synthesised from α-amino acids.51 The rearranged product 65 was 
successfully synthesised in excellent diastereoselectivity utilising coordination of a 
nitrogen directing group of allylic trichloroacetimidate 63 to the palladium(II)-metal centre 
(Scheme 25). The Boc protected nitrogen directs the catalyst to the back face of the alkene 
via a chair-like transition state 64.  
OH
NHBoocc
O
NHBoocc
HN
CCll3
O
NHBoocc
HN
CCll3
Cll3CCN
NaaH
96%
48%, >>99% d..ee..
62 63
64
HN
O
N
H Boocc
Cll3C
[Pd]
H
65
--Pd(IIII)
Pd(IIII)
 
 
                                Scheme 25- The first ether-substrate directed Overman rearrangement  
Recent work by Jamieson and Sutherland has demonstrated that allylic 
trichloroacetimidates 66 can be prepared with a number of different ether groups.52 They 
discovered that the bulky, sterically hindered ether groups such as TBDMS, Tr and Bn, 
prevented efficient coordination to the palladium giving allylic trichloroacetamides 67 and 
68 in low diastereoselectivity (Table 2). However, when smaller groups such as 
methoxymethyl (MOM)-ether were employed it was found that these groups were very 
effective at directing the facial coordination of the palladium(II)-catalyst. This allowed 
good yields and high diastereoselectivities.52,53 
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Table 2- Rearrangement of allylic trichloroacetimidates with various ether directing groups 
 
This enhancement of diastereoselectivity was due to the coordination of both oxygen atoms 
of the MOM group to the palladium catalyst (Scheme 26).53  
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Scheme 26- Coordination of both oxygen atoms to palladium 
More recently Sutherland and co-workers expanded this work by utilising a variety of 
different metal catalysts for the ether-directed Overman rearrangement (Table 3).29 Their 
results showed that the diastereoselectivity of allylic trichloroacetamide products 25 and 26 
was highest if PdCl2(MeCN)2, PdCl2(PhCN)2, PCl2, PdBr2 or Pd(OAc)2 were used as 
catalysts in THF. The best results were achieved when the reaction was performed using 
the PdCl2(MeCN)2 catalyst. However, no rearrangement was observed when other metal 
catalysts such as PdI2, salts of Ni(II), Ru(II) and Hg(II) were used. Rearranged products 25 
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and 26 were obtained by treatment of allylic trichloroacetimidate 24 with Pt(II) and Au(III) 
with no improvement in diastereoselectivity.  
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Table 3- Directed rearrangement of allylic trichloroacetimidate 24 using various catalysts 
Sutherland and co-workers have also reported that through using non-coordinating 
solvents, the competition with the MOM-ether group for the coordination of the Pd(II)-
catalyst is decreased, thus allowing an increased directing effect of the MOM-ether.29 A 
number of different solvents were tested and it was discovered that toluene was the most 
efficient solvent for this rearrangement (up to 15 : 1 dr) (Table 4). This theory was proven 
when the highly coordinating ionic solvent 1-butyl-3-methylimidazolium tetrafluoroborate 
was used as a solvent, resulting in a decreased diastereoselectivity (5 : 1 dr).  
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        Table 4- The effect of various solvents upon the directing effect of the MOM group 
More recently, in a similar study of metal catalysts for the ether-directed Overman 
rearrangement, Jaunzeme and Jirgensons found that the diastereoselectivity of δ-methoxy 
and δ-TBDMSO substituted allylic trichloroacetamides 70 and 71 could be enhanced if 
PtCl2 was used as a catalyst (Table 5).28 Their results also showed that oxazoline 72 was 
formed due to a significant side reaction which reduced the yield of the reaction. 
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Table 5- Diastereoselective rearrangement of δ-methoxy and δ-TBDMSO-imidates 
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1.1.1.5 Applications of the Overman Rearrangement  
1.1.1.5.1 Applications in Amino Acid Synthesis 
Overman rearrangements have found widespread applications in the syntheses of amino 
acids. Mehmandoust and co-workers have utilised PdCl2(PhCN)2 to catalyse the 
rearrangement of allylic trichloroacetimidate 74 to the corresponding allylic amide 75 with 
successful control of the transfer of chirality from allylic imidate 74 to the new C-N bond 
(Scheme 27).54 Cyclisation followed by Boc protection of the resulting amido alcohol 75 
gave oxazolidinone 76. This was followed by a CsCO3 hydrolysis and oxidation to give the 
desired optically active amino acids 77. 
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Scheme 27- Synthesis of α,β-unsaturated amino acids using the Overman rearrangement 
Recently, Swift and Sutherland have employed the highly diastereoselective Overman 
rearrangement process for the synthesis of the dihydroxylated α-amino acid 81.55 Their 
approach begun with the commercially available acetonide protected α,β-unsaturated ester 
78 which was converted in two steps to allylic trichloroacetimidate 79 (Scheme 28). The 
Overman rearrangement was then carried out using (S)-COP-Cl 50 as catalyst to form the 
rearranged products 80a and 80b. Oxidation of the threo-allylic trichloroacetamide 80b 
using a protocol reported by Sharpless56 was followed by deprotection of the amine and 
dihydroxy groups then to give the amino acid 81. 
  
31 
  
O
O
CO2Ett
778
O
O
OHN
CCll380aa
HO CO2H
OH
NH2
81
1.. RuuCll3..xxH2O,,
    NaaIIO4, CCll4, 
   MeeCN,, H2O
2.. 6M HCll,, 
47%
 ∆∆
O
O
OHN
CCll3779
DCM,, 38 ooC
81%
(S)--COP--Cll 50
O
O
OHN
CCll380b
++
1
 ::
52
 
Scheme 28- Dihydroxylated α-amino acid synthesis by Sutherland and co-workers 
This paper also demonstrated that the directed Overman rearrangement can be used for the 
synthesis of the natural butyric amino acid 85 (Scheme 29). It was proposed that the 
acetonide protecting group of compound 78 should be replaced with a more stable 
protecting group such as TBDPS. Cleavage of the acetonide protecting group under 
standard conditions, allows the opposite 2R-stereocentre of the butyric acid isomer 85 to be 
selectively synthesised. Their results showed that PdCl2(MeCN)2 was the most efficient 
metal catalyst for the Overman rearrangement of allylic trichloroacetimidate 82. 
Unfortunately, the diastereoselectivity of this reaction was disappointing in a 1 : 4 ratio, 
this is due to the presence of the bulky TBDPS group attached at the primary alcohol. This 
group prevents the effective coordination of both MOM-ether oxygen atoms to the metal 
catalyst. In a similar synthetic route to that used for the synthesis of substrate 81, the 
desired amino acid 85 was achieved from allylic acetamide 83. 
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Scheme 29- Synthesis of butyric amino acid using a substrate directed rearrangement  
1.1.1.5.2 Applications in Natural Product Synthesis 
Kurth and Soares have utilized N-allyl ketene N,O-acetals as chiral auxiliaries of the aza-
Claisen rearrangement.57 These auxiliaries provide absolute stereocontrol of the (S)-
configuration at C-1 for the synthesis of the natural product, (+)-dihydropellescensin-2 91. 
The total synthesis of compound 91 was achieved from the simple starting material 2-
methylcyclohexanone (86) (Scheme 30), which was converted in several steps to N-
allylketene N,O-acetal 87. Thermal aza-Claisen rearrangement was then carried out in 
decalin to give 88 in moderate yield as the major product. A two step N-methylation 
followed by base-catalysed hydrolysis led to formation of cyclohexaneacetic acid 89. After 
the successful synthesis of 89, attention was focused on introducing the furan ring. 
Reduction of 89 gave the corresponding alcohol which was readily converted to iodide 90. 
Finally, spontaneous coupling with 3-lithiofuran gave the target compound 91.  
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Scheme 30- Kurth synthesis of (+)-dihydropellescensin-2 
The thermal Overman rearrangement has been utilised for the synthesis of many different 
drug molecules including those with antitumor and antimetabolite properties. In addition to 
this, the natural products (±)-acivicin 99 and (±)-bromo-acivicin 97 have also been 
synthesised. An early synthesis of these natural products was reported by Vyas and co-
workers in 1984.58 The allylic trichloroacetamide 94 was synthesised over two steps from 
the commercially available diol 92, which was subsequently converted to a 3 : 2 mixture of 
cycloadducts 95 and 96 respectively (Scheme 31). The threo isomer 95 was then subjected 
to Jones oxidation followed by removal of the trichloroacetyl group to give the natural 
product (±)-bromo-acivicin 97. Substitution of bromine with chlorine in compound 95 
gave chloro-alcohol 98. Once again Jones oxidation followed by removal of the 
trichloroacetyl group gave the other natural product (±)-acivicin 99. 
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Scheme 31- Synthesis of (±)-acivicin and (±)-bromo-acivicin  
1.1.1.5.3 Applications in Alkaloid Synthesis 
The Overman rearrangement has also found wide application in the synthesis of alkaloids. 
Jamieson and Sutherland utilised the MOM-ether directed, palladium-catalysed Overman 
rearrangement as the key step for the synthesis of the alkaloid, (+)-α-conhydrine 106 and 
its pyrrolidine analogue 107 (Scheme 32).59 In this approach, the allylic 
trichloroacetimidate 100 was converted to the corresponding allylic trichloroacetamide 101 
in a highly efficient diastereoselective rearrangement. The erythro-allylic amide 101 was 
converted to dienes 102 and 103 in a few steps, followed by ring closing metathesis to give 
heterocycles 104 and 105 in excellent yield. These were then further functionalised to 
complete the synthesis of (+)-α-conhydrine 106 and its pyrrolidine analogue 107. 
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Scheme 32- Synthesis of (+)-α-conhydrine using a directed Overman rearrangement 
1.1.1.6 Conclusions to the Overman rearrangement 
The Overman rearrangement is one of the most important transformations in organic 
synthesis and has stimulated the interest of many organic chemists. This process can be 
carried out either thermally or catalytically using complexes of soft metal salts such as 
Hg(II), Pd(II), B(III), Au(I) and Pt(II) at low temperature. It has been widely used for the 
synthesis of nitrogen-containing compounds, especially for amino acids, amino sugars, and 
other complex natural products. Efforts have also focused on developing an asymmetric 
Pd(II)-catalysed Overman rearrangement using chiral palladium catalysts such as COP-Cl 
catalyst. Alternatively, the MOM-ether directed Overman rearrangement has been 
extensively employed utilising non-coordinating solvents to enhance the 
diastereoselectivity of the reaction.  
The first part of the research in this thesis will detail efforts to utilise the palladium-
catalysed Overman rearrangement for the attempted production of carbocyclic nucleosides 
and the total synthesis of (+)-physoperuvine. The ether-directed Overman rearrangement 
will be described for the highly efficient synthesis of (+)-monanchorin as well as 
clavaminol A, C and H.  
 
  
36 
1.2 Olefin Metathesis 
Olefin metathesis has become one of the most important C=C bond forming methodologies 
and has now found extensive use in organic synthesis and polymer sciences. Although the 
origin of the word metathesis comes from the Greek “metathesis” which means change of 
position or transposition, it was first used to describe this reaction by Calderon in 1967.60 
In mid-1950’s, Eleuterio and co-workers reported the first catalysed metathesis reactions.61 
They reported that the heating of propene with the molybdenum metal or its oxide led to 
ethylene and 2-butene formation. The main olefin metathesis reactions can be utilised in 
several closely related reaction types (Scheme 33).62-64  
nn
-- C2H4
-- C2H4
R1
R2
++ C2H4
CM
RCM
ROM
ROMP
++R1
R2
 
Scheme 33- Some of the most common types of olefin metathesis reactions 
 
1.2.1 Ring Closing Metathesis Reaction 
The ring closing metathesis (RCM) reaction is one of the most important among the olefin 
metathesis reactions, it is well known as a powerful and reliable methodology for the 
construction of carbocyclic and heterocyclic ring systems by the formation of new C=C 
bonds in an intramolecular process. In 1970, Chauvin suggested a basic catalytic cycle as 
the mechanism of this unusual C-C bond forming reaction.65 It was known as the ‘carbene 
mechanism’ which involved the fragmentation of the olefin via a series of alternating 
[2+2]-cycloadditions and cycloreversions. The driving force for this transformation is the 
release of the highly volatile gas ethylene (Scheme 34). Subsequent studies by Grubbs, 
Schrock and Chauvin have led to highly efficient ruthenium, molybdenum and tungsten 
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catalysts for the metathesis process, and this work was awarded the Nobel Prize for 
Chemistry in 2005.66 
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Scheme 34- Basic Chauvin mechanism for ring closing metathesis 
The first example of ring closing metathesis was reported by Tsuji,67 who synthesised 
several macrocycles similar to 109 from oleic acid and oleyl alcohol. The cyclisation was 
based on the ring closing metathesis reaction of substrate 108 using tungsten-based 
catalysts (Scheme 35). 
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Scheme 35- First ring closing metathesis by Tsuji  
The ring closing metathesis reaction can be utilised successfully in a tandem process with 
other transformations including Claisen rearrangements,68 aza-Michael reactions,69 
isomerisations,70 dehydrogenation-hydrogenation reactions,71 Diels-Alder reactions,72 
Kharasch additions73 and dihydroxylations.74 This versatility is due to the stability of 
ruthenium-based catalysts and their excellent tolerance towards many functional groups. 
Synthetically, the RCM reaction is considered versatile, easy to carry out and friend to 
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environment. It can be applied to a broader number of substrates under quite mild 
conditions, allowing the preparation of both small and large sized rings (from 5 up to 30 
membered ring) often in excellent yields.75-77 
1.2.1.1 Ring Closing Metathesis using Transition Metal Catalysts 
Transition metals are important in modern organic synthesis, often playing crucial roles in 
the total synthesis of many natural products.78 The first metal carbene catalyst was reported 
by Katz in 1976 who demonstrated that complex 110 could initiate the metathesis process 
albeit at a low rate with a variety of di- and tri-substituted cycloalkenes, with both E- and 
Z-2-pentenes (Figure 2).79-82 At the same time, Schrock and co-workers reported a study 
showing that high oxidation state metal alkylidene complexes successfully underwent 
olefin metathesis.83-85 Unfortunately, these catalysts are incompatible with a number of 
functional groups and are unstable to air and moisture. This was followed by work by 
Grubbs and co-workers who developed a number of ruthenium-carbene complexes such as 
Grubbs first-generation 111, Grubbs second-generation 112 and Grubbs third-generation 
113 catalysts (Figure 2).86-90 In contrast to other olefin metathesis catalysts, these 
complexes are more stable than tungsten and molybdenum complexes and can tolerate 
other functional groups in the alkene. They are also compatible with a large variety of 
solvents. Additionally, these commercially available catalysts can be prepared from a wide 
range of different alkyl- and aryldiazoalkane compounds. Extensive studies by Grubbs 
have shown that Grubbs 1st generation 111 and Grubbs second-generation 112 catalysts 
can be utilised for the formation of cycloalkenes of almost any ring size ≥5, including 
medium sized and macrocyclic products.88,90 Furthermore, Grubbs second-generation 
catalyst 112 is a highly active catalyst for a wide variety of olefin cross-metathesis 
reactions,92 including those with sterically demanding and electron-deficient olefins.92-96 
In another significant contribution to the ruthenium-based metathesis field, the Hoveyda 
group synthesised isopropoxystyrene-coordinated catalyst 114 (Figure 2). This catalyst is 
thermally stable and can efficiently catalyse the RCM of dienes containing terminal olefins 
and enables the formation of various tri- and tetra-substituted olefins at low temperatures 
in high yields.97 They also showed that the heterocyclic ligand significantly enhances the 
catalytic activity, and the styrenyl ether allows the easy recovery of the ruthenium 
complex.           
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Figure 2- Common ruthenium carbene complexes used in the RCM reaction 
In 1992, Grubbs and Fu reported the first exploitation of a RCM reaction for the formation 
of five-membered unsaturated heterocycles and carbocycles 116 from dienes 115 using 
molybdenum 117 and ruthenium 118 carbene catalysts (Table 6).98-101 This study also 
showed the formation of six- and seven-membered  tri- and tetra-substitiuted cyclic olefins. 
 
Table 6- Synthesis of cycloalkenes using ring closing metathesis 
In a comprehensive kinetic study, Grubbs and Fujimura reported the first asymmetric ring 
closing metathesis reaction for the synthesis of disubstituted cyclopentenes of the type 121 
using the chiral molybdenum alkylidene catalyst 122 (Scheme 36).102 Results from this 
study showed that dienes which contain a trisubstituted olefin moiety such as 119 are the 
preferred substrates as they can slow the cyclisation step and also control the site of first 
  
40 
metathesis leading to a kinetic resolution. Additionally, the 6-membered ring can be also 
prepared; however the yield and selectivity were moderate.   
Scheme 36- The first example of asymmetric ring closing metathesis 
1.2.1.2 Applications of Ring Closing Metathesis Reactions             
Previous work by the Sutherland group reported a one-pot tandem Overman rearrangement 
and ring closing metathesis reaction for the synthesis of 5-, 6-, 7- and 8-membered cyclic 
allylic trichloroacetamides 128.103 In order to conduct such chemistry, a synthetic route to 
allylic alcohols 125 was required. The corresponding allylic alcohols were rapidly 
synthesised in two steps from the commercially available alcohols 123 (Scheme 37). The 
synthesis begins utilising a one-pot Swern oxidation and Horner-Wadsworth-Emmons 
reaction to give E-α,β-unsaturated esters 124. Subsequent reduction of these esters using 
DIBAL-H gave allylic alcohols 125 in excellent yield. 
1.. (COCll)2,, DMSO,, 
NEtt3
2.. DBU,, LiiCll,,
(EttO)2POCH2CO2Ett
DIIBAL--H
 (2..2 eeq)OH
CO2Ett
OH
123 124 125
nnnn nn
nn == 1, 82%
nn == 2,, 877%
nn == 3,, 100%
nn == 4, 90%  
Scheme 37- Synthesis of E-allylic alcohols 
The allylic alcohols 125 were then converted to the desired allylic trichloroacetimidate 
substrates 126, using trichloroacetonitrile and a catalytic amount of DBU (Scheme 38). 
Allylic trichloroacetamidates 126 were then subjected to a one-pot tandem process 
involving an Overman rearrangement with bis(acetonitrile)palladium(II) chloride catalysis 
to give allylic trichloroacetamides 127. This was followed by a ring closing metathesis 
reaction using Grubbs 1st generation catalyst 111.  This provided the desired cyclic allylic 
trichloroacetamides 128 in good to excellent yields.  
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Scheme 38- Synthesis of 5-, 6-, 7- and 8-membered rings using a tandem process (aGrubbs 2nd 
generation catalyst 112 was used for the RCM step) 
Hoveyda and co-workers have reported the use of the catalytic ring closing metathesis 
reaction as a crucial part of the enantioselective synthesis of fluvirucin, Sch38516 134, a 
natural product that has potent biological activity against the influenza A virus and also 
possesses antifungal activity.104 The synthesis includes a convergent asymmetric synthesis 
of acid 129 and amine 130 which were synthesised from commercially available 
dihydrofuran and 3-methyl-3-buten-1-ol, respectively over several steps (Scheme 39). 
Fragments 129 and 130 were coupled and this was followed by a diastereoselective 
glycosylation with perfluoroglycoside 131 to give compound 132. Compound 132 was 
then subjected to ring closing metathesis using Schrock catalyst 117 to generate the 
macrocycle 133 in high yield. The stereocontrolled hydrogenation of 133 was followed by 
the removal of the acetate and trifluoroacetate groups and completed the synthesis of 
fluvirucin B1 134 in high yield.  
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Scheme 39- Synthesis of fluvirucin via a RCM reaction 
 
Recently Donohoe and co-workers have utilised double ring closing metathesis reactions 
for the synthesis of the natural product, (–)-(Z)-deoxypukalide 139.105 (–)-(Z)-
Deoxypukalide 139 belongs to a family of marine natural products which have exhibited a 
wide range of biological activities including neurotoxicity, anti-inflammatory effects and 
anti-feedant properties. The synthesis started with the commercially available (S)-perillyl 
alcohol 135 which was converted to the mixed acetal 136 in four steps (Scheme 40). The 
first ring closing metathesis was performed on compound 136 to give 137 which was then 
subjected to several transformations to form lactone 138. Lactone 138 was then subjected 
to the second ring closing metathesis to complete the synthesis of the target compound 139 
in good yield. 
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Scheme 40- Synthesis of (–)-(Z)-deoxypukalide using a double RCM reaction 
1.2.2 Cross-metathesis Reaction 
The cross-metathesis reaction can also be described as the intermolecular coupling 
between two different olefins and can potentially yield three new types of alkene: one 
desired heterodimeric product 140 and two undesired homodimeric products 141 and 142 
(Scheme 41). The cross-metathesis reaction has been described as a less important process 
than the ring closing metathesis reaction in the application of organic chemistry, this is 
because it is less effective and less selective.106 However, some cross-metathesis substrates 
(e.g. unsaturated boranes, stannanes and halides) are generally easier and less expensive to 
prepare than those associated with other common catalytic C-C bond forming reactions. 
This reaction can tolerate a wide variety of functional groups in very low catalyst loadings 
(1-5 mol%) under mild conditions in relatively short reaction times and also a high degree 
of chemo-, regio-, and stereoselectivity can be achieved. In addition to this, the olefinic 
products are suitable for further structural elaboration such as hydrogenation, epoxidation, 
halogenation and cycloaddition.  
R1 R2 R2R1 R1++ ++
R2 R1 R2
++
Caatt..
142140 141
                        
Scheme 41- Cross-metathesis and its potential by-products 
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An early report of this reaction was described by Crowe and co-workers,107 who reported 
that a highly selective cross-metathesis product 145 can be prepared using molybdenum 
catalyst 117 when π-substituted terminal alkenes such as acrylonitrile 143 were treated 
with an alkene which possesses a small, electron rich and non-conjugated substituent such 
as 144 (Scheme 42). The use of this olefin partner confers an additional advantage; it is the 
least expensive reagent conceivable for the introduction of a nitrile functionality into 
organic molecules. 
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Scheme 42- Selective cross-metathesis by Crowe 
Further studies reported by Grubbs and co-workers suggested a new methodology for 
selective cross-metathesis.108 In a two step procedure, various desired cross-metathesis 
products 149 were synthesised with minimal amounts of competing dimerisation (self-
metathesis) products. Firstly homodimerisation of a terminal olefin 146 in a cross-
metathesis reaction using Grubbs 1st generation catalyst 111 provided mostly trans (4:1) 
disubstituted olefins 147 in high yields (Scheme 43). Homodimers 147 were subsequently 
treated in excess with a second terminal olefin 148 to give cross coupled products 149 in 
good yields. 
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Scheme 43- Two-step selective cross-metathesis 
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1.2.2.1 Applications of Cross-metathesis Reactions 
Recently, cross-metathesis reactions have been effective in the synthesis of natural 
products and fragrance compounds.109 
In 2004, Basu and Rai utilised the cross-metathesis reaction as the key step for the 
synthesis of the natural product, D-erythro-ceramide 155.110 D-erythro-Ceramide 155 was 
found to be a crucial component of lipid rafts and influences cell signalling events at the 
membrane. It also participates in a variety of activities in the cellular life cell, including 
growth, differentiation and even programmed death.111 The synthesis started from 
commercially available (–)-D-tartrate 150 which underwent nine transformations to give 
the building block 151 (Scheme 44). Compound 151 was reduced to the corresponding 
amine and protected as the Fmoc carbamate 152. E-Selective cross-metathesis of 152 with 
pentadecene was then achieved in high yield using Grubbs 2nd generation catalyst 112 to 
give coupled product 153. Removal of the Fmoc group, followed by acylation`gave the 
fully protected ceramide 154. Finally removal of the PMB and TBDMS groups gave the 
desired natural product, D-erythro-ceramide 155.             
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Scheme 44- Synthesis of D-erythro-ceramide via a cross-metathesis reaction 
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More recently, Sutherland and Drummond utilised a ruthenium catalysed cross-metathesis 
reaction as one of the key steps in the synthesis of optically active α-amino acids.112 These 
α-amino acids were found to be important structural building blocks for a variety of 
biological applications. The well selected starting material, hydrocinnamic acid 156 was 
converted to the morpholine amide 157 which was treated with vinylmagnesium bromide 
to give the first cross-metathesis partner 158 (Scheme 45). Vinyl ketone 158 was then 
subjected to a cross-metathesis reaction using a series of terminal alkenes to introduce the 
cross coupled compounds 159. E-Alkenes 159 were then successfully converted to the 
desired α-amino acids 160 and (2S,4S)-γ-hydroxynorvaline 161 in several steps.  
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Scheme 45- Synthesis of α-amino acids using a cross-metathesis reaction 
Further utilisation of the cross-metathesis reaction was reported by Hoveyda and co-
workers in 2011.113 They synthesised an anti-oxidant plasmalogen phospholipid, C18 
(plasm)-16:0 (PC) 166 which is found in electrically active tissues and is implicated in 
Alzheimer’s disease. As shown in Scheme 46, the highly stereoselective product 165 was 
easily achieved by the cross-metathesis reaction of enol ether 162 and commercially 
available 1-octadecene (163) using catalyst 164. Stereoisomerically pure Z-165 was then 
subjected to several transformations to complete the synthesis of the target compound 166. 
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Scheme 46- Synthesis of plasmalogen phospholipid by Hoveyda and co-workers 
1.2.3 Conclusions to the Olefin Metathesis Reactions 
Olefin metathesis reactions such as ring closing metathesis and cross-metathesis are 
considered a fundamentally important class of reactions in chemical synthesis. These 
processes have emerged as powerful C-C bond forming reactions and are widely used in 
organic synthesis. Extensive efforts to improve the metal carbene catalysts has led to the 
development of Mo-carbene and Ru-carbene complexes. These in turn have led to new 
applications in these processes. The intramolecular ring closing metathesis reaction is the 
most commonly known reaction and can be achieved under mild conditions using Grubbs 
1st generation catalyst, providing an efficient synthetic method for making various ring 
sizes. Excellent results for the development of the intermolecular metathesis have also 
been achieved. 
The second part of the research programme described in this thesis will strive to utilise a 
ring closing metathesis reaction for the synthesis of carbocyclic nucleosides and the 
complete synthesis of (+)-physoperuvine. The RCM works in a highly efficient manner 
and in excellent yields using a tandem process for the synthesis of 5- and 7-membered 
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rings, as the key steps. This thesis will also describe the cross-metathesis reaction as the 
key step for the synthesis of (+)-monanchorin. 
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2.0 Results and Discussion 
2.1 (+)-Physoperuvine 
(+)-Physoperuvine 168 is a bicyclic, tropane alkaloid which was first isolated from the 
leaves and roots of the Indian plant Physalis peruviana Linne by Ray and co-workers in 
1976 (Scheme 47).114 Early chemical and spectroscopic investigations identified the 
structure as 3-(methylamino)cycloheptanone 167.114,115 Analysis using both CD and NMR 
spectroscopy and the development of a racemic synthesis showed that the monocyclic 
amino ketone 167 is in equilibrium with the bicyclic tautomer 168, and is known to exist 
almost entirely in this form.116,117 This natural product exhibits a variety of biological 
activities having antiviral, antifungal and antibacterial properties. 
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Scheme 47- Structure of (+)-physoperuvine   
 
2.1.1 Previous Syntheses of Physoperuvine 
An early synthesis of racemic (±)-physoperuvine 172 using an intramolecular cyclisation 
of the seven-membered ring 171 was reported by Lallemand and co-workers in 1992 
(Scheme 48).118 The synthesis began with the conversion of the commercially available 4-
aminocyclohexanol hydrochloride 169 to the corresponding cyclohexanone 170 followed 
by ring enlargement using diazomethane to give aminocycloheptanone 171. Finally 
removal of the benzyl protecting group under standard conditions yielded the desired 
product 172.  
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              Scheme 48- Synthesis of racemic physoperuvine 172 by Lallemand and co-workers 
Later in 1995, in a study expanding the scope of their Rh-BINAP asymmetrisation 
reaction, Ogasawara and Hiroya reported the first asymmetric synthesis of (–)-
physoperuvine 181.119 As shown in Scheme 49, diol 174 was prepared from starting 
material 173, which was subsequently silyl protected to give compound 175. The silyl enol 
ether 175 was subjected to a catalytic asymmetrisation reaction using Rh-(S)-BINAP-
cycloocta-1,5-diene (176) to give a mixture of the silyl enol ether 177 and the siloxy 
ketone 178 (4:1). Compound 177 was then treated with tetrabutylammonium fluoride to 
furnish the siloxy ketone 178 in high yield. Removal of the second silyl protecting group 
gave (R)-hydroxyl ketone 179, which was mesylated under standard conditions to give 
compound 180. Substitution of the mesyl group with methylamine formed (–)-
physoperuvine 181 in moderate yield. 
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Scheme 49- First asymmetric synthesis of (–)-physoperuvine 181 
2.1.2 Retrosynthetic Analysis of (+)-Physoperuvine 
The proposed retrosynthetic analysis of (+)-physoperuvine 168 is shown in Scheme 50.120 
It was envisaged that the synthesis of the tropane alkaloid 168 would require the synthesis 
of the cyclic allylic trichloroacetamide 183. It was thought that 183 could be obtained 
using a one-pot tandem Overman rearrangement and ring closing metathesis reaction of the 
allylic trichloroacetimidate 184. The allylic trichloroacetamidate 184 could be easily 
prepared from commercially available ethyl-6-heptenoate (186) using a one-pot Overman 
rearrangement and RCM reaction process. After the one-pot process, allylic oxidation of 
the cycloheptene ring would give ketone 182. Hydrogenation and deprotection of 182 
would then give (+)-physoperuvine 168.  
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Scheme 50- Retrosynthetic analysis of (+)-physoperuvine 168 
 
2.1.3 Synthesis of (±)-Physoperuvine 
2.1.3.1 Synthesis of (2E)-nona-2,8-dien-1-ol 185 
 
The first synthetic step in the synthesis of (2E)-nona-2,8-dien-1-ol (185) was a DIBAL-H 
reduction of the commercially available material, ethyl 6-heptenoate (186) (Scheme 51). 
Using reaction conditions reported by Sumitani and co-workers, the reaction was initially 
carried out using DIBAL-H (2.2 equivalents).121 1H NMR spectroscopic analysis of the 
reaction mixture after three hours showed that the reaction had reached completion and a 
94% yield of 6-hepten-1-ol (187) was obtained. Generation of the corresponding (E)-α,β-
unsaturated ester 188 was then achieved in 85% yield using a one-pot Swern oxidation, 
followed by a Horner-Wadsworth-Emmons (HWE) reaction using Masamune-Roush 
conditions.122,123 The Sutherland group had discovered previously that the Masamune-
Roush procedure for this one-pot process is the most efficient, giving exclusively the E-
alkene.123 
 
  
53 
OH
1. (COCl)2, 
DMSO
Et3N, DCM O
187
CO2Et
188
CO2Et
DIBAL-H
Et2O, 94%
186
2. DBU, LiCl, MeCN
(EtO)2POCH2CO2Et 
85%
                     
Scheme 51- Synthesis of (E)-α,β-unsaturated ester 188 
 
As all unsaturated esters synthesised previously by Sutherland group have consistently 
shown a coupling pattern with a coupling constant greater than 15.0 Hz in the 1H NMR 
spectrum. Thus, it was easy to identify the E-alkene geometry of product 188 (Figure 3). 
The hydrogen atoms of the alkene show a 15.6 Hz coupling constant proving that the 
geometry is trans. 
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Figure 3- alkene signals in the 1H NMR spectrum of compound 188 
The final stage of the synthesis of allylic alcohol 185 required for the tandem process, 
involved the reduction of (E)-α,β-unsaturated ester 188 using similar reaction conditions 
described as for the preparation of primary alcohol 187. This gave the corresponding 
allylic alcohol 185 in a quantitative yield (Scheme 52). 
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Scheme 52- Synthesis of the allylic alcohol required for tandem process 
 
2.1.3.2 Synthesis of racemic allylic trichloroacetamide 189 
 
Before carrying out the tandem process, the reaction conditions for the Overman 
rearrangement required development. Thus, the next step was the conversion of the allylic 
alcohol 185 to the desired allylic trichloroacetimidate 184 using trichloroacetonitrile and a 
catalytic amount of DBU (Scheme 53). The Overman rearrangement was performed by 
treating the imidate 184 with commercially available bis(acetonitrile)palladium(II) chloride 
at room temperature for three hours giving an 83% yield of allylic trichloroacetamide 189 
over two steps.       
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Scheme 53- Synthesis of allylic trichloroacetamide 189 
 
2.1.3.3 Synthesis of cyclic allylic trichloroacetamide 190  
 
With conditions for the first steps in the tandem process optimised, the one-pot process 
was attempted. The racemic cyclic allylic trichloroacetamide 190 was synthesised in 82% 
yield using the one-pot process by conversion of the allylic alcohol 185 to the allylic 
trichloroacetimidate 184 (Scheme 54). With the desired allylic trichloroacetimidate 184 in 
hand, this was subjected to bis(acetonitrile)palladium(II) chloride catalysis, which gave the 
rearranged allylic trichloroacetamide 189. This was then treated with Grubbs 1st generation 
catalyst 111 to effect the RCM reaction under dilute conditions (0.005 M). The reason for 
these dilute conditions is to prevent the formation of dimeric products by lowering the 
chance of an intermolecular process.124 The desired 7-membered allylic trichloroacetamide 
190 was successfully obtained in 82% yield over the three steps. Due to the lower cost and 
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greater availability of Grubbs 1st generation catalyst 111 as a RCM catalyst, it was decided 
to continue using this, even though other catalysts give slightly better yields.103 It was also 
proposed that the racemic cyclic allylic trichloroacetamide 190 be used for the 
development of the subsequent steps as it is significantly less costly to prepare than the 
optically active material. 
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Scheme 54- Synthesis of 7-membered cyclic allylic trichloroacetamide 190 
 
2.1.3.4 Completion of (±)-Physoperuvine 172 
 
The next stage of the synthesis of (±)-physoperuvine 172 required the introduction of the 
N-methyl group and the standard conditions of sodium hydride and methyl iodide was 
initially investigated.125 Many attempts to methylate 190 to obtain 192 were unsuccessful, 
and led to hydrolysis of the allylic trichloroacetamide functional group and recovery of the 
corresponding amine 191 in 58% yield (Scheme 55). It was decided that the trichloroacetyl 
group was unstable under these conditions. 
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Scheme 55- Attempt at methylation 
 
As methylation was not possible in the presence of the trichloroacetyl protecting group, a 
change of the protecting group was necessary at this stage. It was proposed that it should 
be replaced with an alternative protecting group, using a one-pot procedure.  
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The trichloroacetyl group of compound 190 was removed under hydrolytic conditions and 
the resulting amine was reprotected as the Boc-carbamate using Boc2O. This was 
accomplished in a one-pot process in quantitative yield (Scheme 56).59,125 This was 
followed by a successful methylation of compound 193 using sodium hydride and methyl 
iodide to form 194 in an 84% yield.  
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Scheme 56- Reprotection and introduction of the N-methyl group 
 
The last key step in the synthesis of (±)-physoperuvine 172 involved the allylic oxidation 
of the cycloheptene ring. Chidambaram and co-workers reported that there are relatively 
few general procedures, that have been used for the oxidation of cycloheptenes.126 Despite 
this, there are many procedures describing the efficient allylic and benzylic oxidation of 
organic compounds.127-132 An early paper by Sharpless described the problems associated 
with the allylic oxidation of cyclic alkenes with the classic oxidant, selenium dioxide.133 
There are often a number of side-products formed during this reaction which often result in 
low yields of the desired α,β-unsaturated ketone. The first attempt at allylic oxidation of 
194 utilised a manganese(III)-acetate catalysed procedure with t-BuOOH as the oxidant 
under an oxygen atmosphere (Scheme 57).129 This gave the α,β-unsaturated ketone 195 in 
only 22% yield, despite increasing the amounts of oxidant and a thorough reaction 
optimisation.  
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Scheme 57- Attemps at allylic oxidation using Mn(III) 
A second attempt at the allylic oxidation of 194 used Yu and Corey’s procedure which 
involved a palladium mediated oxidation with t-BuOOH as the oxidant under basic 
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conditions (Scheme 58).128 Initially a palladium hydroxide on carbon catalyst was 
employed giving the α,β-unsaturated ketone 195 in only a 16% yield. By switching the 
catalyst to palladium on carbon there was an improvement in the reaction outcome, giving 
a reasonable 45% yield of the desired α,β-unsaturated ketone. Subsequent hydrogenation 
of 195 under standard conditions then proceeded smoothly to give the saturated ketone 196 
in 66% yield. This was then followed by removal of the Boc-protecting group under acidic 
conditions which led directly to the synthesis of (±)-physoperuvine 172 in 60% yield.  
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Scheme 58- Synthesis of (±)-physoperuvine 
 
2.1.4 Synthesis of (+)-Physoperuvine 
 
With the synthesis of (±)-physoperuvine 172 completed successfully and in good yield, 
attention was turned to the synthesis of the natural product, (+)-physoperuvine 168. As 
mentioned previously, extensive studies by the Sutherland group have focused their efforts 
towards the development of an asymmetric tandem Overman rearrangement and RCM 
reaction.103 These studies involved the successful employment of both the (S)- and (R)-
COP-Cl catalysts 50 and 51 in the tandem process for the synthesis of six membered cyclic 
allylic amides with excellent yield and enantioselectivity (88% ee). As such, it was 
proposed that in a one-pot process, the (S)-enantiomer of the cyclic allylic 
trichloroacetamide 183 could be synthesised using an asymmetric one-pot tandem 
Overman rearrangement and RCM reaction of allylic trichloroactimidate 184 (Scheme 59), 
using commercially available (S)-COP-Cl 50 to catalyse the rearrangement and Grubbs 
first generation catalyst 111 to effect the RCM reaction. The enantioselectivities of the 
reactions were determined using chiral High Performance Liquid Chromatography (HPLC) 
which had been developed previously in the Sutherland group in a comparison of the 
reaction products with their corresponding racemic mixtures.103 Using (S)-COP-Cl 50 as 
part of the tandem process, gave 183 in 86% yield and 84% ee. The enantiomeric excess 
can be improved up to >99% by recrystallisation using a mixture of ethyl acetate and 
petroleum ether. Using the steps already developed for (±)-physoperuvine 172, the 
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synthesis of (+)-physoperuvine 168 was completed. The optical rotation and spectroscopic 
data of the synthetic material was in good agreement with those reported for the naturally 
derived (+)-physoperuvine.120  
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Scheme 59- Synthesis of (+)-physoperuvine 168 using the asymmetric tandem process 
 
2.1.5 Conclusions  
 
In a one-pot tandem process using a palladium-catalysed Overman rearrangement followed 
by a ruthenium-catalysed ring closing metathesis reaction, a 7-membered cyclic allylic 
trichloroacetamide was successfully synthesised in a highly efficient manner and excellent 
yield. This cyclic allylic trichloroacetamide could then be easily employed for the 
synthesis of the tropane alkaloid, (±)-physoperuvine. An asymmetric one-pot tandem 
process has also been employed for the synthesis of the 7-membered ring using 
commercially available (S)-COP-Cl catalyst to give the natural product, (+)-
physoperuvine. Initial problems with the introduction of the N-methyl group were easily 
overcome by using a one-pot procedure, involving removal of the trichloroacetyl group 
and reprotection of the resulting amine as a Boc-carbamate.  
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2.2 Carbocyclic Nucleosides 
 
Carbocyclic nucleosides have been the focus of recent attention in the development of new 
antitumor and antiviral therapeutic agents.134 The search for antiviral agents, particularly 
for the treatment of human immunodeficiency virus (HIV) and hepatitis B virus (HVB), 
resulted in the discovery of carbovir 201, which has been shown to possess significant in 
vitro activity as an inhibitor of HIV reverse transcriptase (Figure 4).135-137 More recently, a 
new reverse transcriptase inhibitor 1592 U89 202, which is currently in phase II clinical 
trials, has been discovered and is reported to hold remarkable promise for the treatment of 
HIV.138 Carbocyclic nucleosides in which the ribofuranose ring oxygen is replaced with a 
methylene moiety have been shown to have a range of biological activities such as 
antivirial, antitumour, antiparasitic, antiathritic and immunosuppressive properties.139 The 
nucleosides possess these properties as they have a similar shape to ribonucleosides, 
however, replacement of the oxygen atom with a methylene provides stability to allow 
inhibition of nucleoside-dependent enzymatic processes. Research into the development of 
more potent and less toxic analogues led to the generation of noraristeromycin 203. The 
identification of noraristeromycin as a potential therapeutic agent has generated much 
interest in this area and led to many syntheses of carbocyclic nucleosides and investigation 
into their medicinal chemistry.140 Recently, Cowart and co-workers reported the synthesis 
and biological activity of amino-analogues of noraristeromycin such as compound 204 
which are significantly more potent (200 times) at inhibiting enzymes such as adenosine 
kinase.141 
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Figure 4- Various derivatives of carbocyclic nucleosides  
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2.2.1 Retrosynthesis of Carbocyclic Nucleosides 
 
The proposed retrosynthesis of carbocyclic nucleosides 203 and 204 is shown in Scheme 
60.  Disconnection of the purine ring system 207 of both carbocyclic nucleosides 203 and 
204 would give allylic acetates 205 and 206 respectively which could be made from the 
corresponding cyclic allylic trichloroacetamides 208 and 209. Chiral amides 208 and 209 
could be prepared using a one-pot tandem Overman rearrangement and ring closing 
metathesis reaction of allylic acetimidate 210 which could be easily prepared from the 
commercially available 4-pentene-1-ol 211. 
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Scheme 60- Retrosynthetic analysis of carbocyclic nucleosides 203 and 204 
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2.2.2 Attempted Synthesis of Carbocyclic Nucleosides 
 
Using a similar approach for the synthesis of the 7-membered ring of physoperuvine, the 
synthesis of the 5-membered carbocyclic amide was conducted. Initially a one-pot tandem 
Overman rearrangement and ring closing metathesis reaction was employed for the rapid 
and efficient synthesis of the racemic cyclic allylic trichloroacetamide 215 (Scheme 61). 
Due to the less costly synthesis of the racemic cyclic allylic trichloroacetamide 215, it was 
proposed that it could be used for the development of the subsequent steps. The synthesis 
began with a straightforward conversion of 4-pentene-1-ol (211) to the corresponding α,β-
unsaturated ester 212 using a one-pot Swern oxidation and Horner-Wadsworth-Emmons 
reaction. Ester 212 was reduced using DIBAL-H to generate the allylic alcohol 213 
followed by reaction with trichloroacetonitrile and DBU to give the key allylic 
trichloroacetimidate substrate 210. The allylic imidate 210 was then treated with 
PdCl2(MeCN)2 to give allylic trichloroacetamide 214 followed by the addition of Grubbs I 
catalyst 111 to give the cyclic allylic trichloroacetamide 215 in 74% yield over the three 
steps. 
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Scheme 61- Synthesis of the racemic cyclic amide 215 
 
Having successfully synthesised the racemic cyclic allylic trichloroacetamide 215 in high 
yield, attention was then turned to the synthesis of the asymmetric analogue 208 required 
for the synthesis of noraristeromycin 203 (Scheme 62). This was achieved in a similar 
manner to the racemic reactions in good yield over the three steps and in high 
enantioselectivity using (R)-COP-Cl 51 to catalyse the Overman rearrangement. 
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Scheme 62- Asymmetric synthesis of cyclic allylic trichloroacetamide 208 
 
 
The next synthetic step of the synthesis was the allylic oxidation of the cyclic allylic 
trichloroacetamide 215. In an attempt to synthesise the key α,β-unsaturated ketone 217, a 
one-pot procedure using a tandem process with allylic oxidation as the final key step was 
initially investigated. Consequently, allylic alcohol 213 was converted to α,β-unsaturated 
ketone 217. However, a poor yield was obtained over the four steps (Scheme 63).  
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Scheme 63- A one-pot tandem process with allylic oxidation 
As the allylic oxidation could not be achieved in good yield using the one-pot procedure, it 
was decided to replace the trichloroacetyl group with a more stable protecting group. The 
cyclic allylic trichloroacetamide 208 was reprotected using the same conditions as 
described for 190 to give 218 in a quantitative yield (Scheme 64). Allylic oxidation was 
then carried out following the Yu and Corey procedure with an excess of t-BuOOH under 
basic conditions.128 Unfortunately, this gave the desired α,β-unsaturated ketone 219 in 
only 25% yield. 
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Scheme 64- Allylic oxidation using the Corey procedure  
Alternatively, it was also decided to attempt other allylic oxidation and hydroxylation on 
Boc-analogue 220 in the hope that these reactions might yield the ketone 221 or the allylic 
alcohol 222 in higher yields (Scheme 65). Straightforward conversion of racemic cyclic 
allylic trichloroacetamide 215 to the Boc-protected compound 220 which was then 
subjected to different reaction conditions following procedures developed firstly by 
Chandrasekaran using pyridinium chlorochromate (PCC) and secondly by Sharpless using 
the classic oxidant, selenium oxide with t-BuOOH, but neither yielded the desired products 
with full recovery of the starting material.133,142 
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Scheme 65- Attempts at allylic oxidation and hydroxylation of 220 
In a final attempt it was hoped that utilising several methodologies would provide α,β-
unsaturated ketone 221 in high yield (Scheme 66). Initially, a protocol described by Yeung 
and co-workers that reported the first solvent-assisted nonmetallic based generation of a 
reactive and controllable tert-butylperoxy radical was investigated.143 It was shown that 
this radical process could promote allylic oxidation of various olefinic substrates using 
commercially available diacetoxyiodobenzene and t-BuOOH in a σ-donor solvent such as 
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n-butyl butanoate. However, treatment of Boc-protected 220 with diacetoxyiodobenzene 
and t-BuOOH give compound 221 in only 15% yield. 
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Scheme 66- Attempts at allylic oxidation of 220 using Yeung’s procedure  
Unfortunately none of these procedures were successful and as a consequence of this, it 
was proposed to use an alternative synthetic strategy involving the stereoselective 
functionalisation of the alkene of cyclic allylic trichloroacetamide 215. It was hoped that a 
hydroxyl group could be introduced at C-2 and a leaving group at C-3 of the cyclopentane 
ring (Scheme 67). Treatment of cyclic allylic trichloroacetamide 215 with N-
iodosuccinimide gave 4-hydro-1,3-oxazole 223. Without purification, compound 223 was 
then treated with DBU and the resulting intermediate 224 was subjected to hydrolysis 
under acidic conditions. This allowed the isolation of the allylic alcohol 225 as the major 
product in 45% yield over the three steps. It was proposed that 225 could be subjected to 
an allylic acetate rearrangement for the synthesis of the carbonucleoside core (see future 
work). 
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Scheme 67- Synthesis of allylic alcohol 225 
2.2.3 Conclusions to the Carbocyclic Nucleosides 
 
In summary, the 5-membered cyclic allylic trichloroacetamide was successfully 
synthesised in a one-pot tandem process, using a palladium-catalysed Overman 
rearrangement followed by a ruthenium-catalysed ring closing metathesis reaction. This 
cyclic allylic trichloroacetamide was made in excellent yield and subjected to allylic 
oxidation using various methods, however efforts to optimise the reaction outcome were 
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unsuccessful. An asymmetric one-pot tandem process was also developed for the 
asymmetric synthesis of the 5-membered ring which was required for the synthesis of 
noraristeromycin and amino-carbocyclic nucleoside.  
2.2.4 Future Work 
Future work for this project includes the optimisation of the allylic oxidation of Boc-
protected 220. It is hoped that a protocol described by Trost and co-workers who 
synthesised glycosidase inhibitors, allosamizoline and mannostatin can be applied.144 The 
subsequent allylic oxidation of Boc-protected 220 using selenium dioxide followed by 
addition of Dess-Martin periodinane would then give the α,β-unsaturated ketone 221 
(Scheme 68). 
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Scheme 68- Trost’s allylic oxidation procedure 
 
After the allylic oxidation has been optimised the next stage of the synthesis of the amino-
carbocyclic nucleoside 229 will involve the reduction of the resulting ketone 221 under 
Luche conditions and will lead to the formation of the cis-amino alcohol 222 (Scheme 
69).145 The alcohol functional group will then be activated using acetic anhydride to give 
the allylic acetate 226. A common strategy for the introduction of nucleoside bases is the 
palladium-catalysed displacement of an allylic ester. Thus, treatment of the allylic acetate 
226 with 6-chloropurine 207 in the presence of Pd(0) will allow the direct introduction of 
the purine ring system with retention of relative stereochemistry.146,147 At this stage, 
dihydroxylation of 227 will be carried out using standard Upjohn conditions,148 which will 
give compound 228. Finally, deprotection of the amine will complete this short synthesis 
of analogue 229.  
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Scheme 69- Proposed synthesis of the carbocyclic nucleoside 229  
An alternative route shown in Scheme 70 could be used for the synthesis of 
noraristeromycin 233. This will include the conversion of the cyclic allylic 
trichloroacetamide 215 to the allylic alcohol 230 following the same steps described for the 
synthesis of allylic alcohol 225 (Scheme 70). Allylic acetate rearrangement followed by 
dihydroxylation of the alkene 231 using Upjohn conditions will furnish compound 232. 
Having introduced all functional groups onto the carbocyclic ring, a few additional steps 
will then complete the synthesis of noraristeromycin 233.  
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Scheme 70- Second proposed synthesis of the carbocyclic nucleoside 233 
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If the racemic carbocyclic nucleosides 229 and 233 can be prepared, the asymmetric 
synthesis of the carbocyclic nucleosides 203 and 204 will be attempted in the future. 
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2.3 (+)-Monanchorin 
 
(+)-Monanchorin 234 is a bicyclic alkaloid which was isolated by McKee and co-workers. 
In addition to this, the pentacyclic guanidine alkaloid crambescidin acid 236 was also 
isolated from the sponge Monanchora ungiculata in the Maldive Islands (Figure 5).149 (+)-
Monanchorin 234 is a weakly cytotoxic natural product that exhibits a variety of biological 
functions including antifungal, antiviral, antimicrobial, and Na+/K+ and Ca2+ ATPase 
inhibitory activities. The carbon skeleton was assigned on the basis of 2D NMR 
experiments, leading to two possible structures, 234 and 235 which differ in the connection 
of the guanidine to the carbon chain. More recently, Yu and Snider developed a synthetic 
route to (+)- and (–)-monanchorin and showed that the natural product is as shown for 
structure 234.150 
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Figure 5- Guanidine alkaloids isolated from the sponge monanchora ungiculata 
 
2.3.1 Previous Synthesis of (+)-Monanchorin 
 
In 2009, Snider and co-workers synthesised (–)-monanchorin 234 in an enantiospecific, six 
step synthesis from intermediate 237.150 As shown in Scheme 71, (4E)-decenal (237) was 
converted to the optically pure epoxy acetal 239 in two steps using Shi’s D-fructose 
derived ketone to induce asymmetry. A ring opening reaction of the epoxy acetal 239 
followed by hydrogenation of the resulting azides gave amine 240 as the minor component 
with other regioisomer 241 (3 : 5 ratio). Treatment of amine 240 with the activated 
guanidine unit then gave the protected guanidino alcohol 242. This was followed by 
removal of both Boc and acetal protecting groups to form the desired compound (–)-
monanchorin 234 in 21% overall yield. The synthesis was repeated using Shi’s L-fructose 
derived ketone for the asymmetric epoxidation step which eventually gave the naturally 
occurring (+)-monanchorin in similar overall yield. 
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Scheme 71- Snider’s synthesis of (–)-monanchorin 
2.3.2 Retrosynthetic Analysis of (+)-Monanchorin 
 
The proposed retrosynthetic analysis of (+)-monanchorin 234 is outlined in Scheme 72.151 
Ring opening of the guanidine alkaloid ring would lead back to guanidine analogue 243 
which could be made from E-alkene 244. Disconnection of the carbon backbone of 244 at 
the alkene linkage and removal of the Cbz-protecting group would lead to the allylic amide 
245 and 2-vinyl-1,3-dioxolane (246). The allylic amide 245 could be easily prepared using 
the ether-directed Overman rearrangement of allylic trichloroacetimidate 247. The imidate 
247 may be synthesised from primary alcohol 248 which could be made from 
commercially available (R)-glycidol 249 using a regioselective ring opening reaction. 
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 Scheme 72- Retrosynthetic analysis of (+)-monanchorin 
 
2.3.3 Synthesis of (+)-Monanchorin 
 
2.3.3.1 Synthesis of allylic alcohol 254     
     
The first step of the synthesis of the guanidine alkaloid (+)-monanchorin involved 
protection of commercially available (R)-glycidol 249 with a silyl ether to give 250 in an 
88% yield (Scheme 73). A regioselective copper(I)-catalysed epoxide opening using n-
butyllithium then gave 251 in an excellent yield and as a single regioisomer. Previously, 
the Sutherland group have reported that the methoxymethyl (MOM) ether was the most 
selective directing group for an Overman rearrangement, giving the rearranged products in 
high diastereoselectivity.52,53 As such, the secondary alcohol 251 was protected using 
bromomethyl methyl ether and Hünig’s base to give the silyl ether 252 in a 96% yield. 
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Scheme 73- Synthesis of the protected diol 252 
 
With the desired protected compound 252 in hand, it was selectivity deprotected to the 
primary alcohol 248 in a quantitative yield using TBAF (Scheme 74). The primary alcohol 
248 was then subjected to a one-pot Swern oxidation followed by a Horner-Wadsworth-
Emmons reaction, which gave exclusively the E-α,β-unsaturated ester 253 in 86% yield. 
DIBAL-H reduction of the α,β-unsaturated ester 253 gave the allylic alcohol 254 in 92% 
yield. 
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Scheme 74- Synthesis of allylic alcohol 254 required for the directed rearrangement 
 
2.3.3.2 Synthesis of allylic trichloroacetamide 245 
 
As mentioned previously, the Sutherland group has shown that amides such as 245a can be 
obtained with high diastereoselectivity when a MOM-ether group (at the δ-position) is 
used to direct the Pd(II)-catalysed Overman rearrangement reaction and when using a non-
  
72 
coordinating solvent such as toluene.5,6,59 Treatment of the allylic alcohol 254 with 
trichloroacetonitrile and DBU gave allylic trichloroacetimidate 247 (Scheme 75). Allylic 
trichloroacetamidate 247 was subjected to a palladium(II)-catalysed Overman 
rearrangement using PdCl2(MeCN)2 in toluene. This gave the erythro-allylic 
trichloroacetamide 245a as the major product and threo-allylic trichloroacetamide 245b as 
the minor in a combined 55% yield over the two steps and in a 12 : 1 ratio, respectively. 
Trace amounts of the [1,3]-rearranged product 245c were also isolated. However, with the 
addition of p-benzoquinone as an oxidant agent the desired allylic trichloroacetamides 
245a and 245b could be obtained in a substantially improved 84% yield over the two steps 
(once again in a 12 : 1 ratio). Flash column chromatography allowed the separation of the 
desired major isomer 245a from 245b.  
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Scheme 75- Synthesis of erythro- and threo-allylic trichloroacetamides 
 
As shown in Scheme 76, the diastereoselective outcome of product 245a is controlled by 
the directing effect of an oxygen atom at the δ-position and not by the steric bulk of the 
side chain of the compound. This diastereoselectivity was explained by the coordination of 
the MOM group to the palladium metal catalyst which directs the catalyst to the back face 
of the alkene forming the allylic trichloroactimidate via reacting state conformation 255a. 
This allows the intramolecular attack to take place only from the front face of the alkene 
which then leads to the formation of the anti-diastereomer 245a as the major product. In 
contrast to this, coordination of the catalyst to the front face of the alkene (least hindered 
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position) would force the rearrangement to proceed only from the back face which would 
form the syn-diastereomer 245b. 
HN
O
O
H
C5H11
Cll3C
O
[Pd]
C5H11
OHN
CCll3
OMOM
247
C5H11
OHN
CCll3
OMOM
C5H11
OHN
CCll3
OMOM
245aa 245b
--Pd(IIII)
Cll3C
N OH
MOMO
H
H11C5 [Pd]
--Pd(IIII)
Pd (IIII)
255aa 255b
 
Scheme 76- Transition states of allylic trichloroacetimidate 
The formation of the [1,3]-rearranged product (anti-Claisen) 245c of the bulky allylic 
acetimidate 247 has a negative effect on the reaction outcome (Scheme 77). This is formed 
due to possible elimination of Pd(0) from the cyclisation pathway which then forms the 
[1,3]-product via an ionisation pathway which has previously been reported by Ikariya.10 
This problem can be overcome by reoxidising the Pd(0) back to Pd(II) using the oxidant p-
benzoquinone. This then inhibits the formation of the [1,3]-product thus increasing the 
yield of the desired [3,3]-products.  
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Scheme 77- [3,3]- and [1,3]-rearrangement pathways 
 
2.3.3.3 Cross-metathesis step 
The next step of the synthesis required cross-metathesis to extend the carbon backbone and 
introduce the aldehyde moiety for the final cyclisation. This was found to be a significant 
challenge in the synthesis of (+)-monanchorin 234. Grubbs and co-workers reported that 
conjugated olefins including acrolein were found to be unreactive in reactions using 
Grubbs 2nd generation catalyst 112.152 On the other hand, unconjugated acrolein acetals 
were found to be viable metathesis substrates. They examined the activity of the cross-
metathesis reaction of crotonaldehydes, and α,β-unsaturated carbonyl compounds and 
discovered certain acetals were particularly robust as substrates for reaction with terminal 
olefins. According to these studies, an initial optimisation of the cross-metathesis reactions 
was carried out to obtain the coupled alkene.153 They observed that reactions using older 
samples of diethyl acetal gave low yields, presumably due to small amounts of the 
hydrolysis-derived acrolein. 
 As such, allylic trichloroacetamide 245a was treated with a variety of terminal alkenes and 
crotonaldehyde as cross-metathesis partners in the presence of Grubbs 2nd generation 
catalyst 112 (10 mol%) in dichloromethane (Scheme 78). Cross-metathesis was observed 
in moderate yield when crotonaldehyde 256 was used giving compound 257 in 50% yield. 
A decrease in cross-metathesis efficiency was observed as the ratio of acrolein 258 to 
Grubbs 2nd generation catalyst was increased. It was proposed that the commercial purity 
of acrolein 258 may have inhibited catalyst activity. The reactivity of acetal 259 was 
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unexpected, as it was originally thought that allylic disubstitution would hinder the cross-
metathesis reaction. This reaction gave 260 in low yield. 
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Scheme 78- Attempts at efficient cross-metathesis 
 
As cross-metathesis was moderately successful for formation of 257, further 
transformations were investigated using this intermediate. However, attempts to 
hydrogenate 257 under standard conditions, failed to give the desired product 261 (Scheme 
79). Surprisingly, spectroscopic data showed that (4R,5S)-4-(2-chloroacetylamino)-5-
methoxy-1-decane-1-ol (262) was formed in a 62% yield. Under hydrogenation conditions 
reduction of the aldehyde and the MOM groups, and also cleavage of the two C-Cl bonds 
was observed. As of yet, no explanation has been produced to explain the reduction of the 
MOM group to the methoxy.  
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                  Scheme 79- Attempted hydrogenation of cross coupled product 
 
2.3.3.4 Synthesis of carbamate E-alkene 
 
As cross coupling could not be promoted in good yield and the subsequent hydrogenation 
of the alkene 257 was not possible in the presence of the trichloroacetyl protecting group, it 
was proposed that the trichloroacetyl should be replaced with an alternative. Using a one-
pot procedure, the trichloroacetyl functional group was removed under hydrolytic 
conditions and the resulting amine was reprotected using a Cbz-protecting group which 
formed carbamate 263 in 81% yield over the two steps. This was followed by an attempted 
coupling of 265 which was prepared from propene-1-ol 264. However, the desired 
compound 266 was not formed. Instead 267a and 267b were isolated in 77% yield and in 
1:1 ratio (Scheme 80). It is proposed in this reaction that the Ru(II) catalyst does not 
facilitate a cross-metathesis reaction and instead proceeds an isomerisation reaction. 
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Scheme 80- Further attempt at a cross coupling reaction 
 
2.3.3.5 Synthesis of the cross coupled product  
Grubbs and co-workers have previously reported that cross-metathesis reactions can be 
achieved in an excellent yield using a commercially available 2-vinyl-1,3-dioxolane 246 
with enhanced acid-stability compared to diethyl acetal 259.153  
As such, the protected alkene 263 was successfully subjected to a cross-metathesis with 2-
vinyl-1,3-dioxolane 246 which was chosen as a selective cross-metathesis reactant in view 
of its versatile reactivity. This reaction provided exclusively the E-alkene 244 in an 
excellent 87% yield after optimisation. Subsequent hydrogenation under standard 
conditions then proceeded smoothly to give the saturated amine 268 in 71% yield (Scheme 
81). 
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                    Scheme 81- Optimised cross-metathesis with 2-vinyl-1,3-dioxolane 246 
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2.3.3.6 Completion of (+)-monanchorin 
 
Previous work by Bernatowicz and co-workers reported that the Boc protected derivative 
of 1-guanylpyrazole was found to be a reactive reagent for amine guanylation.154,155 This 
derivative can serve as a valuable synthetic tool where the guanylation of relatively 
unreactive amines under mild conditions is required. This derivative also can serve as a 
versatile synthon in the synthesis of complex guanidine containing compounds. Recently, 
the Sutherland group reported that the commercially available N,N’-di-Boc-1H-pyrazole-1-
carboxamidine 269 can be coupled with amine derivatives giving the Boc-protected 
guanidine analogues in excellent yields.125,156,157   Thus, amine 268 was then reacted with 
carboxamidine 269 using Hünig’s base which gave intermediate 243 in 87% yield. 
Removal of both Boc protecting groups, the MOM group and release of the aldehyde under 
acidic conditions formed the aminal (+)-monanchorin 234 in 75% yield (Scheme 82). 
Spectroscopic data and optical activity were entirely consistent with that previously 
published by the McKee and Snider groups.149,150 
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                                  Scheme 82- Synthesis of (+)-monanchorin 
 
The proposed mechanism for the (+)-monanchorin cyclisation is shown in Scheme 83. A 
one-pot acid mediated deprotection of the aldehyde, guanidine and hydroxyl groups gave 
an δ-hydroxy aldehyde intermediate which then underwent stepwise cyclisation likely 
forming the C-O bond and then the C-N bond to give (+)-monanchorin 234. 
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                                Scheme 83- Proposed mechanism of (+)-monanchorin 
 
2.3.4 Conclusions  
 
In summary, the bicyclic guanidine alkaloid, (+)-monanchorin has been prepared in a 
fourteen-step synthesis and a 15% overall yield from commercially available (R)-glycidol. 
Using highly efficient methods involving a MOM-ether directed Overman rearrangement 
which had previously been developed in the Sutherland group generated the second key 
stereogenic centre. This was followed by a cross-metathesis reaction to form the carbon 
backbone of the natural product. Initial efforts to perform the cross-metathesis reaction in a 
good yield using a variety of olefin partners were unsuccessful. Significant progress with 
the cross-metathesis reaction using 2-vinyl-1,3-dioxolane coupled with a one-pot acid 
mediated deprotection allowed the synthesis of (+)-monanchorin.  
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2.4 Clavaminol A, C and H 
 
Clavaminol A 270, C 271, H 272 and desacetyl-clavaminol H 273 are new marine 
sphingoid compounds extracted recently from the Mediterranean ascidian Clavelina 
phlegraea (Figure 6).158,159 The absolute configuration of these 2-amino-3-alkanols were 
determined against standards using CD spectroscopy.160 These natural products were found 
to have (2R,3S)-configuration. In contrast to this, the more commonly known other 2-
amino-3-alkanols including (2S,3R)-2-aminododecan-3-ol (274) and (2S,3R)-xestoaminol 
C 275 isolated from Clavelina oblonga and Spisula polynima, respectively have (2S,3R)-
configuration.161,162 These (2S,3R)-2-amino-3-alkanols possess many biological activities 
including antifungal activity against Candida albicans ATCC 10231, and can also inhibit 
cell proliferation which prevents the formation of actin stress fibres in Candida 
glabrata.163 Despite having (2R,3S)-configuration, clavaminols A, C and H possess 
cytotoxic properties against A549 (lung carcinoma), T47D (breast carcinoma) and AGS 
(gastric carcinoma) cell lines by activating the apoptotic machinery.158  
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Figure 6- Structures of clavaminol A, C, H, desacetyl-clavaminol H 273 and xestoaminol C 
2.4.1 Retrosynthetic Analysis of Clavaminol A, C and H 
The proposed retrosynthetic analysis of clavaminol A, C and H is shown in Scheme 84. 
The key intermediate, allylic trichloroacetimidate 277 could be prepared from the E-α,β-
unsaturated ester 279 which could then be synthesised from the readily available ethyl (R)-
glycidol 249. The stereoselective rearrangement of 277 would allow the formation of the 
allylic trichloroacetamide 276 introducing the (2R)-stereogenic centre. Finally, oxidative 
cleavage of the alkene and deprotection of the amide 276 would give the target 
clavaminols, A 270, C 271 and H 272. 
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Scheme 84- Retrosynthetic analysis of clavaminol A, C and H 
 
2.4.2 Synthesis of Clavaminol A, C and H 
 
2.4.2.1 Synthesis of Clavaminol A and C 
 
2.4.2.1.1 Synthesis of allylic alcohol 282 
 
Using the same synthetic approach for the synthesis of allylic alcohol 254, the allylic 
alcohol 282 was prepared in seven steps (Scheme 85). Protection of (R)-glycidol 249 gave 
the tert-butyldimethylsilyl ether 250 in a quantitative yield. Regioselective ring opening of 
the epoxide using octylmagnesium bromide in the presence of copper(I) bromide dimethyl 
sulfide gave the alcohol 280 in 94% yield. Protection of the secondary hydroxyl group as 
the MOM-ether furnished 279 which was followed by selective removal of the silyl ether 
using TBAF to give primary alcohol 281 in quantitative yield. With the desired primary 
alcohol 281 in hand, this was then subjected to a one-pot Swern oxidation/Horner-
Wadsworth-Emmons reaction to provide exclusively the E-α,β-unsaturated ester 278. 
Reduction of the ester moiety with 2.2 equivalents of the DIBAL-H completed the 
synthesis of allylic alcohol 282 in an 85% overall yield.  
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Scheme 85- Synthesis of allylic alcohol 282 
 
2.4.2.1.2 Synthesis of the allylic trichloroacetamide 276a  
The allylic alcohol 282 was converted to allylic trichloroacetimidate 277 using 
trichloroacetonitrile and a catalytic amount of DBU (Scheme 86). The key allylic 
trichloroacetimidate 277 was then subjected to a Pd(II)-catalysed Overman rearrangement 
using p-benzoquinone in toluene as a non-coordinating solvent. As expected, this resulted 
in a highly diastereoselective formation of the erthyro- and threo-allylic 
trichloroacetamides 276a and 276b in a 70% yield over the two steps and in a 13:1 ratio. 
Once again, the desired allylic trichloroacetamide 276a was easily separated from 275b 
using flash column chromatography. 
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 Scheme 86- Synthesis of allylic trichloroacetamide 276a 
 
2.4.2.1.3 Completion of Clavaminol A and C 
The major allylic trichloroacetamide product from the rearrangement, 276a was then easily 
ozonised, followed by straightforward reduction of the resulting aldehyde to give the 
corresponding alcohol 283 in high yield (Scheme 87). Introduction of the mesylate using 
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methanesulfonyl chloride gave 284 in high yield and was followed by a reaction with 
sodium bromide to give bromide 285. 
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Scheme 87- Synthesis of bromide 285 
 
Interestingly, the key hydrogen atoms of alcohol 283 are observed in very different 
chemical shift values compared to the hydrogen atoms of bromide 285 in the 1H NMR 
spectrum (Figure 7). These differences are observed at 3.70 ppm (3-H) and 3.85 ppm (2-H) 
in alcohol 283 and at 3.58 ppm (3-H) and 4.20 ppm (2-H) in bromide 285. In addition to 
this, both 1-H2 hydrogen atoms in the alcohol were found at a different chemical shift 
values and different multiplicity to that observed in bromide 285. This is likely due to the 
formation of hydrogen bonding between the amide and alcohol functionalities in 283 
causing a downfield shift of one of the 1-H2 hydrgen atoms to 3.97. 
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Figure 7-  1H NMR spectrum of alcohol 283 and bromide 285 
The final stage of the synthesis of clavaminol A 270 and C 271 involved the installation of 
the methyl side chain and an acid-mediated deprotection of the MOM and trichloroacetyl 
groups. In 1994, Jacquinet and co-workers reported that N-trichloroacetyl groups in 
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disaccharide products can be transformed into N-acetyl groups under mild radical reducing 
conditions using a n-tributyltin hydride mediated reaction.164 It was decided to utilise this 
protocol for the transformation of product 285 to 286 where both the primary bromide and 
trichloroacetyl groups are reduced in a single step. The bromide 285 was subjected to a 
reduction under neutral conditions using n-tributyltin hydride. This gave compound 286 in 
85% yield (Scheme 88). This mild and selective method was chosen due to the fact that the 
N-acetyl group required for the synthesis of (+)-clavaminol C 271 could also be formed 
during the reduction of the C-Cl bonds. Finally, removal of both the MOM and N-acetyl 
groups under acidic conditions at 60 oC completed the synthesis of (–)-clavaminol A 270 in 
a quantitative yield. The use of mild acidic conditions led to the synthesis of (+)-
clavaminol C 270 and this was again achieved in a quantitative yield.165    
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Scheme 88- Synthesis of clavaminol A and C 
2.4.2.2 Synthesis of Clavaminol H 
 (+)-Clavaminol H 272 was synthesised in a two step synthetic route from primary alcohol 
283 (Scheme 89).165 The N-trichloroacetyl of alcohol 283 was again reduced using similar 
reaction conditions to that previously reported by Jacquinet and co-workers.164 This gave 
the N-acetyl alcohol derivative 287 in high yield. Selective deprotection of the MOM-
protecting group under mild acidic conditions completed the synthesis of (+)-clavaminol H 
272 in quantitative yield. Removal of both the MOM and N-trichloroacetyl groups using 
acidic conditions at 60 oC directly led to the formation of the cytotoxic amine, (+)-
desacetyl-clavaminol H 273. 
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Scheme 89- Synthesis of (+)-clavaminol H and (+)-desacetyl-clavaminol H 
 
2.4.3 Synthesis of (2S,3R)-clavaminol A, C and H  
Initially in this project, the opposite enantiomers of clavaminol A 270, C 271 and H 272 
which have (2S,3R)-configuration were prepared in a similar manner as described for the 
synthesis of the natural products 270, 271 and 272 starting from (S)-glycidol 288 (Scheme 
90). The reason behind their synthesis was to prove that the optical rotation of (2R,3S)-
enantiomers of clavaminol A 270, C 271 and H 272 were in agreement with the (2R,3S)-
natural products, a result contradictory to that described by the groups of Greck and 
Ferreira.166,167 Greck and Ferreira had previously synthesised clavaminol H and desacetyl-
clavaminol H in (2S,3R)-absolute configuration. As expected, the optical rotation of 274, 
301, 304 and 305 were found to have similar value and opposite sign to that observed for 
the (2R,3S)-natural products. The first stage of this synthesis involved the synthesis of 
alcohol 297 which was required for the synthesis of 274, 301, 304 and 305. This was 
achieved in the same manner as for the synthesis of the (2R,3S)-alcohol 283.   
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Scheme 90- Synthesis of (2S,3R)-alcohol 297 
 
Alcohol 297 was then mesylated and formation of the methyl side by reduction of the 
mesylate 300 with sodium borohydride was then attempted. However, this gave 4,5-
dihydro-1,3-oxazole 299 in 60% yield (Scheme 91). As a consequence of this, an 
alternative method described previously for the formation of compounds 284 and 285 was 
proposed which involved the synthesis of 300 using mesyl chloride and 301 using sodium 
bromide. The bromide 301 was subsequently subjected to similar transformations for the 
synthesis of clavaminol A and C, and this gave unnatural (2S,3R)-clavaminol A 274 and C 
303 in excellent yields.        
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Scheme 91- Synthesis of (2S,3R)-clavaminol A 274 and C 303 
The synthesis of N-acetyl alcohol 305 required for the synthesis of (–)-clavaminol H 306 
and (–)-desacetylclavaminol H 307 was also attempted, using similar reaction conditions to 
that described for the synthesis of compound 287. Initial reactions involving heating under 
reflux for one hour resulted in the cleavage of only two C-Cl bonds which gave 304 in 
84% yield (Scheme 92). Leaving the reaction for 24 hours allowed the reduction of all 
three C-Cl bonds, giving the desired N-acetyl alcohol derivative 305 in high yield. Once 
again, the same procedures previously described for the synthesis of compounds 272 and 
273, were used to prepare (–)-clavaminol H 306 and (–)-desacetyl-clavaminol H 307 in 
quantitative yields.  
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Scheme 92- Synthesis of (–)-clavaminol H and (–)-desacetyl-clavaminol H 
2.4.4 Conclusions 
 
A new 14-step stereoselective synthesis of (–)-clavaminol A and (+)-clavaminol C was 
successfully developed in 49% overall yield from (R)-glycidol.  In addition to this, (+)-
clavaminol H and the cytotoxic (+)-desacetyl-clavaminol H were also synthesised in 12 
steps in a 48% overall yield. Using similar chemistry, the (2S,3R)-enantiomers were also 
synthesised in an efficient manner from (S)-glycidol. This confirmed the assignment of the 
absolute stereochemistry of (2R,3S)-configuration for the natural products. The key steps 
involved a palladium(II)-catalysed directed Overman rearrangement to establish the key 
C–N bond, while a one-pot, tributyltin hydride-mediated reduction allowed the formation 
of the N-acetyl group and the methyl side chain.  
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2.5 NO-inhibitor 
Nitric-oxide synthases (NOS) 308 are a family of enzymes which consist of three isoforms, 
neuronal nNOS, endothelial eNOS and inducible iNOS. They produce nitric oxide (NO) 
via the oxidation of a L-arginine substrate (Figure 8).168,169 The nitric oxide produced by 
these three isoforms has broad biological properties as a second messenger in the 
cardiovascular and nervous systems and as a cytotoxic agent in the immune system as well 
as in a variety of cellular processes.168 However, overproduction of nitric oxide by nNOS 
and iNOS can cause various pathological disorders and many diseases. In recent years, 
medicinal studies have shown that iNOS contributes to a large number of pathologies 
which possess an inflammatory component, including septic shock,170 arthritis,171 
neurodegenerative disorders,172-174 and cancers.175,176 Recently, inhibition of iNOS has 
resulted in a number of proposed applications, but the identification of a potent, highly 
iNOS selective, non-toxic, and bio-available inhibitor remains an important 
pharmacological challenge, and as yet no molecule has been put on the market.177 NO-
inhibitor, acetamidine lysine derivative 309 has been described as one of the most highly 
selective inhibitors for iNOS, with an IC50 of 12 μM (Figure 8). 
HO
NH
H
N
OH
NH2
NO-inhibitor 309
nitric-oxide synthase NOS 308  
Figure 8- NOS enzyme and its NO-inhibitor 308 
 
2.5.1 Previous Synthesis of an Acetamidine Lysine Derivative 
In 1998, Hallinan and co-workers reported the synthesis of the acetamidine lysine 
derivative 309 using the dihydroxylation of a lysine derivative as the key step (Scheme 
93).178 The synthesis began with the conversion of aldehyde 310 to the corresponding 
alkene 311 using a Wittig methylation reaction, followed by the introduction of a vicinal 
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diol using Upjohn dihydroxylation conditions to give 312 and 313 in a ratio of 1 : 1.5. 
Hydrogenation of diol 312 then led to removal of the Cbz-protecting group to give epsilon 
amine 314 in quantitative yield. This was followed by treatment of 314 with methyl 
acetimidate hydrochloride to furnish amidine 315. Finally, removal of the Boc group under 
acidic conditions led to the synthesis of acetamidine lysine derivative 309 in quantitative 
yield.     
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HOAc
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310 311
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314
315 309  
Scheme 93- First synthesis of NO-inhibitor 309 by Hallinan and co-workers 
2.5.2 Retrosynthetic Analysis of NO-inhibitor 309 
The proposed retrosynthetic analysis of NO-inhibitor is outlined in Scheme 94. 
Deprotection of the acetonide, trichloroacetyl groups, substitution of the methyl 
acetimidate with the Cbz groups and dehydrogenation would lead back to 316. 
Disconnection of 316 at the alkene linkage would give allylic amide 317, which was to be 
  
92 
prepared from the key intermediate allylic acetimidate 319 using a stereoselective 
rearrangement introducing the (2S)-stereogenic centre. Allylic acetimidate 319 could be 
made from the ester 320 which could be synthesised from the readily available L-gulonic 
acide γ-lactone 321.       
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NHCbz
+
309 316 317
318
319320321
O
HO OH
O
H
OH
HO
                Scheme 94- Proposed retrosynthetic analysis of the NO-inhibitor 309 
2.5.3 Attempted Synthesis of NO-inhibitor 309 
 
2.5.3.1 Synthesis of allylic alcohol 323 
The synthesis of NO-inhibitor 309 began with the preparation of the protected allylic 
alcohol 323 (Scheme 95). The synthesis of the acetonide protected allylic alcohol 323 was 
achieved in 4 steps from the commercially available L-gulonic acide γ-lactone 321. Firstly, 
L-gulonic acide γ-lactone 321 was reacted selectively with the isopropenyl methyl ether 
using a protocol described by Hubschwerlen to give acetonide 322 in high yield.179 A one-
pot oxidation with sodium periodate (oxidative cleavage of 322) followed by a Horner-
Wadsworth-Emmons (HWE) reaction using potassium carbonate as a base and triethyl 
phosphonoacetate, gave exclusively E-α,β-unsaturated ester 320 in 71% yield over the two 
steps. Straightforward DIBAL-H reduction of the ester afforded the corresponding allylic 
alcohol 323 in 76% yield. 
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Scheme 95- Synthesis of allylic alcohol 323 
 
2.5.3.2 Synthesis of allylic trichloroacetamide 317a 
Once again, the allylic alcohol 323 was readily converted to allylic trichloroacetimidate 
319, which was used without further purification (Scheme 96). Initially, a thermal 
Overman rearrangement was employed as the first key step of this synthesis. The allylic 
trichloroacetimidate 319 was converted to the corresponding two diastereomers 317a, 
317b in a combined 29% yield and formation of the [1,3]-product 317c. However, this 
reaction was low yielding and gave the products in a 5 : 1 : 6 ratio, respectively. The low 
yield achieved was attributed to the decomposition of the unstable allylic imidate 319 
under these conditions. 
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Scheme 96- Rearrangement of the allylic trichloroacetimidate 319 using thermal conditions 
The diastereomeric ratio, as for all previous rearrangements, was determined by examining 
the 1H NMR spectra of the products. This is a simple process to achieve, as the syn-and 
anti-diastereomers have different NMR spectra, which showed dissimilar chemical shifts 
between the two stereogenic hydrogen atoms on each molecule. In the example below 
(Figure 9), the hydrogen atoms of the syn- and anti-diastereomers 317a and 317b at C-3 
and C-4 are observed at similar chemical shifts. However, the hydrogen atoms at C-5 are 
very different for each diastereomer. 
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Figure 9- 1H NMR spectrum of syn-(top) and anti-(bottom) diastereomers 
As the thermal Overman rearrangement at this stage did not proceeded efficiently, it was 
decided to carry out this process by transition metal catalysis. In an extensive study, the 
Sutherland group has previously screened a variety of metal catalysts for the asymmetric 
rearrangement of the enantiomer of 323 in an attempt to find reaction conditions which 
would provide the desired [3,3]-products, whilst eliminating formation of the undesired 
[1,3]-product.55 Based on these reactions, the rearrangement of 319 was also attempted 
using PdCl2(MeCN)2, however, this gave a low yield of 32% of allylic trichloroacetamide 
317a and in modest diastereoselectivity (4:1). A highly successful rearrangement in this 
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project was performed when (R)-COP-Cl catalyst 52 was utilised and this provided the 
syn-diastereomer 317a in good yield as a single diastereomer (over 2 steps) (Scheme 97). 
As expected, the bulky catalyst coordinates to the opposite face of the existing (4R) 
stereocentre (so blocking the front side from attack) thus ensuring that the new C-N bond 
forms on the same side as the stereocentre. This is an example of a matched pairing as the 
chirality of both the substrate and chiral catalyst complement one another; the bulky 
catalyst coordinates to the opposite face to the existing (4R) stereocentre (so blocking the 
back side from attack) thus ensuring that the new C-N bond forms on the same side as the 
stereocentre and giving a significant enhancement in diastereoselectivity. 
O
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HN O
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HN O
O
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DBU
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323
73% (2 steps)
 
 
Scheme 97- Rearrangement of the allylic trichloroacetimidate 319 using (R)-COP-Cl 
 
2.5.3.3 First attempt at a cross coupling reaction 
 
The first cross-metathesis partner 318 required for the cross-coupling step was easily 
prepared from the commercially available 3-butenylamine hydrochloride salt 324 in a 
quantitative yield using standard Cbz-protection conditions (Scheme 98). With the olefin 
partner 318 in hand, it was subjected to a cross-metathesis reaction with allylic 
trichloroacetamide 317a. This gave the homodimeric product 325 and other undesired 
products. 
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Scheme 98- Attempted synthesis of cross coupled product 316  
2.5.3.4 Second attempt at a cross coupling reaction 
 
As the cross methathesis reaction was not possible using partner 318, attention then turned 
to use the protected enone 328 as an alternative olefin partner. This electron-defficient 
olefin partner was generated easily in a two step synthesis from the protected carboxylic 
acid 326 (Scheme 99). The commercially available 326 was converted to the morpholine 
amide 327 in high yield, which was then converted to the corresponding protected enone 
328. This reaction was carried out according to the conditions outlined in a procedure by 
Martin and co-workers, using vinylmagnesium bromide.180 This alkylation was achieved in 
a yield of 46%, although with repetition of this experiment, yields proved to be somewhat 
inconsistent. 
O
N
NHCbz
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NHCbz
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HO2C NHCbz
N
H
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EDCI, DMAP,
DCM
, 87%
THF, 0 oC,
1.5 h, 46%326 327 328
 
Scheme 99- Synthesis of the alternative olefin partner 328 
 
Having synthesised the second olefin partner 328 in good yield, a cross-metathesis reaction 
was then successfully achieved (Scheme 100). According to Grubbs classification, 
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protected enone 328 is considered a type II olefin, while other terminal alkenes such as 
trichloroacetamide 317a are considered as type I.181 Thus, cross-metathesis reactions 
between type I and type II olefins should successfully lead to a selective 
heterodimerisation of the two alkene partners. Based on this study, allylic 
trichloroacetamide 317a was treated with the protected enone 328 using Hoveyda/Grubbs 
II catalyst 114 which gave the desired cross coupled 329 in a 68% yield.  
NHCbz
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328
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Scheme 100- Synthesis of the cross coupled product 329  
 
2.5.4 Conclusions to the attemped Synthesis of NO-inhibitor 
 
In conclusion, the protected cross coupled compound 329 required for the synthesis of NO-
inhibitor 309 was synthesised in reasonable yield over a seven step synthesis. The key 
steps of this synthesis involved a palladium(II)-catalysed Overman rearrangement using 
(R)-COP-Cl to create the new C–N bond in a syn-configuration and a cross-metathesis 
reaction using the protected enone 328. Another proposed olefin partner 318 with the 
cross-metathesis step was also investigated.   
2.5.5 Future Work 
 
Future work for this project includes five additional steps to synthesise the desired 
compound 309. As shown in Scheme 101, the protected enone 329 will be reduced with 
olefin transposition via the tosyl hydrazone to give the (Z)-alkene 330 which will then be 
subjected to a one-pot hydrolysis of the trichloroacetamide and Boc protection of the 
amine. Hydrogenation of the resulting fully protected Z-alkene 331 will reduce the alkene 
and remove the Cbz-protecting group. Finally, reaction of the unprotected amine 332 with 
methyl acetimidate would give the protected NO-inhibitor 333. Acid mediated 
deprotection of the diol and amine functional groups would complete the synthesis of 
target compound 309.   
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Scheme 101- Proposed synthesis of the NO-inhibitor 309 
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3.0 Experimental Section 
 
3.1 General Experimental 
 
All reagents and starting materials were obtained from commercial sources and used as 
received. Dry solvents were purified using a PureSolv 500 MD solvent purification system 
or THF and diethyl ether were distilled from sodium and benzophenone, whilst 
dichloromethane (DCM) was distilled from calcium hydride. All reactions were performed 
under an atmosphere of argon unless otherwise mentioned. Brine refers to a saturated 
solution of sodium chloride. Flash column chromatography was carried out using Fisher 
matrix silica 60. Macherey-Nagel aluminium-backed plates pre-coated with silica gel 60 
(UV254) were used for thin layer chromatography and were visualised by staining with 
KMnO4. 1H NMR and 13C NMR spectra were recorded on a Bruker DPX 400 spectrometer 
with chemical shift values in ppm relative to TMS (δH 0.00 and δC 0.0) or residual 
chloroform (δH 7.28 and δC 77.2) as standard. Mass spectra were obtained using a JEOL 
JMS-700 spectrometer. Melting points were determined on a Reichert platform melting 
point apparatus. Infrared spectra were obtained using a JASCO FTIR 410 using a Golden 
Gate apparatus. Optical rotations were determined as solutions irradiating with the sodium 
D line (λ = 589 nm) using an Autopol V polarimeter. [α]D values are given in units 10-1 
deg cm2 g-1. Chiral HPLC was performed on a Agilent 1100 series instrument and were 
calibrated with the appropriate racemic mixture. 
 
3.2 Synthesis of (±)-Physoperuvine 
 
6-Hepten-1-ol (187)182 
 
OH
1
2
3
4
5
6
7
 
 
Ethyl 6-heptenoate (186) (2.5 g, 16.0 mmol) was dissolved in diethyl ether (200 mL) and 
cooled to –78 °C. DIBAL-H (1 M in hexane) (35 mL, 35.2 mmol) was added dropwise and 
the reaction mixture was stirred at –78 °C for 3 h, before warming to room temperature. 
The solution was cooled to 0 °C and quenched by the addition of a saturated solution of 
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ammonium chloride (50 mL) and warmed to room temperature with vigorous stirring over 
1 h producing a white precipitate. The precipitate was filtered through a pad of Celite® and 
washed with diethyl ether (400 mL). The filtrate was then dried (MgSO4) and concentrated 
in vacuo. Flash chromatography (diethyl ether/petroleum ether, 3:7) gave 6-hepten-1-ol 
(187) (1.71 g, 94% yield) as a yellow oil. Spectroscopic data consistent with literature.182 
δH (400 MHz, CDCl3) 1.32–1.47 (4H, m, 3-H2 and 4-H2), 1.53–1.62 (2H, m, 2-H2), 2.06 
(2H, q, J 6.6 Hz, 5-H2), 3.63 (2H, t, J 6.6 Hz, 1-H2), 4.93 (1H, d, J 10.0 Hz, 7-HH), 4.99 
(1H, d, J 15.6 Hz, 7-HH), 5.80 (1H, ddt, J 15.6, 10.0, 6.6 Hz, 6-H); δC (100 MHz, CDCl3) 
25.2 (CH2), 28.7 (CH2), 32.6 (CH2), 33.7 (CH2), 62.8 (CH2), 114.4 (CH2), 138.9 (CH); m/z 
(CI) 115 (MH+. 100%), 97 (61), 95 (9), 83 (6). 
 
Ethyl (2E)-2,8-nonadienoate (188)183 
 
CO2Ett
9
8
7
6
5
4
3
2
1
 
 
Dimethyl sulfoxide (1.55 mL, 22.0 mmol) was added to a stirred solution of oxalyl 
chloride (1.07 mL, 12.28 mmol) in dichloromethane (100 mL) at –78 °C. The reaction 
mixture was stirred for 0.3 h before 6-hepten-1-ol (187) (1.0 g, 8.77 mmol) in 
dichloromethane (50 mL) was slowly added. The reaction mixture was stirred for a further 
0.3 h before triethylamine (6.10 mL, 43.86 mmol) was added. This reaction mixture was 
stirred for 0.5 h at –78 °C and then allowed to warm to room temperature and stirred for a 
further 2 h. Meanwhile, a solution of lithium chloride (0.67 g, 15.79 mmol), triethyl 
phosphonoacetate (3.13 mL, 15.79 mmol) and 1,8-diazabicyclo[5,4,0]undec-7-ene (2.36 
mL, 15.79 mmol) in acetonitrile (100 mL) was prepared and stirred for 1.0 h. The Swern 
solution was concentrated in vacuo, then the Horner Wadsworth Emmons solution was 
added and the reaction mixture was stirred at room temperature overnight. The reaction 
was quenched by the addition of a saturated solution of ammonium chloride (50 mL) and 
concentrated to give an orange residue, which was then extracted with diethyl ether (4 × 75 
mL). The organic layers were combined, dried (MgSO4) and concentrated to give an 
orange oil. Purification by flash column chromatography (diethyl ether/petroleum ether, 
3:97) yielded ethyl (2E)-2,8-nonadienoate (188) (1.34 g, 85% yield) as a yellow oil. 
Spectroscopic data consistent with literature.183 δH (400 MHz, CDCl3) 1.28 (3H, t, J 7.1 
Hz, OCH2CH3), 1.38–1.53 (4H, m, 5-H2 and 6-H2), 1.95–2.03 (2H, m, 7-H2), 2.10–2.18 
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(2H, m, 4-H2), 4.11 (2H, q, J 7.1 Hz, OCH2CH3), 4.93–4.97 (1H, m, 9-HH), 4.97–5.04 
(1H, m, 9-HH), 5.74–5.78 (1H, m, 8-H), 5.79–5.85 (1H, m, 2-H), 6.96 (1H, dt, J 15.6, 6.9 
Hz, 3-H); δC (100 MHz, CDCl3) 14.3 (CH3), 27.5 (CH2), 28.4 (CH2), 32.0 (CH2), 33.5 
(CH2), 60.2 (CH2), 114.7 (CH2), 121.4 (CH), 138.6 (CH), 149.2 (CH), 166.8 (C); m/z (CI) 
183.1382 (MH+. C11H19O2 requires 183.1385), 113 (8%), 97 (7), 81 (13), 71 (15). 
 
(2E)-Nona-2,8-dien-1-ol (185)183 
 
OH
1
2
3
4
5
6
7
8
9
 
 
The reaction was carried out according to the procedure described for the synthesis of 6-
hepten-1-ol (187) using ethyl (2E)-2,8-nonadienoate (188) (2.0 g, 11.0 mmol). Flash 
column chromatography using (diethyl ether/petroleum ether, 3:7) gave (2E)-nona-2,8-
dien-1-ol (185) (1.56 g, 100% yield) as a pale yellow oil. Spectroscopic data consistent 
with literature.183 δH (400 MHz, CDCl3) 1.22 (1H, br s, OH), 1.38–1.42 (4H, m, 5-H2 and 
6-H2), 2.02–2.10 (4H, m, 4-H2 and 7-H2), 4.09 (2H, t, J 4.9 Hz, 1-H2), 4.92–4.96 (1H, m, 
9-HH), 5.00 (1H, ddt, J 17.0, 3.4, 1.6 Hz, 9-HH), 5.60–5.74 (2H, m, 2-H and 3-H), 5.81 
(1H, ddt, J 17.0, 10.2, 6.7 Hz, 8-H); δC (100 MHz, CDCl3) 26.9 (CH2), 27.1 (CH2), 30.6 
(CH2), 32.2 (CH2), 62.4 (CH2), 112.9 (CH2), 127.5 (CH), 131.9 (CH), 137.4 (CH); m/z (CI) 
123.1169 (MH+–H2O. C9H15 requires 123.1174), 109 (16%), 95 (12), 81 (63), 67 (17). 
 
3-(2’,2’,2’-Trichloromethylcarbonylamino)nona-1,8-diene (189)73 
 
HN O
CCll3
1
2
34
5
6
7
8
9
                           
(2E)-Nona-2,8-dien-1-ol (185) (0.50 g, 3.57 mmol) was dissolved in dichloromethane (20 
mL) and cooled to 0 oC. 1,8-Diazabicyclo[5.4.0]undec-7-ene (0.12 mL, 1.00 mmol) was 
then added to the solution followed by trichloroacetonitrile (0.53 mL, 5.35 mmol). The 
reaction mixture was warmed to room temperature and stirred for 2 h. The reaction mixture 
was then filtered through a short pad of silica gel and washed with diethyl ether (100 mL). 
The resulting filtrate was then concentrated to give the allylic trichloroacetimidate 184 
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which was used without further purification in the rearrangement reactions that followed. 
δH (400 MHz, CDCl3) The resulting allylic trichloroacetimidate 184 was dissolved in 
dichloromethane (100 mL) and added to a sealed tube flask. Bis(acetonitrile)palladium(II) 
chloride (0.10 g, 0.35 mmol) in dichloromethane (10 mL) was added and stirred overnight 
at 45 oC. The reaction mixture was cooled to room temperature and concentrated. Flash 
column chromatography using (diethyl ether/petroleum ether, 1:9) gave 3-(2’,2’,2’-
trichloromethylcarbonylamino)nona-1,8-diene (189) (1.36 g, 83% yield) as a brown oil. 
Spectroscopic data consistent with literature.73 δH (400 MHz, CDCl3) 1.27–1.39 (4H, m, 5-
H2 and 6-H2), 1.49–1.63 (2H, m, 4-H2), 1.98 (2H, q, J 6.8 Hz, 7-H2), 4.31–4.38 (1H, m, 3-
H), 4.90 (2H, ddt, J 10.2, 7.4, 1.4 Hz, 1-H2), 5.14 (2H, dd, J 17.0, 10.6 Hz, 9-H2), 5.66–
5.77 (2H, m, 2-H and 8-H), 6.44 (1H, br s, NH); δC (100 MHz, CDCl3) 24.9 (CH2), 28.4 
(CH2), 33.4 (CH2), 34.2 (CH2), 53.5 (CH), 92.8 (C), 114.7 (CH2), 116.1 (CH2), 136.6 
(CH), 138.4 (CH), 161.2 (C); m/z (CI) 314 (MH+, 5%), 284 (100), 250 (41), 214 (44), 180 
(11), 154 (10), 116 (85), 81 (34). 
 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohepta-2-ene (190)184  
                                                               
HN O
CCll3
4
3
277 1
5
6
 
(2E)-Nona-2,8-dien-1-ol (185) (0.50 g, 3.57 mmol) was dissolved in dichloromethane (20 
mL) and cooled to 0 °C. 1,8-Diazabicyclo[5.4.0]undec-7-ene (0.12 mL, 0.89 mmol) was 
then added to the solution followed by trichloroacetonitrile (0.53 mL, 5.35 mmol). The 
reaction mixture was warmed to room temperature and stirred for 2 h. The reaction mixture 
was then filtered through a short pad of silica gel and washed with diethyl ether (100 mL). 
The resulting filtrate was then concentrated to give allylic trichloroacetimidate 184, which 
was used without further purification. Allylic trichloroacetimidate 184 was dissolved in 
dichloromethane (50 mL). Bis(acetonitrile)palladium(II) chloride (0.10 g, 0.35 mmol) was 
then added to the solution and the reaction mixture was stirred at 45 °C for 24 h. The 
reaction mixture was diluted by adding dichloromethane (450 mL). Grubbs’ catalyst (1st 
Generation) 111 (0.23 g, 0.28 mmol) was then added and the reaction mixture was heated 
at 65 °C overnight. The mixture was cooled to room temperature and then filtered through 
a short pad of Celite® and washed with diethyl ether (400 mL). Concentration of the filtrate 
followed by flash column chromatography (dichloromethane/petroleum ether, 3:7) gave 1-
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(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene (190) (0.75 g, 82% yield) as a 
white solid. Mp 105–106 °C (lit.184 mp 105 °C); Spectroscopic data consistent with 
literature.184 δH (400 MHz, CDCl3) 1.39–1.49 (1H, m, 6-HH), 1.66–1.79 (3H, m, 6-HH and 
7-H2), 1.85–1.98 (2H, m, 5-H2), 2.10–2.29 (2H, m, 4-H2), 4.54–4.62 (1H, m, 1-H), 5.55–
5.62 (1H, m, 2-H), 5.88–5.95 (1H, m, 3-H), 6.72 (1H, br s, NH); δC (100 MHz, CDCl3) 
24.6 (CH2), 25.2 (CH2), 26.5 (CH2), 31.1 (CH2), 50.5 (CH), 90.8 (C), 130.5 (CH), 131.8 
(CH), 158.8 (C); m/z (CI) 256.0060 (MH+. C9H13NO35Cl3 requires 256.0063), 222 (18%), 
95 (12). 
 
1-Aminocyclohepta-2-ene (191) 
 
NH2
1 2
3
45
6
7
 
 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohepta-2-ene (190) (0.10 g, 0.40 mmol) 
was dissolved in tetrahydrofuran (5 mL), then added to a solution of sodium hydride (0.06 
g, 2.00 mmol) in tetrahydrofuran (10 mL) and stirred for 0.5 h at room temperature. 
Methyl iodide (0.14 mL, 2.3 mmol) was added and the reaction mixture was stirred for 5 h. 
The reaction mixture was then heated under reflux overnight at 65 oC. The solution was 
concentrated in vacuo, then quenched with water and acidified with 1 M hydrochloric acid. 
The reaction mixture was extracted with ethyl acetate (4 × 30 mL) and the combined 
organic layers dried with (MgSO4) and concentrated in vacuo. Flash column 
chromatography (ethyl acetate/petroleum ether, 10:1) gave 1-aminocyclohepta-2-ene (191) 
(0.025 g, 58% yield) as a brown oil. νmax/cm–1 (NaCl) 2926 (CH), 1473, 1442, 970, 923, 
796; δH (400 MHz, CDCl3) 1.35–1.42 (1H, m, 6-HH), 1.63–1.84 (3H, m, 6-HH and 7-H2), 
2.01–2.11 (2H, m, 5-H2), 2.23–2.33 (2H, m, 4-H2) 4.60–4.67 (1H, m, 1-H), 5.89–5.96 (1H, 
m, 2-H), 6.20–6.26 (1H, m, 3-H); δC (100 MHz, CDCl3) 24.0 (CH2), 26.5 (CH2), 26.6 (2 × 
CH2), 74.8 (CH), 123.9 (CH), 137.4 (CH); m/z (Cl) 182 (MH+, 35%), 164 (13), 126 (85), 
111 (70), 95 (100), 81 (84). 
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1-(tert-Butoxycarbonylamino)cyclohepta-2-ene (193)185 
 
NBocH
1
2
3
45
6
7
 
 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohepta-2-ene (190) (0.30 g, 1.17 mmol) 
was dissolved in 2 M sodium hydroxide (40 mL) and stirred vigorously for 12 h at room 
temperature. Di-tert-butyl dicarbonate (0.64 g, 2.94 mmol) was added and the solution was 
stirred for 6 h before a further portion of di-tert-butyl dicarbonate (0.64 g, 2.94 mmol) was 
added and the reaction mixture stirred for a further 12 h. The reaction mixture was then 
extracted with ethyl acetate (4 × 30 mL) and the combined organic layers dried (MgSO4) 
and concentrated in vacuo. Flash column chromatography (ethyl acetate/petroleum ether, 
1:9) gave 1-(tert-butoxycarbonylamino)cyclohepta-2-ene (193) (0.24 g, 100% yield) as a 
white solid. Mp 61–63 °C (lit.185 mp 63–65 °C); νmax/cm–1 (NaCl) 3334 (NH), 2925 (CH), 
1679 (CO), 1516, 1367, 1246, 1166, 1016; δH (400 MHz, CDCl3) 1.32–1.38 (1H, m, 6-
HH), 1.44 (9H, s, OtBu), 1.60–1.69 (3H, m, 6-HH and 7-H2), 1.82–1.90 (2H, m, 5-H2), 
2.09–2.18 (2H, m, 4-H2), 4.25–4.32 (1H, m, 1-H), 4.64 (1H, br s, NH), 5.53–5.56 (1H, m, 
2-H), 5.77–5.79 (1H, m, 3-H); δC (100 MHz, CDCl3) 24.8 (CH2), 25.6 (CH2), 26.0 (CH2), 
26.7 (CH3), 32.6 (CH2), 49.9 (CH), 83.4 (C), 129.9 (CH), 133.7 (CH), 153.3 (C); m/z (CI) 
212 (MH+, 10%), 156 (100), 155 (7), 112 (5), 81 (7), 69 (9). 
 
1-[tert-Butoxycarbonyl(methyl)amino]cyclohepta-2-ene (194) 
 
NBoc
1
2
3
45
6
7
 
 
1-(tert-Butoxycarbonylamino)cyclohepta-2-ene (193) (0.05 g, 0.20 mmol) was dissolved in 
tetrahydrofuran (5 mL) and added to a solution of sodium hydride (0.03 g, 0.70 mmol, 
60% in mineral oil) in tetrahydrofuran (10 mL). After 0.5 h, iodomethane (0.08 mL, 1.4 
mmol) was added and the reaction mixture was stirred for 5 h at room temperature. The 
mixture was then heated for 24 h under reflux. The solution was concentrated in vacuo, 
quenched with water and acidified with 1 M hydrochloric acid. The reaction mixture was 
extracted with ethyl acetate (4 × 30 mL) and the combined organic layers dried (MgSO4) 
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and concentrated in vacuo. Flash column chromatography (ethyl acetate/petroleum ether, 
2:8) gave 1-[tert-butoxycarbonyl(methyl)amino]cyclohepta-2-ene (194) (0.044 g, 84% 
yield) as a colourless oil. νmax/cm–1 (NaCl) 2921 (CH), 1692 (CO), 1386, 1364, 1313, 
1134, 906; δH (400 MHz, CDCl3) 1.23–1.26 (1H, m, 6-HH), 1.39 (9H, s, OtBu), 1.61–1.68 
(4H, m, 5-HH, 6-HH and 7-H2), 1.83–1.89 (1H, m, 5-HH), 1.95–2.05 (1H, m, 4-HH), 
2.11–2.22 (1H, m, 4-HH), 2.69 (3H, s, NCH3), 4.73–4.76 (1H, m, 1-H), 5.47–5.50 (1H, m, 
2-H), 5.69–5.77 (1H, m, 3-H); δC (100 MHz, CDCl3) 24.5 (CH2), 25.8 (CH2), 26.2 (3 × 
CH3), 26.3 (CH2), 27.3 (CH3), 30.4 (br, CH2), 54.1 (br, CH), 77.0 (C), 129.5 (br, CH), 
132.3 (br, CH), 153.3 (C); m/z (CI) 226.1806 (MH+. C13H24NO2 requires 226.1807), 198 
(6%), 186 (11), 170 (100), 156 (6), 126 (5), 113 (9), 97 (11), 85 (25). 
 
1-[tert-Butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195)  
  
NBoc
1
2
34
5
6
7
O
 
 
Method A:  To a solution of  1-[tert-butoxycarbonyl(methyl)amino]cyclohepta-2-ene 
(194) (0.05 g, 0.22 mmol) in ethyl acetate (3 mL) was added  tert-butyl hydroperoxide 
(0.10 mL, 0.88 mmol, 5.0–6.0 M in decane) and powdered molecular sieves (4Å, 
activated) (0.10 g). The mixture was stirred for 0.5 h at room temperature. Manganese(III) 
acetate dihydrate (0.006 g, 0.02 mmol) was then added. The solution was degassed, filled 
with oxygen and stirred for 48 h at room tempareture. Further portions of tert-butyl 
hydroperoxide (0.10 mL, 0.88 mmol) and manganese(III) acetate dihydrate (0.006 g, 0.02 
mmol) were added. The reaction mixture was stirred for a further 48 h, filtered through a 
pad of Celite® and washed with ethyl acetate (40 mL). The filtrate was then dried (MgSO4) 
and concentrated in vacuo. Purification was carried out by flash column chromatography 
eluting using (ethyl acetate/petroleum ether, 2:8) to give 1-[tert-
butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195) (0.01 g, 22% yield) as a yellow 
oil. νmax/cm–1 (NaCl) 2931 (CH), 1688 (CO), 1366, 1047, 877, 771; δH (400 MHz, CDCl3) 
1.40 (9H, s, OtBu), 1.75–1.87 (3H, m, 6-HH and 7-H2), 1.94–2.04 (1H, m, 6-HH), 2.48–
2.65 (2H, m, 5-H2), 2.69 (3H, s, NCH3), 4.91–4.98 (1H, m, 1-H), 5.97 (1H, d, J 12.4 Hz, 3-
H), 6.28 (1H, br d, J 12.4 Hz, 2-H); δC (100 MHz, CDCl3) 26.6 (3 × CH3), 28.0 (CH3), 29.1 
(CH2), 30.8 (CH2), 41.8 (CH2), 55.0 (br, CH), 78.5 (C), 130.3 (br, CH), 145.6 (br, CH), 
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153.8 (C), 201.5 (C); m/z (CI) 240.1604 (MH+. C13H22NO3 requires 240.1600), 200 (10%), 
184 (100), 173 (15), 155 (15), 132 (18), 109 (39). 
 
Method B: A mixture of 1-[tert-butoxycarbonyl(methyl)amino]cyclohepta-2-ene (194) 
(0.07 g, 0.30 mmol), 10% palladium on carbon (0.005 g), dichloromethane (5 mL), tert-
butyl hydroperoxide (0.12 mL, 1.1 mmol, 5.0–6.0 M in decane) and anhydrous potassium 
carbonate (0.007 g, 0.05 mmol) was stirred at room temperature for 24 h. A further 
quantity of tert-butyl hydroperoxide (0.12 mL, 1.1 mmol, 5.0–6.0 M in decane) and 10% 
palladium on carbon (0.005 g) were added and the reaction mixture stirred for a further 24 
h. The reaction mixture was filtered through a pad of silica which was subsequently 
washed with dichloromethane. After removal of solvent under reduced pressure, the crude 
material was purified by flash column chromatography using (diethyl ether/petroleum 
ether, 1:1) to give 1-[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195) (0.03 
g, 45% yield) as a yellow oil. Spectroscopic data as described above. 
 
1-[tert-Butoxycarbonyl(methyl)amino]cycloheptanone (196)186 
 
NBoc
1
2
34
5
6
7
O
 
 
To a solution of 1-[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195) (0.06 g, 
0.25 mmol) in methanol (8 mL) was added 10% palladium on carbon (0.004 g). The 
reaction mixture was allowed to stir under an atmosphere of hydrogen at room temperature 
for 18 h. The reaction mixture was filtered through a short pad of Celite®, which was 
washed with methanol and concentrated in vacuo. Flash column chromatography (diethyl 
ether/petroleum ether, 1:1) gave 1-[tert-butoxycarbonyl(methyl)amino]cycloheptanone 
(196) (0.020 g, 66% yield) as a white solid. Mp 65–66 °C (lit.186 for opposite enantiomer, 
mp 68–69 °C); νmax/cm–1 (NaCl) 2916 (CH), 1699 (CO), 1674 (CO), 1446, 1363, 1319, 
1155, 939. Spectroscopic data consistent with literature.185 δH (400 MHz, CDCl3) 1.39 (9H, 
s, OtBu), 1.46–1.78 (4H, m, 6-H2 and 7-H2), 1.88–1.91 (2H, m, 2-H2), 2.32–2.56 (4H, m, 
3-H2 and 5-H2), 2.68 (3H, s, NCH3), 4.02-4.11 (1H, m, 1-H); δC (100 MHz, CDCl3) 20.4 
(br, CH2), 27.2 (3 × CH3), 27.5 (CH3), 29.7 (CH2), 32.6 (br, CH2), 39.2 (CH2), 42.3 (CH2), 
55.9 (br, CH), 78.4 (C), 154.0 (C), 212.8 (C); m/z (EI) 241.1676 (M+. C13H23NO3 requires 
241.1678), 185 (31%), 141 (17), 110 (39), 84 (29), 57 (98). 
  
108 
(±)-Physoperuvine (172)187 
NHO
Mee
3
2
4
1
5
6 7
 
A solution of 1-[tert-butoxycarbonyl(methyl)amino]cycloheptanone (196) (0.03 g, 0.10 
mmol) was dissolved in trifluoroacetic acid (0.5 mL) and stirred at room temperature for 
0.5 h. The solvent was removed under vacuum, and the residue was made basic with 
aqueous sodium carbonate (10 mL, 1.0 M) then extracted with dichloromethane (3 × 20 
mL). The combined organic extracts were dried, filtered and evaporated. Flash column 
chromatography (chloroform/methanol/ammonium hydroxide (30%), 5:4:1) gave (±)-
physoperuvine (172) (0.01 g, 60% yield) as a white solid. Mp 73–74 °C (lit.187 mp 72–73 
°C); Spectroscopic data consistent with literature.187 δH (400 MHz, CDCl3) 1.20–1.34 (1H, 
m, 6-HH), 1.52–1.82 (5H, m, 2-H2, 6-HH and 7-H2), 1.87–2.15 (4H, m, 3-H2 and 5-H2), 
2.38 (3H, s, NCH3), 3.12 (1H, br s, 1-H); m/z (CI) 142 (MH+, 100%), 124 (39), 101 (5), 81 
(9), 71 (12). 
 
3.3 Synthesis of (+)-Physoperuvine 
 
(3S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)nona-1,8-diene (197)73 
 
N O
CCll3
H
 
 
The reaction was carried out according to the procedure described for the synthesis of 3-
(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189) using (2E)-nona-2,8-dien-1-
ol (185) (0.15 g, 0.53 mmol) and (S)-COP-Cl 50 (0.04 g, 0.02 mmol). This yielded (3S)-3-
(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (197) (0.12 g, 81%) as a brown oil. 
[α]D23 –28.2 (c 1.0, CHCl3). All other spectroscopic data as previously reported for 3-
(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189). 
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(1S)-1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohepta-2-ene (183)184 
 
HN O
CCll3  
 
The reaction was carried out according to the procedure described for the synthesis of 1-
(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene (190) using (2E)-nona-2,8-dien-
1-ol (185) (0.35 g, 2.50 mmol), (S)-COP-Cl 50 (0.41 g, 0.28 mmol) and Grubbs’ catalyst 
(1st Generation) 111 (0.16 g, 0.20 mmol). This yielded (1S)-1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohepta-2-ene (183) (0.55 g, 86%) as a white solid. 84% 
ee determined by HPLC analysis using CHIRALPAK IB column (0.5% iPrOH : hexane at 
0.5 mL/min), retention time: tS= 21.5 min, and tR= 22.1 min); [α]D23 –25.0 (c 1.0, CHCl3). 
All other spectroscopic data as previously reported for 1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohepta-2-ene (190). 
 
(1S)-1-(tert-Butoxycarbonylamino)cyclohepta-2-ene (198)185 
 
NBooccH  
 
The reaction was carried out according to the procedure described for the synthesis of 1-
(tert-butoxycarbonylamino)cyclohepta-2-ene (193) using (1S)-1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohepta-2-ene (183) (0.50 g, 2.00 mmol). This gave 
(1S)-1-(tert-butoxycarbonylamino)cyclohepta-2-ene (198) (0.45 g, 100%) as a white solid. 
[α]D23 –9.3 (c 1.0, CHCl3). All other spectroscopic data as previously reported for 1-(tert-
butoxycarbonylamino)cyclohepta-2-ene (193).  
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(1S)-1-[tert-Butoxycarbonyl(methyl)amino]cyclohepta-2-ene (199) 
 
NBoocc  
 
The reaction was carried out according to the procedure described for the synthesis of 1-
[tert-butoxycarbonyl(methyl)amino]cyclohepta-2-ene (194) using (1S)-1-(tert-
butoxycarbonylamino)cyclohepta-2-ene (198) (0.17 g, 0.80 mmol). This gave (1S)-1-[tert-
butoxycarbonyl(methyl)amino]cyclohepta-2-ene (199) (0.18 g, 83%) as a colourless oil. 
[α]D23 +24.0 (c 1.0, CHCl3). All other spectroscopic data as previously reported for 1-[tert-
butoxycarbonyl(methyl)amino]cyclohepta-2-ene (194). 
 
(1S)-1-[tert-Butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (182)   
 
NBoc
O
 
 
The reaction was carried out according to the procedure described for the synthesis of 1-
[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195) using (1S)-1-[tert-
butoxycarbonyl(methyl)amino]cyclohepta-2-ene (199) (0.12 g, 0.53 mmol). This gave 
(1S)-1-[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (182) (0.05 g, 41% yield) 
as a yellow oil. [α]D23 –34.2 (c 1.0, CHCl3). All other spectroscopic data as previously 
reported for 1-[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195). 
 
(1S)-1-[tert-Butoxycarbonyl(methyl)amino]cycloheptanone (200)186                       
 
NBoc
O
 
 
The reaction was carried out according to the procedure described for the synthesis of 1-
[tert-butoxycarbonyl(methyl)amino]cycloheptanone (196) using (1S)-1-[tert-
  
111 
butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (182) (0.10 g, 0.37 mmol). This 
yielded (1S)-1-[tert-butoxycarbonyl(methyl)amino]cycloheptanone (200) (0.055 g, 61%) 
as a white solid. [α]D23 +65.1 (c 1.0, CHCl3). All other spectroscopic data as previously 
reported for 1-[tert-butoxycarbonyl(methyl)amino]cycloheptanone (196). 
 
(+)-Physoperuvine (168)187 
 
NHO
Mee
 
 
The reaction was carried out according to the procedure described for the synthesis of (±)-
physoperuvine (172) using (1S)-1-[tert-butoxycarbonyl(methyl)amino]cycloheptanone 
(200) (0.03 g, 0.10 mmol). This gave (+)-physoperuvine (168) (0.01 g, 60% yield) as a 
white solid. [α]D23 +18.3 (c 1.3, H2O, lit.187 [α]D25 +17.9 (c 1.3, H2O). All other 
spectroscopic data as previously reported for (±)-physoperuvine (172). 
 
3.4 Attempted Synthesis of Carbocyclic Nucleosides 
 
Ethyl (2E)-2,6-heptadienoate (212)188 
 
CO2Ett
7
6
5
4
3
2
1  
 
The reaction was carried out according to the procedure described for the synthesis of ethyl 
(2E)-2,8-nonadienoate (188) using 4-penten-1-ol 211 (3.0 g, 34.83 mmol). Flash column 
chromatography (petroleum ether/diethyl ether, 20:1) yielded ethyl (2E)-2,6-heptadienoate 
(212) (4.6 g, 87% yield) as a yellow oil. Spectroscopic data consistent with literature.188 δH 
(400 MHz, CDCl3) 1.28 (3H, t, J 7.2 Hz, OCH2CH3), 2.19–2.24 (2H, m, 5-H2), 2.28–2.33 
(2H, m, 4-H2), 4.19 (2H, q, J 7.2 Hz, OCH2CH3), 4.99–5.09 (2H, m, 7-H2), 5.75–5.80 (1H, 
m, 6-H), 5.81–5.85 (1H, m, 2-H), 6.96 (1H, dt, J 15.6, 6.8 Hz, 3-H); δC (100 MHz, CDCl3) 
14.3 (CH3), 31.5 (CH2), 32.0 (CH2), 60.2 (CH2), 115.5 (CH2), 121.7 (CH), 137.1 (CH), 
148.3 (CH), 166.7 (C); m/z (CI) 155.1075 (MH+. C9H15O2 requires 155.1072), 137 (16%), 
107 (17), 73 (22). 
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(2E)-Hepta-2,6-dien-1-ol (213)188 
 
OH
1
2
3
4
5
6
7
 
 
The reaction was carried out according to the procedure described for the synthesis of 6-
hepten-1-ol (187) using ethyl (2E)-2,6-heptadienoate (212) (5.00 g, 32.46 mmol). Flash 
column chromatography (petroleum ether/diethyl ether, 7:3) yielded, (2E)-hepta-2,6-dien-
1-ol (213) (3.10 g, 86% yield) as a colourless oil. Spectroscopic data consistent with 
literature.188 δH (400 MHz, CDCl3) 1.34 (1H, br s, OH), 2.10–2.15 (4H, m, 4-H2 and 5-H2), 
4.09 (2H, d, J 4.8 Hz, 1-H2), 4.96–5.04 (2H, m, 7-H2), 5.62–5.73 (2H, m, 2-H and 3-H), 
5.73–5.84 (1H, m, 6-H); δC (100 MHz, CDCl3) 31.5 (CH2), 33.3 (CH2), 63.7 (CH2), 114.9 
(CH2), 129.4 (CH), 132.4 (CH), 138.1 (CH); m/z (CI) 113.0964 (MH+. C7H13O requires 
113.0966), 95 (100%), 81 (14), 73 (13). 
 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclopenta-2-ene (215)103 
 
                                                            
1 2
34
5
HN O
CCll3                    
 
The reaction was carried out according to the procedure described for the synthesis of 1-
(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene (190) using (2E)-hepta-2,6-dien-
1-ol (213) (4.00 g, 35.71 mmol), bis(acetonitrile)palladium(II) chloride (0.92 g, 3.57 
mmol) and Grubbs’ catalyst (1st Generation) (2.94 g, 3.57 mmol). Purification by flash 
column chromatography (elution with petroleum ether/diethyl ether, 24:1) gave 1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopenta-2-ene (215) as a white solid (6.0 g, 74% yield 
over 3 steps). Spectroscopic data consistent with literature.103 Mp 82–83 °C; (lit.103 81–82 
°C); δH (400 MHz, CDCl3) 1.66–1.73 (1H, m, 4-HH), 2.35–2.55 (3H, m, 4-HH and 5-H2), 
4.93–5.01 (1H, m, 1-H), 5.72–5.76 (1H, m, 2-H), 6.05–6.10 (1H, m, 3-H), 6.57 (1H, br s, 
NH); δC (100 MHz, CDCl3) 30.5 (CH2), 30.9 (CH2), 57.6 (CH), 90.8 (C), 129.0 (CH), 
136.2 (CH), 160.8 (C); m/z (CI) 229.9718 (MH+. C7H9NO35Cl237Cl requires 229.9721), 
228 (100%), 194 (22), 162 (5), 67 (13). 
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(1R)-1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclopenta-2-ene (208)103 
 
                                                                   
HN O
CCll3  
The reaction was carried out according to the procedure described for the synthesis of 1-
(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene (190) using (2E)-hepta-2,6-dien-
1-ol (213) (0.23 g, 2.05 mmol), (R)-COP-Cl 51 (0.30 g, 0.20 mmol) and Grubbs’ catalyst 
(1st Generation) 111 (0.17 g, 0.20 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 7:3) gave (1R)-1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopenta-2-ene (208) (0.33 g, 71%) as a white solid. 
[α]D23 +87.4 (c 1.0, CHCl3); All other spectroscopic data as previously reported for 1-
(2’,2’,2’-trichloromethylcarbonylamino)cyclopenta-2-ene (215). 
 
(1R)-1-(tert-Butoxycarbonylamino)cyclopenta-2-ene (218)189 
 
                                                             NHBoocc 
 
The reaction was carried out according to the procedure described for the synthesis of 1-
(tert-butoxycarbonylamino)cyclohepta-2-ene (193) using (1R)-1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopenta-2-ene (208)  (0.50 g, 2.00 mmol). This gave 
(1R)-1-(tert-butoxycarbonylamino)cyclopenta-2-ene (218) (0.45 g, 100%) as a white solid. 
[α]D23 +65.0  (c 1.0, CHCl3), lit.189 [α]D25 +77.0 (c 5.1, CH2Cl2). All other spectroscopic 
data as previously reported for 1-(tert-butoxycarbonylamino)cyclohepta-2-ene (220).  
 
(1R)-1-(tert-Butoxycarbonylamino)cyclopenta-2-en-4-one (219)145  
 
                                                         
1 2
3
5
NHBoocc
O
 
 
The reaction was carried out according to the procedure described for the synthesis of 1-
[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195) using (1R)-1-(tert-
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butoxycarbonylamino)cyclopenta-2-ene (218) (0.10 g, 0.54 mmol). Purification by flash 
column chromatography (petroleum ether/diethyl ether, 9:1) gave (1R)-1-(tert-
butoxycarbonylamino)cyclopenta -2-en-4-one (219) (0.025 g, 25%) as white solid. [α]D23 
+16.8 (c 1.0, CHCl3), lit.145 [α]D25 +69.6 (c 2.6, CHCl3); All other spectroscopic data as 
previously reported for 1-(tert-butoxycarbonylamino)cyclopenta-2-en-4-one (221) 
 
1-(tert-Butoxycarbonylamino)cyclopenta-2-ene (220)189 
 
NHBoocc 
 
The reaction was carried out according to the procedure described for the synthesis of 1-
(tert-butoxycarbonylamino)cyclohepta-2-ene (193) using 1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopenta-2-ene (215) (0.23 g, 1.00 mmol). Flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 1-(tert-
butoxycarbonylamino)cyclopenta-2-ene (220) (0.18 g, 100% yield over 2 steps) as a white 
solid. Spectroscopic data consistent with literature.189 Mp 85–86 °C; (lit.189 mp 87.5 °C); 
δH (400 MHz, CDCl3) 1.52 (9H, s, OtBu), 1.57–1.58 (1H, m, 4-HH), 2.27–2.42 (3H, m, 4-
HH and 5-H2), 4.49 (1H, br s, NH), 4.66–4.76 (1H, m, 1-H), 5.66–5.71 (1H, m, 3-H), 5.87–
5.93 (1H, m, 2-H); δC (100 MHz, CDCl3) 28.4 (3 × CH3), 31.0 (CH2), 31.7 (CH2), 56.8 
(CH), 79.2 (C), 131.5 (CH), 134.1 (CH), 155.8 (C); m/z (CI) 184 (MH+. 45%), 128 (100), 
119 (27), 113 (11), 84 (7). 
 
1-(tert-Butoxycarbonylamino)cyclopenta-2-en-4-one (221)145 
 
NHBoocc
O
 
 
Method A: A solution of 1-(tert-butoxycarbonylamino)cyclopenta-2-ene (220) (0.10 g, 
0.54 mmol) in n-butyl butanoate (1 mL), diacetoxyiodobenzene (0.53 g, 1.64 mmol) and 
potassium carbonate (0.037 g, 0.27 mmol) was vigorously stirred at –20 °C. tert-Butyl 
hydroperoxide (0.40 mL, 2.18 mmol, 5.0–6.0 M in decane) was added dropwise. The 
solution was heated for 72 h, cooled and the solvent was removed in vacuo. Flash column 
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chromatography (petroleum ether/diethyl ether, 5:5) gave 1-(tert-
butoxycarbonylamino)cyclopenta-2-en-4-one (221) (0.016 g, 15%) as white solid. Mp 
122–124 °C; (lit.145 mp 124–125 °C); δH (400 MHz, CDCl3) 1.46 (9H, s, OtBu), 2.18 (1H, 
d, J 10.8 Hz, 5-HH), 2.88 (1H, dd, J 10.8, 6.4 Hz, 5-HH), 4.67 (1H, br s, NH), 4.90–5.10 
(1H, m, 1-H), 6.22–6.28 (1H, m, 3-H), 7.50–7.58 (1H, m, 2-H); δC (100 MHz, CDCl3) 28.3 
(3 × CH3), 42.4 (CH2), 50.1 (CH), 80.1 (C), 135.3 (CH), 155.0 (CH), 162.2 (C), 207.0 (C); 
m/z (CI) 198 (MH+. 4%), 155 (4), 142 (100), 126 (4), 69 (12). 
 
Method B: The reaction was carried out according to the procedure described for the 
synthesis of 1-[tert-butoxycarbonyl(methyl)amino]cyclohept-2-en-4-one (195) using 1-
(tert-butoxycarbonylamino)cyclopenta-2-ene (220) (0.10 g, 0.54 mmol). Purification by 
flash column chromatography (petroleum ether/diethyl ether, 9:1) gave 1-(tert-
butoxycarbonylamino)cyclopenta-2-en-4-one (221) (0.025 g, 25%) as white solid. 
Spectroscopic data as described above. 
 
(1S,2R)-1-(2’,2’,2’-Trichloromethylcarbonylamino)-2-hydroxycyclopenta-3-ene (225) 
 
1
2
34
5
HN O
CCll3
OH
 
 
To a solution of 1-(2’,2’,2’-trichloromethylcarbonylamino)cyclopenta-2-ene (215) (0.40 g, 
1.75 mmol) in chloroform (5 mL), N-iodosuccinimide (0.14 g, 0.65 mmol) was added and 
the mixture was heated at 61 °C for 15 h. The solvent was removed in vacuo. The resulting 
residue was dissolved in ethyl acetate (20 mL) and the organic phase washed with water (3 
× 10 mL), dried (MgSO4) and the solvent removed in vacuo. The residue obtained 223 was 
dissolved in toluene (10 mL) and 1,8-diazabicyclo[5,4,0]undec-7-ene (0.10 mL, 0.65 
mmol) was added. The reaction mixture was heated under reflux for 12 h under argon. The 
reaction mixture was then cooled and solvent was removed in vacuo. The resulting dark 
coloured solid 224 was dissolved in methanol (10 mL). 2.0 M Hydrochloric acid (5 mL) 
was added and reaction mixture was stirred at room temperature for 1 h. The reaction 
mixture was then diluted with a saturated solution of sodium hydrogencarbonate (10 mL) 
and extracted with ethyl acetate (3 × 10 mL). The organic layers were combined, dried 
(MgSO4) and concentrated in vacuo. Purification by flash column chromatography 
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(petroleum ether/diethyl ether, 5:5) gave (1S,2R)-1(2’,2’,2’-
trichloromethylcarbonylamino)-2-hydroxycyclopenta-3-ene (225) (0.19 g, 45%) as white 
solid. Mp 111–113 °C; νmax/cm–1 (NaCl) 3379 (OH), 2945 (CH), 1693 (CO), 1505, 1096, 
909, 822; [α]D23 +53.7  (c 1.0, CHCl3); δH (400 MHz, CDCl3) 2.13 (1H, br s, OH), 2.32–
2.39 (1H, m, 5-HH), 2.86–2.93 (1H, m, 5-HH), 4.32 (1H, ddd, J 14.0, 6.8, 3.6 Hz, 1-H), 
4.72–4.79 (1H, m, 2-H), 5.91–5.95 (1H, m, 3-H), 6.07 (1H, dt, J 6.0, 3.6 Hz, 4-H), 7.36 
(1H, br s, NH); δC (100 MHz, CDCl3) 37.2 (CH2), 52.4 (CH), 74.3 (CH), 92.6 (C), 131.2 
(CH), 135.3 (CH), 162.0 (C); m/z (CI) 243.9695 (MH+. C7H935Cl3NO2 requires 243.9699), 
226 (100%), 192 (31), 126 (20), 85 (21). 
 
3.5 Synthesis of (+)-Monanchorin 
 
(2S)-1-(tert-Butyldimethylsilyloxy)-2,3-epoxypropane (250)190 
 
O
OTBDMS
1
23
 
 
A mixture of (R)-(+)-glycidol 249 (4.61 g, 60.70 mmol), tert-butyldimethylsilyl chloride 
(9.15 g, 60.70 mmol) and imidazole (4.13 g, 60.70 mmol) were dissolved in 
tetrahydrofuran (300 mL) and stirred overnight at room temperature. A white precipitate 
was removed by filtration and washed with diethyl ether (200 mL). The combined filtrate 
was concentrated and purified by flash column chromatography using (diethyl 
ether/petroleum ether, 1:10) which gave (2S)-1-(tert-butyldimethylsilyloxy)-2,3-
epoxypropane (250) (11.5 g, 88%) as a colourless oil. Spectroscopic data consistent with 
literature.190 [α]D23 –6.1 (c 1.3, CHCl3); δH (400 MHz, CDCl3) 0.09 (3H, s, SiCH3), 0.10 
(3H, s, SiCH3), 0.81 (9H, s, SiC(CH3)3), 2.56 (1H, dd, J 5.1, 2.6 Hz, 1-HH), 2.70 (1H, dd, 
J 5.1, 4.1 Hz, 1-HH), 2.98–3.03 (1H, m, 2-H), 3.60 (1H, dd, J 11.9, 4.8 Hz, 3-HH), 3.80 
(1H, dd, J 11.9, 3.1 Hz, 3-HH); δC (100 MHz, CDCl3) –5.3 (CH3), –5.2 (CH3), 18.4 (C), 
25.9 (3 × CH3), 44.5 (CH2), 52.5 (CH), 63.8 (CH2); m/z (CI) 189.1309 (MH+. C9H21O2Si 
requires 189.1311), 145 (35%), 131 (50), 89 (62), 73 (12). 
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(2S)-1-(tert-Butyldimethylsilyloxy)heptan-2-ol (251)191 
 
OTBDMS
OH
1
2
3
4
5
6
7  
 
A solution of n-butyllithium (2.5 M in hexane) (0.53 mL, 1.33 mmol) was added dropwise 
to a solution of copper iodide (0.11 g, 0.58 mmol) in tetrahydrofuran (15 mL) at –78 °C 
and the white suspension was stirred for 1 h. (2S)-1-(tert-Butyldimethylsilyloxy)-2,3-
epoxypropane (250) (0.10 g, 0.53 mmol) in THF (10 mL) was then added and the reaction 
mixture was warmed to 0 °C and stirred for 3 h. The reaction was quenched by the addition 
of a saturated solution of ammonium chloride (10 mL) and extracted with ethyl acetate (3 
× 20 mL). The organic layers were combined, dried (MgSO4) and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 20:1) gave 
(2S)-1-(tert-butyldimethylsilyloxy)heptan-2-ol (251) (0.06 g, 90%) as a colourless oil. 
Spectroscopic data consistent with literature.191 νmax/cm–1 (NaCl) 3434 (OH), 2929 (CH), 
1464, 1255, 1106, 837, 778; [α]D23 +7.3 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.09 (6H, s, 
2 × SiCH3), 0.79–0.84 (12H, m, 7-H3 and SiC(CH3)3), 1.19–1.42 (8H, m, 3-H2, 4-H2, 5-H2 
and 6-H2), 2.37 (1H, br s, OH), 3.31 (1H, dd, J 10.4, 8.3 Hz, 1-HH), 3.51–3.60 (2H, m, 1-
HH and 2-H); δC (100 MHz, CDCl3) –5.4 (CH3), –5.3 (CH3), 14.1 (CH3), 18.3 (C), 22.6 
(CH2), 25.3 (CH2), 25.9 (3 × CH3), 32.0 (CH2), 32.8 (CH2), 67.3 (CH2), 71.9 (CH); m/z 
(CI) 247 (MH+. 11%), 206, (3), 150 (4), 88 (3), 52 (100). 
                                  
(2S)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)heptane (252) 
 
4
5
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OMOM
1
2
3
6
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A solution of (2S)-1-(tert-butyldimethylsilyloxy)heptan-2-ol (251) (5.00 g, 20.3 mmol) 
was dissolved in dichloromethane (200 mL) and cooled to 0 °C. Diisopropylethylamine 
(10.6 mL, 61.0 mmol) was then added followed by bromomethyl methyl  ether (3.40 mL, 
41.7 mmol). The solution was stirred for 0.5 h at 0 °C then heated under reflux overnight. 
The reaction mixture was cooled to room temperature, acidified with 1.0 M hydrochloric 
acid (15 mL) and extracted with dichloromethane (3 × 100 mL). After removal of the 
solvent under reduced pressure, the resulting material was purified by flash column 
chromatography (petroleum ether/diethyl ether, 20:1) to give (2S)-1-(tert-
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butyldimethylsilyloxy)-2-(methoxymethoxy)heptane (252) as a pale yellow oil (5.70 g, 
96%). νmax/cm–1 (NaCl) 2930 (CH), 1464, 1256, 1111, 1039, 838, 776; [α]D23 –32.7 (c 1.0, 
CHCl3); δH (400 MHz, CDCl3) 0.01 (6H, s, Si(CH3)2), 0.80–0.86 (12H, m, 7-H3 and 
Si(CH3)3), 1.24–1.43 (8H, m, 3-H2, 4-H2, 5-H2 and 6-H2), 3.33 (3H, s, OCH3), 3.51–3.58 
(3H, m, 1-H2 and 2-H), 4.60 (1H, d, J 6.7 Hz, OCHHO), 4.73 (1H, d, J 6.7 Hz, OCHHO); 
δC (100 MHz, CDCl3) –6.5 (CH3), –6.4 (CH3), 13.0 (CH3), 17.3 (C), 21.6 (CH2), 24.0 
(CH2), 24.9 (3 × CH3), 30.7 (CH2), 31.0 (CH2), 54.4 (CH3), 64.9 (CH2), 77.2 (CH) 95.2 
(CH2); m/z (CI) 291.2354 (MH+. C15H35O3Si requires 291.2355), 259 (100), 229 (12), 203 
(6), 133 (3), 85 (8). 
 
(2S)-2-(Methoxymethoxy)heptan-1-ol (248) 
 
4
5
OH
OMOM
1
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3
6
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A solution of tetrabutylammonium fluoride (1.0 M in tetrahydrofuran) (24.7 mL, 24.8 
mmol) was added to a solution of (2S)-1-(tert-butyldimethylsilyloxy)-2-
(methoxymethoxy)heptane (252) (6.00 g, 20.7 mmol) in tetrahydrofuran (300 mL) at 0 °C. 
The reaction mixture was warmed to room temperature and stirred overnight. The reaction 
mixture was then concentrated and the resulting residue was re-suspended in diethyl ether 
(200 mL). The solution was washed with water (100 mL) and the aqueous layer was then 
extracted with diethyl ether (3 × 100 mL). The combined organic extracts were dried 
(MgSO4), concentrated and purified by flash column chromatography (petroleum 
ether/diethyl ether, 5:2) to give (2S)-2-(methoxymethoxy)heptan-1-ol (248) as a colourless 
oil (3.65 g, 100%). νmax/cm–1 (NaCl) 3450 (OH), 2931 (CH), 1466, 1103, 1041; [α]D23 
+57.1 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.90 (3H, t, J 7.0 Hz, 7-H3), 1.23–1.54 (8H, 
m, 3-H2, 4-H2, 5-H2 and 6-H2), 3.11 (1H, dd, J 8.7, 3.3 Hz, OH), 3.43 (3H, s, OCH3), 3.48–
3.62 (3H, m, 1-H2 and 2-H), 4.70 (1H, d, J 6.9 Hz, OCHHO), 4.75 (1H, d, J 6.9 Hz, 
OCHHO); δC (100 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 25.2 (CH2), 31.7 (CH2), 31.8 
(CH2), 55.7  (CH3), 65.8 (CH2), 82.5 (CH), 97.0 (CH2); m/z (CI) 177.1491 (MH+. C9H21O3 
requires 177.1491), 145 (100), 143 (8), 115 (42), 97 (18). 
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Ethyl (2E,4S)-4-(methoxymethoxy)nona-2-enoate (253) 
 
4
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The reaction was carried out according to the procedure described for the synthesis of ethyl 
(2E)-2,8-nonadienoate (188) using (2S)-2-(methoxymethoxy)heptan-1-ol (248) (3.33 g, 
19.0 mmol). Purification by flash column chromatography using (diethyl ether/petroleum 
ether, 2:5) yielded ethyl (2E,4S)-4-(methoxymethoxy)nona-2-enoate (253) (4.62 g, 86%) 
as a colourless oil. νmax/cm–1 (NaCl) 2934 (CH), 1723 (CO), 1658 (C=C), 1467, 1368, 
1273, 1156, 1038; [α]D23 –67.7 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.89 (3H, t, J 6.7 Hz, 
9-H3), 1.28–1.43 (9H, m, 6-H2, 7-H2, 8-H2 and OCH2CH3), 1.51–1.66 (2H, m, 5-H2), 3.38 
(3H, s, OCH3), 4.16–4.24 (3H, m, 4-H and OCH2CH3), 4.57 (1H, d, J 6.8 Hz, OCHHO), 
4.63 (1H, d, J 6.8 Hz, OCHHO), 5.92 (1H, d, J 15.7 Hz, 2-H), 6.82 (1H, dd, J 15.7, 6.4 Hz, 
3-H); δC (100 MHz, CDCl3) 14.0 (CH3), 14.2 (CH3), 22.6 (CH2), 24.8 (CH2), 31.7 (CH2), 
34.9 (CH2), 55.6 (CH3), 60.5 (CH2), 75.2 (CH), 94.6 (CH2), 121.8 (CH), 148.0 (CH), 166.3 
(C); m/z (CI) 245.1752 (MH+. C13H25O4 requires 245.1753), 215 (22), 183 (100), 173 (10), 
137 (4), 109 (4). 
 
(2E,4S)-4-(Methoxymethoxy)nona-2-ene-1-ol (254) 
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The reaction was carried out according to the procedure described for the synthesis of 6-
hepten-1-ol (187) using ethyl (2E,4S)-4-(methoxymethoxy)nona-2-enoate (253) (4.56 g, 
18.7 mmol). Flash column chromatography (diethyl ether/petroleum ether, 2:5) gave 
(2E,4S)-4-(methoxymethoxy)nona-2-ene-1-ol (254) (3.50 g, 92%) as a colourless oil. 
(Found: C, 65.18; H, 11.09. C11H22O3 requires C, 65.34; H, 10.89%); νmax/cm–1 (NaCl) 
3407 (OH), 2932 (CH), 1673 (C=C), 1467, 1378, 1213, 1115, 1096, 1039, 920; [α]D23 –
69.8 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.89 (3H, t, J 6.7 Hz, 9-H3), 1.27–1.55 (7H, m, 
6-H2, 7-H2, 8-H2 and OH), 1.58–1.64 (2H, m, 5-H2), 3.37 (3H, s, OCH3), 3.99–4.06 (1H, 
m, 4-H), 4.16 (2H, td, J 5.6, 1.4 Hz, 1-H2), 4.53 (1H, d, J 6.7 Hz, OCHHO), 4.70 (1H, d, J 
6.7 Hz, OCHHO), 5.56 (1H, ddt, J 15.5, 7.4, 1.4 Hz, 3-H), 5.82 (1H, dtd, J 15.5, 5.6, 0.6 
  
120 
Hz, 2-H); δC (100 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 25.1 (CH2), 31.7 (CH2), 35.5 
(CH2), 55.4 (CH3), 62.8 (CH2), 76.4 (CH), 93.6 (CH2), 131.5 (CH), 132.1 (CH); m/z (CI) 
203 (MH+. 10%), 185 (19), 142 (83), 138 (37), 124 (100), 100 (19), 83 (49). 
 
(3R,4S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-(methoxymethoxy)nona-1-ene 
(245a) 
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Method A: The reaction was carried out according to the procedure described for the 
synthesis of 3-(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189) using (2E,4S)-
4-(methoxymethoxy)nona-2-ene-1-ol (254) (0.20 g, 1.00 mmol) and 
bis(acetonitrile)palladium(II) chloride (0.025 g, 0.10 mmol). Flash column 
chromatography (diethyl ether/petroleum ether, 1:20) gave (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)nona-1-ene (245a) as a colourless oil 
(0.20 g, 55% over 2 steps). νmax/cm–1 (NaCl) 3284 (NH), 2933 (CH), 1715 (CO), 1644 
(C=C), 1517, 1236, 1100, 1037, 822; [α]D23 +59.0 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 
0.89 (3H, t, J 6.8 Hz, 9-H3), 1.24–1.53 (6H, m, 6-H2, 7-H2 and 8-H2), 1.58–1.68 (2H, m, 5-
H2), 3.43 (3H, s, OCH3), 3.54–3.59 (1H, m, 4-H), 4.36–4.42 (1H, m, 3-H), 4.74 (1H, d, J 
6.8 Hz, OCHHO), 4.66 (1H, d, J 6.8 Hz, OCHHO), 5.30–5.37 (2H, m, 1-H2), 5.85 (1H, 
ddd, J 16.8, 10.4, 6.7 Hz, 2-H), 8.27 (1H, br d, J 7.6 Hz, NH); δC (100 MHz, CDCl3) 14.0 
(CH3), 22.4 (CH2), 25.4 (CH2), 31.7 (CH2), 33.0 (CH2), 56.0 (CH), 56.7 (CH3), 83.9 (CH), 
93.0 (C), 98.2 (CH2), 119.0 (CH2), 131.6 (CH), 161.5 (C); m/z (FAB) 346.0747 (MH+. 
C13H2335Cl3NO3 requires 346.0744), 314 (57%), 284 (28), 213 (100), 201 (11), 179 (14), 
123 (34). 
 
Method B: The reaction was carried out according to the procedure described for the 
synthesis of 3-(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189) using (2E,4S)-
4-(methoxymethoxy)nona-2-ene-1-ol (254) (0.74 g, 3.66 mmol), 
bis(acetonitrile)palladium(II) chloride (0.10 g, 0.36 mmol) and p-benzoquinone (0.21 g, 
2.00 mmol). Flash column chromatography (diethyl ether/petroleum ether, 1:20) gave 
(3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)nona-1-ene 
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(245a) as a colourless oil (0.90 g, 75% over 2 steps). Spectroscopic data as described 
above. 
 
(2E,4R,5S)-4-(2’,2’,2’-Trichloromethylcarbonylamino)-5-(methoxymethoxy)-2-decen-
1-al (257) 
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Method A: A solution of (3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)nona-1-ene (245a) (0.10 g, 0.28 mmol) was dissolved in 
dichloromethane (10 mL) and degassed with argon. Acrolein (0.10 g, 1.44 mmol) and 
Grubbs 2nd generation catalyst (0.02 g, 0.03 mmol) were added. The reaction mixture was 
heated under reflux overnight. The mixture was concentrated under vacuum. Purification 
by flash column chromatography (diethyl ether/petroleum ether, 1:19) gave (2E,4R,5S)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-5-(methoxymethoxy)-2-decen-1-al (257) (0.009 
g, 9%) as a yellow oil. νmax/cm–1 (NaCl) 3273 (NH), 2932 (CH), 2858, 1713 (CO), 1694 
(CO), 1519, 1466, 1099, 1033, 822; [α]D23 +55.2 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 
0.91 (3H, t, J 6.8 Hz, 10-H3), 1.27–1.60 (6H, m, 7-H2, 8-H2 and 9-H2), 1.63–1.72 (2H, m, 
6-H2), 3.43 (3H, s, OCH3), 3.67 (1H, ddd, J 8.8, 6.4, 2.0 Hz, 5-H), 4.62–4.67 (2H, m, 
OCHHO and 4-H), 4.75 (1H, d, J 6.7 Hz, OCHHO), 6.30 (1H, ddd, J 15.8, 7.8, 1.6 Hz, 2-
H), 6.81 (1H, dd, J 15.8, 5.8 Hz, 3-H), 8.59 (1H, br d, J 7.8 Hz, NH), 9.61 (1H, d, J 7.8 Hz, 
1-H); δC (100 MHz, CDCl3) 14.0 (CH3), 22.5 (CH2), 25.4 (CH2), 31.5 (CH2), 33.2 (CH2), 
55.5 (CH), 56.0 (CH3), 84.1 (CH), 92.5 (C), 98.4 (CH2), 134.4 (CH), 149.8 (CH), 161.8 
(C), 193.0 (CH); m/z (CI) 376.0659 (MH+. C14H2335Cl237ClNO4 requires 376.0665), 342 
(41%), 314 (100), 278 (19), 207 (9), 181 (9), 145 (46). 
 
Method B: The reaction was carried out according to the procedure described above using 
(3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)nona-1-ene 
(245a) (0.10 g, 0.28 mmol), crotonaldehyde (0.12 g, 1.44 mmol) and Grubbs 2nd generation 
catalyst (0.02 g, 0.03 mmol). Purification by flash column chromatography (diethyl 
ether/petroleum ether, 2:8) gave (2E,4R,5S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-
(methoxymethoxy)-2-decen-1-al (257) (0.05 g, 50%) as a yellow oil. Spectroscopic data as 
described above. 
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(4R,5S)-4-(2’-chloromethylcarbonylamino)-5-methoxy-1-decane-1-ol (262) 
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The reaction was carried out according to the procedure described for the synthesis of1-
[tert-butoxycarbonyl(methyl)amino]cycloheptanone (196) using (2E,4R,5S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-(methoxymethoxy)-2-decen-1-al (257) (0.05 g, 0.26 
mmol). Flash column chromatography (diethyl ether/petroleum ether, 7:3) gave (4R,5S)-4-
(2’-chloromethylcarbonylamino)-5-methoxy-1-decane-1-ol (262) (0.023 g, 62%) as a 
colourless oil. νmax/cm–1 (NaCl) 3294 (NH), 2918 (CH), 1669 (CO), 1466, 1267, 1071, 
774; [α]D23 +52.3 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.82 (3H, t, J 6.8 Hz, 10-H3), 
1.36–1.61 (12H, m, 2-H2, 3-H2, 6-H2, 7-H2, 8-H2 and 9-H2), 3.27 (3H, s, OCH3), 3.27–3.33 
(2H, m, 1-H2), 3.55–3.67 (1H, m, 5H), 3.82–3.92 (1H, m, 4-H), 4.00 (2H, s, CH2Cl), 6.80 
(1H, br d, J 7.8 Hz, NH); δC (100 MHz, CDCl3) 14.0 (CH3), 22.6 (CH2), 25.2 (CH2), 25.7 
(CH2), 26.2 (CH2), 31.8 (CH2), 33.3 (CH2), 42.7 (CH2), 54.3 (CH), 58.7 (CH3), 72.2 (CH2), 
74.2 (CH), 166.4 (C); m/z (FAB) 280.1679 (MH+. C13H27 35ClNO3  requires 280.1681), 262 
(12%), 178 (7), 81 (18). 
 
(3R,4S)-3-(Benzyloxycarbonylamino)-4-(methoxymethoxy)nona-1-ene (263) 
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A solution of (3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)nona-1-ene (245a) (2.00 g, 5.77 mmol) was dissolved in 2.0 M sodium 
hydroxide solution (70 mL) and heated at 45 °C overnight. The reaction mixture was 
cooled to room temperature and benzyl chloroformate (3.25 mL, 23.1 mmol) was added 
and stirred overnight at room temperature. The reaction mixture was extracted with ethyl 
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acetate (4 × 100 mL) and the combined organic layers dried (MgSO4) and concentrated in 
vacuo. Purification by flash column chromatography (diethyl ether/petroleum ether, 3:7) 
gave (3R,4S)-3-(benzyloxycarbonylamino)-4-(methoxymethoxy)nona-1-ene (263) (1.55 g, 
81%) as a colourless oil. νmax/cm–1 (NaCl) 3339 (NH), 2933 (CH), 1722 (CO), 1519, 1234, 
1099, 1038; [α]D23 +48.7 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.9 Hz, 9-
H3), 1.27–1.60 (8H, m, 5-H2, 6-H2, 7-H2 and 8-H2), 3.39 (3H, s, OCH3), 3.54–3.57 (1H, m, 
4-H), 4.24 (1H, t, J 7.0 Hz, 3-H), 4.63 (1H, d, J 7.0 Hz, OCHHO), 4.68 (2H, m, OCHHO 
and NH), 5.11 (2H, s, PhCH2), 5.20–5.28 (2H, m, 1-H2), 5.76–5.89 (1H, m, 2-H), 7.28–
7.38 (5H, m, Ph); δC (100 MHz, CDCl3) 14.0 (CH3), 22.3 (CH2), 25.3 (CH2), 31.5 (CH2), 
32.1 (CH2), 55.8 (CH3), 56.0 (CH), 66.5 (CH2), 82.7 (CH), 97.3 (CH2), 117.4 (CH2), 128.0 
(2 × CH), 128.5 (3 × CH), 133.8 (CH), 136.7 (C), 156.0 (C); m/z (CI) 336.2177 (MH+. 
C19H30NO4 requires 336.2175), 304 (45%), 260 (10), 228 (9), 181 (7), 147 (9), 91 (23). 
 
1-(tert-Butyldimethylsilyloxy)-2-propene (265)192 
 
OTBDMS
1
2
3  
 
The reaction was carried out according to the procedure described for the synthesis of (2S)-
1-(tert-butyldimethylsilyloxy)-2,3-epoxypropane (250) using propene-1-ol (264) (1.0 g, 
17.21 mmol). Flash column chromatography (petroleum ether/ethyl acetate, 20:1) gave 1-
(tert-butyldimethylsilyloxy)-2-propene (265) as a colourless oil (2.37 g, 80% yield). 
Spectroscopic data consistent with literature.192 δH (400 MHz, CDCl3) 0.05 (6H, s, 
Si(CH3)2), 0.83 (9H, s, Si(CH3)2), 4.10 (2H, dd, J 4.5, 1.9 Hz, 1-H2), 5.00 (1H, ddt, J 10.4, 
1.9, 1.8 Hz, 3-HH), 5.17 (1H, ddt, J 17.1, 1.9, 1.8 Hz, 3-HH), 5.85 (1H, ddt, J 17.1, 10.4, 
4.5 Hz, 2-H); δC (100 MHz, CDCl3) –5.2 (2 × CH3), 11.5 (C), 26.0 (3 × CH3), 64.1 (CH2), 
114.0 (CH2), 137.5 (CH); m/z (CI) 279 (MH+. 11%), 173 (14), 137 (12), 85 (69), 69 (98).  
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(2Z,4S)-3-(N-Benzyloxycarbonyl)-4-(methoxymethoxy)-nona-2-ene (267a) and 
(2E,4S)-3-(N-Benzyloxycarbonyl)-4-(methoxymethoxy)-nona-2-ene (267b) 
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                                             267a                                                      267b 
 
The reaction was carried out according to the procedure for the synthesis of (2E,4R,5S)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-5-(methoxymethoxy)-2-decen-1-al (257) using 
(3R,4S)-3-(benzyloxycarbonylamino)-4-(methoxymethoxy)nona-1-ene (263) (0.10 g, 0.30 
mmol), 1-(tert-butyldimethylsilyloxy)-2-propene (265) (0.20 mL, 0.90 mmol) and Grubbs 
2nd generation catalyst (0.05 g, 0.06 mmol). Flash column chromatography (petroleum 
ether/diethylether, 7:3) gave 267a followed by 267b (0.077 g, 77% combined yield) as a 
brown oil. 267a: νmax/cm–1 (NaCl) 3325 (NH), 2934 (CH), 1723 (CO), 1539, 1243, 1023, 
916, 699; [α]D23 –73.3 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.78 (3H, t, J 6.6 Hz, 9-H3), 
1.18–1.55 (8H, 5-H2, 6-H2, 7-H2 and 8-H2), 1.59 (3H, d, J 7.2 Hz, 1-CH3), 3.26 (3H, s, 
OCH3), 4.34 (1H, d, J 6.6 Hz, OCHHO), 4.44–4.50 (2H, m, 4-H and OCHHO), 5.01 (2H, 
s, PhCH2), 6.06–6.15 (2H, m, 2-H and NH), 7.21–7.28 (5H, m, Ph); δC (100 MHz, CDCl3) 
11.8 (CH3), 14.0 (CH3), 22.5 (CH2), 25.1 (CH2), 31.6 (CH2), 33.4 (CH2), 55.7 (CH3), 66.6 
(CH2), 70.7 (CH), 93.7 (CH2), 111.0 (CH), 128.2 (2 × CH), 128.6 (CH), 131.6 (C), 136.3 
(C), 154.1 (C); m/z (FAB) 336.2175 (MH+, C19H29NO4 requires 336.2172), 304 (70%), 260 
(10), 216 (70), 180 (30), 107 (72), 69 (23). 267b: νmax/cm–1 (NaCl) 3312 (NH), 2932 (CH), 
1721 (CO), 1498, 1222, 1034, 920, 697; [α]D23 –82.0 (c 1.0, CHCl3); δH (400 MHz, 
CDCl3) 0.86 (3H, t, J 6.6 Hz, 9-H3), 1.25–1.57 (8H, m, 5-H2, 6-H2, 7-H2 and 8-H2), 1.62 
(3H, d, J 6.7 Hz, 1-H3), 3.35 (3H, s, OCH3), 4.00 (1H, t, J 6.8 Hz, 4-H), 4.44 (1H, d, J 6.7 
Hz, OCHHO), 4.67 (1H, d, J 6.7 Hz, OCHHO), 5.13 (2H, s, OCH2Ph), 5.43 (1H, q, J 6.7 
Hz, 2-H ), 5.83 (1H, br s, NH), 7.31–7.37 (5H, m, Ph); δC (100 MHz, CDCl3) 13.2 (CH3), 
14.0 (CH3), 22.5 (CH2), 25.3 (CH2), 31.7 (CH2), 33.0 (CH2), 55.8 (CH3), 66.5 (CH2), 78.7 
(CH), 93.4 (CH2), 121.7 (CH), 128.1 (CH), 128.6 (2 × CH), 131.6 (C), 136.3 (C), 154.1 
(C); m/z (FAB) 336.2175 (MH+. C19H29NO4 requires 336.2172), 304 (9%), 274 (98), 184 
(17), 166 (42), 91 (52). 
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2-[(1E,3R,4S)-3-(Benzyloxycarbonylamino)-4-(methoxymethoxy)nona-2-enyl]-1,3-
dioxolane (244) 
4
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The reaction was carried out according to the procedure described for the synthesis of 
(2E,4R,5S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-(methoxymethoxy)-2-decen-1-al 
(257) using (3R,4S)-3-(benzyloxycarbonylamino)-4-(methoxymethoxy)nona-1-ene (263) 
(0.10 g, 0.30 mmol), 2-vinyl-1,3-dioxolane (246) (0.09 g, 0.90 mmol) and Grubbs 2nd 
generation catalyst (0.03 g, 0.03 mmol). Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 1:1) gave 2-[(1E,3R,4S)-3-(benzyloxycarbonylamino)-4-
(methoxymethoxy)nona-2-enyl]-1,3-dioxolane (244) (0.80 g, 87%) as a yellow oil. 
νmax/cm–1 (NaCl) 3338 (NH), 2953 (CH), 1722 (CO), 1522, 1235, 1149, 1037, 699; [α]D23 
+2.9 (c 1.5, CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.5 Hz, 9-H3), 1.27–1.58 (8H, m, 
5-H2, 6-H2, 7-H2 and 8-H2), 3.38 (3H, s, OCH3), 3.52–3.59 (1H, m, 4-H), 3.85–4.00 (4H, 
m, OCH2CH2O), 4.29–4.36 (1H, m, 3-H), 4.62 (1H, d, J 7.0 Hz, OCHHO), 4.70 (1H, d, J 
7.0 Hz, OCHHO), 5.07 (1H, d, J 12.0 Hz, OCHHPh), 5.12 (1H, d, J 12.0 Hz, OCHHPh), 
5.29 (1H, d, J 5.9 Hz, OCHO), 5.70 (1H, dd, J 15.9, 5.6 Hz, 2-H), 5.84 (1H, d, J 8.8 Hz, 
NH), 5.90 (1H, dd, J 15.9, 5.9 Hz, 1-H), 7.28–7.35 (5H, m, Ph); δC (100 MHz, CDCl3) 
14.0 (CH3), 22.3 (CH2), 25.4 (CH2), 31.7 (CH2), 32.1 (CH2), 54.6 (CH), 55.9 (CH3), 64.8 
(CH2), 65.0 (CH2), 66.6 (CH2), 82.7 (CH),  97.3 (CH2), 103.1 (CH), 128.1 (2 × CH), 128.5 
(3 × CH), 129.4 (CH), 131.3 (CH), 131.6 (CH), 136.6 (C), 155.8 (C); m/z (CI) 408.2381 
(MH+. C22H34NO6 requires 408.2386), 377 (21%), 300 (12), 284 (31), 246 (100), 214 (32), 
145 (21), 91 (92). 
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2-[(3R,4S)-3-(N,N’-Bis(tert-butoxycarbonyl)guanidino)-4-(methoxymethoxy)nonyl]-
1,3-dioxolane (243) 
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To a solution of 2-[(1E,3R,4S)-3-(benzyloxycarbonylamino)-4-(methoxymethoxy)nona-2-
enyl]-1,3-dioxolane (244) (0.02 g, 0.06 mmol) in methanol (5 mL) was added 10% 
palladium on carbon (0.03 g). The reaction mixture was allowed to stir under an 
atmosphere of hydrogen at room temperature for 18 h. The reaction mixture was filtered 
through a short pad of Celite® which was washed with methanol (50 mL). The resulting 
solution was concentrated in vacuo to give 2-[(3R,4S)-3-amino-4-
(methoxymethoxy)nonyl]-1,3-dioxolane (268) (0.01 g, 71%) as a colourless oil which was 
used without further purification. 2-[(3R,4S)-3-Amino-4-(methoxymethoxy)nonyl]-1,3-
dioxolane (268) (0.01 g, 0.04 mmol) was dissolved in methanol (7 mL). 
Diisopropylethylamine (0.06 mL, 0.33 mmol) and N,N’-bis(tert-butoxycarbonyl)-1H-
pyrazole-1-carboxamidine (269) (0.02 g, 0.06 mmol) were then added. The reaction 
mixture was stirred for 20 h at room temperature. The methanol was removed in vacuo. 
The resulting residue was dissolved in ethyl acetate (10 mL) and acidified with 0.2 M 
hydrochloric acid. The organic layer was washed with brine (10 mL), extracted with ethyl 
acetate (2 × 10 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 10:1) gave 2-[(3R,4S)-3-(N,N’-
bis(tert-butoxycarbonyl)guanidino)-4-(methoxymethoxy)nonyl]-1,3-dioxolane (243) (0.02 
g, 87%) as a colourless oil. νmax/cm–1 (NaCl) 3325 (NH), 2933 (CH), 1795, 1720 (CO), 
1638 (C=N), 1332, 1155, 1034 (C=N), 757; [α]D23 –8.1 (c 1.5, CHCl3); δH (400 MHz, 
CDCl3) 0.89 (3H, t, J 6.7 Hz, 9-H3), 1.25–1.35 (6H, m, 6-H2, 7-H2 and 8-H2), 1.47 (9H, s, 
OtBu), 1.48 (9H, s, OtBu), 1.50–1.82 (6H, m, 1-H2, 2-H2 and 5-H2), 3.38 (3H, s, OCH3), 
3.61–3.66 (1H, m, 4-H), 3.82–3.89 (2H, m, OCHHCHO), 3.94–3.99 (2H, m, 
OCHHCHHO), 4.34–4.42 (1H, m, 3-H), 4.62 (1H, d, J 6.9 Hz, OCHHO), 4.69 (1H, d, J 
6.9 Hz, OCHHO), 4.88 (1H, t, J 4.4 Hz, OCHO), 8.44 (1H, d, J 9.2 Hz, NH), 11.53 (1H, br 
s, NH); δC (100 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 23.2 (CH2), 25.5 (CH2), 28.1 (3 × 
CH3), 28.3 (3 × CH3), 30.3 (CH2), 31.1 (CH2), 31.8 (CH2), 52.0 (CH), 55.8 (CH3), 64.8 
(CH2), 64.9 (CH2), 78.8 (C), 79.7 (C), 82.8 (CH), 96.4 (CH2), 104.3 (CH), 153.1 (C), 156.1 
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(C), 163.8 (C); m/z (FAB) 518.3443 (MH+. C25H48N3O8 requires 518.3441), 462 (9%), 406 
(55), 362 (22), 311 (14), 260 (7), 199 (6), 111 (12). 
 
(+)-Monanchorin (234)149,150 
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To a solution of 2-[(3R,4S)-3-(N,N’-bis(tert-butoxycarbonyl)guanidino)-4-
(methoxymethoxy)nonyl]-1,3-dioxolane (243)  (0.04 g, 0.07 mmol) in dichloromethane (5 
mL) was added trifluoroacetic acid  (0.35 mL, 4.64 mmol). The reaction mixture was 
heated under reflux for 12 h. The reaction mixture was quenched with potassium carbonate 
(0.10 g, 0.77 mmol), filtered and concentrated under vacuum. Flash column 
chromatography (dichloromethane/methanol, 2:1) gave (+)-monanchorin (234) (0.01 g, 
75%) as a colourless oil. Spectroscopic data consistent with literature.149,150 [α]D22 +33.7 (c 
0.8, MeOH), lit149 [α]D25 +39.0 (c 3.9, MeOH); δH (400 MHz, CDCl3) 0.91 (3H, t, J 6.7 Hz, 
15-H3), 1.22–1.35 (5H, m, 12-HH, 13-H2 and 14-H2), 1.42–1.49 (2H, m, 11-HH, 12-HH), 
1.60–1.66 (1H, m, 11-HH), 2.00–2.11 (2H, m, 8-HH and 9-HH), 2.19–2.23 (1H, m, 8-HH), 
2.28–2.37 (1H, m, 9-HH), 3.23–3.27 (1H, m, 5-H), 4.29–4.35 (1H, m, 6-H), 4.84 (1H, t, J 
6.2 Hz, 1-H), 8.56 (1H, br s, NH), 8.96 (1H, br s, NH); δC (100 MHz, CDCl3) 14.0 (CH3), 
22.5 (CH2), 23.8 (CH2), 25.1 (CH2), 28.9 (CH2), 31.6 (CH2), 33.6 (CH2), 51.3 (CH), 76.7 
(CH), 79.5 (CH), 159.1 (C); m/z (CI) 212 (MH+. 85%), 170 (15), 129 (19), 113 (31), 81 
(67). 
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3.6 Synthesis of Clavaminol A, C and H 
 
(2S)-1-(tert-Butyldimethylsilyloxy)undecan-2-ol (280)    
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The reaction was carried out according to the procedure described for the synthesis of (2S)-
1-(tert-butyldimethylsilyloxy)heptan-2-ol (251) using (2S)-1-(tert-butyldimethylsilyloxy)-
2,3-epoxypropane (250) (5.00 g, 26.6 mmol), octylmagnesium bromide (2.0 M in diethyl 
ether) (26.60 mL, 53.1 mmol) and copper(I) bromide dimethyl sulfide (6.01 g, 29.2 mmol). 
Purification by flash column chromatography (petroleum ether/diethyl ether, 30:1) gave 
(2S)-1-(tert-butyldimethylsilyloxy)undecan-2-ol (280) (7.55 g, 94%) as a colourless oil. 
νmax/cm–1 (NaCl) 3423 (OH), 2927 (CH), 1464, 1254, 1109, 837, 777; [α]D23 –19.4 (c 2.7, 
CHCl3); δH (400 MHz, CDCl3) 0.07 (6H, s, 2 × SiCH3), 0.80–0.84 (12H, m, 11-H3 and 
SiC(CH3)3), 1.22–1.44 (16H, m, 3-H2, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, and 10-H2), 2.42 
(1H, d, J 3.2 Hz, OH), 3.38 (1H, dd, J 10.8, 8.4 Hz, 1-HH), 3.60–3.65 (2H, m, 1-HH and 2-
H); δC (100 MHz, CDCl3) –5.4 (CH3), –5.3 (CH3), 14.1 (CH3), 18.3 (C), 22.7 (CH2), 25.6 
(CH2), 25.9 (3 × CH3), 29.3 (CH2), 29.6 (2 × CH2), 29.7 (CH2), 32.0 (CH2), 32.8 (CH2), 
67.3 (CH2), 71.8 (CH); m/z (CI) 303.2722 (MH+. C17H39O2Si requires 303.2719), 285 
(24%), 185 (10), 133 (11), 113 (14), 69 (60). 
 
(2S)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)undecane (279)    
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The reaction was carried out according to the procedure described for the synthesis of (2S)-
1-(tert-butyldimethylsilyloxy)-2-(methoxymethoxy)heptane (252) using (2S)-1-(tert-
butyldimethylsilyloxy)undecan-2-ol (280) (5.00 g, 16.6 mmol). Purification by flash 
column chromatography (petroleum ether/diethyl ether, 30:1) gave (2S)-1-(tert-
butyldimethylsilyloxy)-2-(methoxymethoxy)undecane (279) as a colourless oil (5.72 g, 
100%). (Found: C, 65.92; H, 12.23. C19H42O3Si requires C, 65.90; H, 12.14%); νmax/cm–1 
(NaCl) 2927 (CH), 1465, 1254, 1113, 1040, 837, 776; [α]D23 +49.9 (c 1.4, CHCl3); δH (400 
  
129 
MHz, CDCl3) 0.01 (6H, s, Si(CH3)2), 0.83–0.85 (12H, m, 11-H3 and SiC(CH3)3), 1.18–
1.44 (16H, m, 3-H2, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, and 10-H2), 3.32 (3H, s, OCH3), 
3.48–3.60 (3H, m, 1-H2 and 2-H), 4.59 (1H, d, J 6.8 Hz, OCHHO), 4.72 (1H, d, J 6.8 Hz, 
OCHHO); δC (100 MHz, CDCl3) –5.1 (2 × CH3), 14.1 (CH3), 18.3 (C), 22.7 (CH2), 25.4 
(CH2), 25.9 (3 × CH3), 29.3 (CH2), 29.6 (2 × CH2), 29.7 (CH2), 31.7 (CH2), 31.9 (CH2), 
55.4 (CH3), 65.9 (CH2), 78.2 (CH), 96.3 (CH2); m/z (CI) 347.2983 (MH+. C19H43O3Si 
requires 347.2981), 315 (100%), 285 (24), 259 (8), 221 (6), 133 (7), 97 (18), 81 (52), 69 
(68). 
 
(2S)-2-(Methoxymethoxy)undecan-1-ol (281)    
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The reaction was carried out according to the procedure described for the synthesis of (2S)-
2-(methoxymethoxy)heptan-1-ol (248) using (2S)-1-(tert-butyldimethylsilyloxy)-2-
(methoxymethoxy)undecane (279) (5.00 g, 14.5 mmol). Purification by flash column 
chromatography (petroleum ether/diethyl ether, 5:2) gave (2S)-2-
(methoxymethoxy)undecan-1-ol (281) as a colourless oil (3.35 g, 100%). νmax/cm–1 (NaCl) 
3435 (OH), 2925 (CH), 1466, 1106, 1037, 918; [α]D23 +6.7 (c 1.2, CHCl3); δH (400 MHz, 
CDCl3) 0.90 (3H, t, J 6.8 Hz, 11-H3), 1.26–1.52 (16H, m, 3-H2, 4-H2, 5-H2, 6-H2, 7-H2, 8-
H2, 9-H2, and 10-H2), 3.15 (1H, dd, J 8.8, 3.2 Hz, OH), 3.43 (3H, s, OCH3), 3.46–3.62 (3H, 
m, 1-H2 and 2-H), 4.70 (1H, d, J 6.9 Hz, OCHHO), 4.75 (1H, d, J 6.9 Hz, OCHHO); δC 
(100 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 25.5 (CH2), 29.3 (CH2), 29.5 (CH2), 29.6 (2 × 
CH2), 31.6 (CH2), 31.8 (CH2), 55.6 (CH3), 65.7 (CH2), 82.5 (CH), 97.0 (CH2); m/z (CI) 
233.2119 (MH+. C13H29O3 requires 233.2117), 215 (10%), 201 (94), 183 (38), 171 (100), 
153 (14), 113 (6), 81 (18), 69 (26). 
 
Ethyl (2E,4S)-4-(methoxymethoxy)tridecan-2-enoate (278) 
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The reaction was carried out according to the procedure described for the synthesis of ethyl 
(2E)-2,8-nonadienoate (188) using (2S)-2-(methoxymethoxy)undecan-1-ol (281) (5.38 g, 
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23.1 mmol). Purification by flash column chromatography using (diethyl ether/petroleum 
ether, 1:10) yielded ethyl (2E,4S)-4-(methoxymethoxy)tridecan-2-enoate (278) (6.61 g, 
95%) as a colourless oil. (Found: C, 67.85; H, 10.86. C17H32O4 requires C, 68.00; H, 
10.67%); νmax/cm–1 (NaCl) 2927 (CH), 1724 (CO), 1658 (C=C), 1467, 1368, 1268, 1154, 
1035, 722; [α]D23 –62.1 (c 1.1, CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.8 Hz, 13-
H3), 1.21–1.62 (19H, m, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2 and OCH2CH3), 
3.38 (3H, s, OCH3), 4.16–4.24 (3H, m, 4-H and OCH2CH3), 4.58 (1H, d, J 6.8 Hz, 
OCHHO), 4.64 (1H, d, J 6.8 Hz, OCHHO), 5.97 (1H, dd, J 16.0, 1.2 Hz, 2-H), 6.82 (1H, 
dd, J 16.0, 6.4 Hz, 3-H); δC (100 MHz, CDCl3) 14.2 (CH3), 14.3 (CH3), 22.7 (CH2), 25.2 
(CH2), 29.3 (CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 31.9 (CH2), 34.9 (CH2), 55.7 
(CH3), 60.5 (CH2), 75.2 (CH), 94.6 (CH2), 121.8 (CH), 148.0 (CH), 166.4 (C); m/z (CI) 
301.2378 (MH+. C17H33O4 requires 301.2379), 271 (15%), 239 (100), 173 (6), 145 (5), 69 
(17). 
 
(2E,4S)-4-(Methoxymethoxy)tridecan-2-ene-1-ol (282)     
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The reaction was carried out according to the procedure described for the synthesis of 6-
hepten-1-ol (187) using (2E,4S)-4-(methoxymethoxy)tridecan-2-enoate (278) (4.70 g, 15.7 
mmol). Flash column chromatography (diethyl ether/petroleum ether, 2:5) gave (2E,4S)-4-
(methoxymethoxy)tridecan-2-ene-1-ol (282) (3.84 g, 95%) as a colourless oil. (Found: C, 
70.15; H, 11.99. C15H30O3 requires C, 69.77; H, 11.63%); νmax/cm–1 (NaCl) 3399 (OH), 
2925 (CH), 2855, 1466, 1377, 1213, 1152, 1128, 1096, 1036, 973; [α]D23 –87.3 (c 1.0, 
CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.4 Hz, 13-H3), 1.26–1.62 (17H, m, 5-H2, 6-
H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2, 12-H2 and OH), 3.37 (3H, s, OCH3), 4.01 (1H, q, J 7.0 
Hz, 4-H), 4.16 (2H, td, J 5.6, 1.2 Hz, 1-H2), 4.53 (1H, d, J 6.8 Hz, OCHHO), 4.70 (1H, d, J 
6.8 Hz, OCHHO), 5.56 (1H, ddt, J 15.6, 7.0, 1.2 Hz, 3-H), 5.81 (1H, dt, J 15.6, 5.6 Hz, 2-
H); δC (100 MHz, CDCl3) 14.1 (CH3), 22.7 (CH2), 25.4 (CH2), 29.3 (CH2), 29.6 (2 × CH2), 
29.6 (CH2), 31.9 (CH2), 35.6 (CH2), 55.4 (CH3), 62.9 (CH2), 76.3 (CH), 93.8 (CH2), 131.7 
(CH), 131.9 (CH); m/z (CI) 241.2166 (MH+–H2O. C15H29O2 requires 241.2168), 197 
(100%), 179 (33), 155 (14), 131 (21), 85 (28). 
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(3R,4S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-(methoxymethoxy)tridecan-1-
ene (276a)    
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The reaction was carried out according to the procedure described for the synthesis of 3-
(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189) using (2E,4S)-4-
(methoxymethoxy)tridecan-2-ene-1-ol (282) (2.55 g, 9.90 mmol), 
bis(acetonitrile)palladium(II) chloride (0.38 g, 1.48 mmol) and p-benzoquinone (2.13 g, 
19.8 mmol). Purification by flash column chromatography (diethyl ether/petroleum ether, 
1:20) gave (3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)tridecan-1-ene (276a) as a colourless oil (2.78 g, 70% over 2 steps). 
νmax/cm–1 (NaCl) 3287 (NH), 2855 (CH), 1717 (CO), 1643 (C=C), 1517, 1237, 1036, 822, 
758; [α]D23 +66.0 (c 1.1, CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.8 Hz, 13-H3), 
1.24–1.65 (16H, m, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, 11-H2 and 12-H2), 3.43 (3H, s, 
OCH3), 3.56 (1H, ddd, J 8.4, 4.8, 2.0 Hz, 4-H), 4.36–4.41 (1H, m, 3-H), 4.65 (1H, d, J 6.8 
Hz, OCHHO), 4.74 (1H, d, J 6.8 Hz, OCHHO), 5.30–5.36 (2H, m, 1-H2), 5.85 (1H, ddd, J 
17.2, 10.4, 6.8 Hz, 2-H), 8.24 (1H, br d, J 7.6 Hz, NH); δC (100 MHz, CDCl3) 14.1 (CH3), 
22.7 (CH2), 25.7 (CH2), 29.3 (CH2), 29.5 (2 × CH2), 29.5 (CH2), 31.9 (CH2), 33.0 (CH2), 
55.9 (CH), 56.7 (CH3), 83.9 (CH), 93.0 (C), 98.2 (CH2), 118.9 (CH2), 131.6 (CH), 161.4 
(C); m/z (CI) 402.1369 (MH+. C17H3135Cl3NO3 requires 402.1370), 370 (100%), 336 (36), 
308 (25), 270 (19), 214 (60), 180 (19), 85 (20), 69 (31). 
 
(2R,3S)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol 
(283) 
 
OMOM
12
3
4
5
6
7
8
9
10
11
OH
12
HN O
CCl3  
(3R,4S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-(methoxymethoxy)tridecan-1-ene 
(276a) (0.94 g, 2.33 mmol) was dissolved in a mixture of dichloromethane (40 mL) and 
methanol (20 mL) and cooled to –78 °C. Ozone was bubbled through the reaction mixture 
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until the solution turned slightly blue. After excess ozone was purged with argon gas, 
sodium borohydride (0.08 g, 2.33 mmol) was added in portions. The solution was stirred 
for 1.5 h at 0 °C, then acidified with 1 M hydrochloric acid (10 ml). The reaction was 
quenched by the addition of water (20 mL) and then extracted with diethyl ether (4 × 50 
mL). The organic layers were combined, dried (MgSO4) and concentrated to give an 
orange oil. Purification by flash column chromatography using (diethyl ether/petroleum 
ether, 5:5) yielded (2R,3S)-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecan-1-ol (283) (0.84 g, 88% over 2 steps) as a colourless oil. 
(Found: C, 47.26; H, 7.45; N, 3.32. C16H30Cl3NO4 requires C, 47.23; H, 7.38; N, 3.44%); 
νmax/cm–1 (NaCl) 3416 (NH), 2926 (CH), 1712 (CO), 1522, 1467, 1214, 1034, 906, 822, 
756; [α]D23 +23.3 (c 1.3, CHCl3); δH (400 MHz, CDCl3) 0.91 (3H, t, J 6.8 Hz, 12-H3), 
1.25–1.78 (16H, m, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 2.70 (1H, dd, J 
9.6, 3.6 Hz, OH), 3.47 (3H, s, OCH3), 3.74–3.84 (2H, m, 1-HH and 3-H), 3.95 (1H, dq, J 
8.2, 3.6 Hz, 2-H), 4.08 (1H, dt, J 12.0, 3.6 Hz, 1-HH), 4.65 (1H, d, J 6.8 Hz, OCHHO), 
4.73 (1H, d, J 6.8 Hz, OCHHO), 8.01 (1H, br d, J 8.2 Hz, NH); δC (100 MHz, CDCl3) 14.1 
(CH3), 22.7 (CH2), 25.7 (CH2), 29.3 (CH2), 29.5 (CH2), 29.5 (2 × CH2), 31.9 (CH2), 32.9 
(CH2), 54.7 (CH), 56.1 (CH3), 61.2 (CH2), 82.6 (CH), 92.7 (C), 97.9 (CH2), 162.2 (C); m/z 
(CI) 406.1317 (MH+. C16H3135Cl3NO4 requires 406.1319), 374 (100%), 340 (43), 288 (14), 
272 (6), 183 (4), 121 (3), 81 (6). 
 
(2R,3S)-1-Methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (284) 
 
OMOM
12
3
4
5
6
7
8
9
10
11
OMs
12
HN O
CCl3  
 
A solution of (2R,3S)-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecan-1-ol (283) (0.38 g, 0.95 mmol) was dissolved in 
dichloromethane (40 mL). Methanesulfonyl chloride (0.16 mL, 1.47 mmol), triethylamine 
(0.29 mL, 2.16 mmol) and 4-dimethylaminopyridine (DMAP, catalytic) were added at 0 
°C and the solution stirred at room temperature for 24 h. The reaction mixture was then 
washed with water (20 mL), extracted with dichloromethane (3 × 30 mL). The resulting 
organic layer was dried (MgSO4) and concentrated to give the crude product, which was 
purified by flash column chromatography (diethyl ether/petroleum ether, 2:3) to give 
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(2R,3S)-1-methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (284) (0.39 g, 87%) as a colourless oil. νmax/cm–1 (NaCl) 3346 
(NH), 2926 (CH), 1716 (CO), 1524, 1359, 1177, 1034, 823; [α]D23 +25.8 (c 1.7, CHCl3); 
δH (400 MHz, CDCl3) 0.88 (3H, t, J 7.2 Hz, 12-H3), 1.21–1.72 (16H, m, 4-H2, 5-H2, 6-H2, 
7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 3.06 (3H, s, OSO2CH3), 3.45 (3H, s, OCH3), 3.59–
3.65 (1H, m, 3-H), 4.23–4.29 (1H, m, 2-H), 4.34 (1H, dd, J 10.4, 7.8 Hz, 1-HH),  4.50 (1H, 
dd, J 10.4, 4.4 Hz, 1-HH), 4.63 (1H, d, J 6.8 Hz, OCHHO), 4.74 (1H, d, J 6.8 Hz, 
OCHHO), 8.15 (1H, br d, J 8.4 Hz, NH); δC (100 MHz, CDCl3) 14.1 (CH3), 22.7 (CH2), 
25.8 (CH2), 29.3 (CH2), 29.4 (CH2), 29.5 (2 × CH2), 31.9 (CH2), 33.0 (CH2), 37.8 (CH3), 
53.2 (CH), 56.0 (CH3), 66.4 (CH2), 82.4 (CH), 92.6 (C), 98.3 (CH2), 162.2 (C); m/z (CI) 
484.1089 (MH+. C17H3335Cl3NO6S requires 484.1094), 452 (83%), 418 (19), 388 (100), 
354 (85), 322 (44), 279 (74), 201 (10), 153 (6), 85 (11). 
 
(2R,3S)-1-Bromo-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (285) 
 
OMOM
12
3
4
5
6
7
8
9
10
11
Br
12
HN O
CCl3  
 
(2R,3S)-1-methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (284) (0.41 g, 0.85 mmol) was dissolved in dimethyl 
sulfoxide (20 mL), then sodium bromide (0.44 g, 4.26 mmol) was added and the reaction 
mixture was heated under reflux overnight. The reaction mixture was cooled and 
concentrated in vacuo. The resulting residue was dissolved in diethyl ether (20 mL) and 
washed with water (2 × 30 mL). The organic layer was dried and concentrated in vacuo. 
Purification by column chromatography (petroleum ether/diethyl ether, 14:1) gave (2R,3S)-
1-bromo-2-(trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecane (285) (0.30 g, 
75%) as a colourless oil. νmax/cm–1 (NaCl) 3337 (NH), 2925 (CH), 1718 (CO), 1523, 1148, 
1034, 821; [α]D23 +32.8 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.81 (3H, t, J 6.8 Hz, 12-
H3), 1.16–1.59 (16H, m, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 3.37 (3H, 
s, OCH3), 3.50 (1H, dd, J 10.8, 7.6 Hz, 1-HH), 3.56–3.61 (2H, m, 1-HH and 3-H), 4.16–
4.23 (1H, m, 2-H), 4.57 (1H, d, J 6.8 Hz, OCHHO), 4.65 (1H, d, J 6.8 Hz, OCHHO), 7.62 
(1H, br d, J 9.2 Hz, NH); δC (100 MHz, CDCl3) 14.1 (CH3), 22.7 (CH2), 25.4 (CH2), 29.3 
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(CH2), 29.5 (CH2), 29.5 (2 × CH2), 31.4 (CH2), 31.9 (CH2), 32.5 (CH2), 54.6 (CH), 56.1 
(CH3), 81.7 (CH), 92.7 (C), 97.8 (CH2), 161.8 (C); m/z (CI) 470.0442 (MH+. 
C16H3081Br35Cl3NO3 requires 470.0451), 438 (100%), 436 (63), 408 (16), 354 (9), 201 (4), 
171 (3), 95 (2), 69 (8). 
 
(2R,3S)-2-Acetylamino-3-(methoxymethoxy)dodecane (286) 
 
OMOM
12
3
4
5
6
7
8
9
10
11
12
NHAc  
 
A mixture of (2R,3S)-1-bromo-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (285) (0.14 g, 0.29 mmol), tributyltin hydride (1.01 mL, 3.47 
mmol), AIBN (0.02 g) in toluene (9 mL) and N,N-dimethylacetamide (3 mL) were 
degassed under argon for 0.3 h and then heated under reflux for 24 h. The reaction mixture 
was cooled, washed with water (20 mL), extracted with diethyl ether (3 × 20 mL) and 
concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/diethyl ether, 1:8) gave (2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecane (286) 
(0.07 g, 85%) as a white solid. Mp 35–37 °C; νmax/cm–1 (NaCl) 3290 (NH), 2925 (CH), 
1648 (CO), 1546, 1374, 1038, 920; [α]D23 +46.1 (c 1.7, CHCl3); δH (400 MHz, CDCl3) 
0.90 (3H, t, J 7.2 Hz, 12-H3), 1.11 (3H, d, J 6.8 Hz, 1-H3), 1.28–1.62 (16H, m, 4-H2, 5-H2, 
6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 1.98 (3H, s, COCH3), 3.43–3.48 (4H, m, OCH3 
and 3-H), 3.98–4.06 (1H, m, 2-H), 4.64 (1H, d, J 6.8 Hz, OCHHO), 4.74 (1H, d, J 6.8 Hz, 
OCHHO), 6.65 (1H, br d, J 7.6 Hz, NH); δC (100 MHz, CDCl3) 14.0 (CH3), 14.1 (CH3), 
22.7 (CH2), 23.6 (CH3), 25.9 (CH2), 29.3 (CH2), 29.5 (CH2), 29.6 (CH2), 29.7 (CH2), 31.9 
(CH2), 32.7 (CH2), 47.2 (CH), 55.7 (CH3), 84.4 (CH), 98.1 (CH2), 169.1 (C); m/z (CI) 
288.2543 (MH+. C16H34NO3 requires 288.2539), 256 (29%), 226 (9), 184 (3), 131 (4), 86 
(5). 
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(2R,3S)-2-Aminododecan-3-ol (Clavaminol A) (270)158 
 
OH
12
3
4
5
6
7
8
9
10
11
12
NH2  
 
(2R,3S)-2-Acetylamino-3-(methoxymethoxy)dodecane (286) (0.02 g, 0.06 mmol) was 
dissolved in 6 M hydrochloric acid (10 mL) and heated to 60 °C for 24 h. The reaction 
mixture was then cooled before being washed with diethyl ether (3 × 10 mL). The aqueous 
layer was concentrated to give (2R,3S)-2-aminododecan-3-ol (270) (0.014 g, 100%) as a 
white solid. Mp 107–109 °C; νmax/cm–1 (NaCl) 3389 (NH), 2928 (CH), 1610, 1500, 1025, 
721; [α]D23 –4.5 (c 1.5, MeOH), lit.158 [α]D25 –4.25 (c 0.0094, MeOH); δH (400 MHz, 
CD3OD) 0.93 (3H, t, J 7.2 Hz, 12-H3), 1.24 (3H, d, J 6.8 Hz, 1-H3), 1.31–1.59 (16H, m, 4-
H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 3.30 (1H, qd, J 6.8, 3.2 Hz, 2-H), 
3.70–3.75 (1H, m, 3-H); δC (100 MHz, CD3OD) 12.1 (CH3), 14.5 (CH3), 23.8 (CH2), 27.0 
(CH2), 30.5 (CH2), 30.7 (CH2), 30.7 (2 × CH2), 33.1 (CH2), 34.0 (CH2), 52.6 (CH), 71.7 
(CH); m/z (CI) 202.2175 (MH+. C12H28NO requires 202.2171), 184 (15%), 156 (10), 97 
(4), 85 (6), 71 (7). 
 
(2R,3S)-2-Acetylaminododecan-3-ol (Clavaminol C) (271)158 
 
OH
12
3
4
5
6
7
8
9
10
11
12
NHAc  
 
(2R,3S)-2-Acetylamino-3-(methoxymethoxy)dodecane (286) (0.02 g, 0.07 mmol) was 
dissolved in 2 M hydrochloric acid (10 mL) and stirred at room temperature for 24 h. The 
reaction mixture was washed with diethyl ether (3 × 10 mL) and the organic layers were 
concentrated in vacuo. Purification by flash column chromatography (diethyl 
ether/methanol, 15:1) yielded (2R,3S)-2-acetylaminododecan-3-ol (271) (0.02 g, 100%) as 
a white solid. Mp 103–105 °C; νmax/cm–1 (NaCl) 3283 (NH), 2918 (CH), 1645 (CO), 1558, 
1467, 1126, 747; [α]D23 +11.1 (c 2.1, MeOH), lit.158 [α]D25 +11.4 (c 0.0022, MeOH); δH 
(400 MHz, CDCl3) 0.81 (3H, t, J 7.2 Hz, 12-H3), 1.03 (3H, d, J 6.8 Hz, 1-H3), 1.17–1.43 
(16H, m, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 1.92 (3H, s, COCH3), 2.12 
(1H, d, J 6.0 Hz, OH), 3.54–3.61 (1H, m, 3-H), 3.90–3.98 (1H, m, 2-H), 5.71 (1H, br d, J 
7.2 Hz, NH); δC (100 MHz, CDCl3) 14.0 (CH3), 14.2 (CH3), 22.7 (CH2), 23.5 (CH3), 26.0 
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(CH2), 29.3 (CH2), 29.6 (CH2), 29.6 (CH2), 29.7 (CH2), 31.9 (CH2), 33.6 (CH2), 49.5 (CH), 
74.3 (CH), 170.0 (C); m/z (CI) 244.2275 (MH+. C14H30NO2 requires 244.2277), 226 (5%), 
151 (5), 113 (5), 85 (39), 69 (58). 
 
(2R,3S)-2-Aminododecan-1,3-diol (273) 
 
OH
12
3
4
5
6
7
8
9
10
11
OH
12
NH2  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-aminododecan-3-ol (270) using (2R,3S)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (283) (0.04 g, 0.10 
mmol). The water layer was concentrated to give (2R,3S)-2-aminododecan-1,3-diol (273) 
(0.02 g, 100%) as a colourless oil. νmax/cm–1 (NaCl) 3348 (NH/OH), 2924 (CH), 1600, 
1467, 1051; [α]D23 +6.6 (c 0.6, MeOH); δH (400 MHz, CD3OD) 0.92 (3H, t, J 6.8 Hz, 12-
H3), 1.25–1.58 (16H, m, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 3.33–3.35 
(1H, m, 2-H), 3.73 (1H, dd, J 11.6, 8.8 Hz, 1-HH), 3.79–3.85 (1H, m, 3-H), 3.87 (1H, dd, J 
11.6, 3.6 Hz, 1-HH); δC (100 MHz, CD3OD) 14.5 (CH3), 23.8 (CH2), 27.1 (CH2), 30.5 
(CH2), 30.6 (CH2), 30.7 (2 × CH2), 33.1 (CH2), 34.2 (CH2), 58.5 (CH), 58.9 (CH2), 70.3 
(CH); m/z (CI) 218.2113 (MH+. C12H28NO2 requires 218.2120), 200 (4%), 186 (3), 171 (4), 
81 (5), 69 (6). 
 
(2R,3S)-2-Acetylamino-3-(methoxymethoxy)dodecan-1-ol (287) 
 
OMOM
12
3
4
5
6
7
8
9
10
11
OH
12
NHAc  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecane (286) using (2R,3S)-2-
(trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (283) (0.30 g, 0.73 
mmol) and tributyltin hydride (2.50 mL, 8.85 mmol). Flash column chromatography using 
(diethyl ether/methanol, 15:1) yielded (2R,3S)-2-acetylamino-3-
(methoxymethoxy)dodecan-1-ol (287) (0.20 g, 91%) as a colourless oil. νmax/cm–1 (NaCl) 
3297 (NH/OH), 2925 (CH), 1656 (CO), 1551, 1376, 1035; [α]D23 +34.6 (c 2.5, CHCl3); δH 
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(400 MHz, CDCl3) 0.75 (3H, t, J 6.8 Hz, 12-H3), 1.10–1.52 (16H, m, 4-H2, 5-H2, 6-H2, 7-
H2, 8-H2, 9-H2, 10-H2, and 11-H2), 1.89 (3H, s, COCH3), 3.18 (1H, dd, J 8.6, 3.2 Hz, OH), 
3.29 (3H, s, OCH3), 3.48 (1H, ddd, J 8.4, 4.8, 3.2 Hz, 3-H), 3.55 (1H, ddd, J 11.2, 8.6, 3.2 
Hz, 1-HH), 3.71–3.77 (1H, m, 1-HH), 3.80–3.86 (1H, m, 2-H), 4.47 (1H, d, J 6.8 Hz, 
OCHHO), 4.54 (1H, d, J 6.8 Hz, OCHHO), 6.60 (1H, br d, J 8.0 Hz, NH); δC (100 MHz, 
CDCl3) 14.1 (CH3), 22.7 (CH2), 23.4 (CH3), 25.8 (CH2), 29.3 (CH2), 29.5 (CH2), 29.6 (2 × 
CH2), 31.9 (CH2), 32.7 (CH2), 53.3 (CH), 56.0 (CH3), 62.4 (CH2), 82.7 (CH), 98.0 (CH2), 
170.6 (C); m/z (CI) 304.2483 (MH+. C16H34NO4 requires 304.2488), 272 (58%), 242 (8), 
200 (3), 147 (4), 102 (4), 85 (4). 
 
(2R,3S)-2-Acetylaminododecan-1,3-diol (Clavaminol H) (272)159 
 
OH
12
3
4
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OH
12
NHAc  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylaminododecan-3-ol (271) using (2R,3S)-2-acetylamino-3-
(methoxymethoxy)dodecan-1-ol (287) (0.02 g, 0.08 mmol). Flash column chromatography 
using (diethyl ether/methanol, 15:1) yielded (2R,3S)-2-acetylaminododecan-1,3-diol (272) 
(0.02 g, 100%) as a white solid. Mp 107–109 °C; νmax/cm–1 (NaCl) 3289 (NH/OH), 2917 
(CH), 1650 (CO), 1551, 1371, 1091; [α]D23 +3.3 (c 1.4, MeOH), lit.159 [α]D25 +3.19 (c 
0.0013, MeOH); δH (400 MHz, CDCl3) 0.81 (3H, t, J 6.8 Hz, 12-H3), 1.14–1.53 (16H, m, 
4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 1.99 (3H, s, COCH3), 2.44 (1H, d, J 
6.8 Hz, 3-OH), 2.53 (1H, dd, J 6.8, 3.6 Hz, 1-OH), 3.66–3.80 (3H, m, 1-HH, 2-H and 3-H), 
3.96 (1H, dt, J 11.2, 3.6 Hz, 1-HH), 6.35 (1H, br d, J 7.2 Hz, NH); δC (100 MHz, CDCl3) 
14.1 (CH3), 22.7 (CH2), 23.5 (CH3), 26.0 (CH2), 29.3 (2 × CH2), 29.6 (2 × CH2), 31.9 
(CH2), 34.6 (CH2), 53.6 (CH), 62.5 (CH2), 74.4 (CH), 170.4 (C); m/z (CI) 260 (MH+. 
100%), 242 (29), 228 (6), 186 (4), 102 (3), 85 (18). 
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3.7 Synthesis of (2S,3R)-Clavaminol A, C and H 
 
(2R)-1-(tert-Butyldimethylsilyloxy)-2,3-epoxypropane (289)193 
 
O
OTBDMS  
 
The reaction was carried out according to the procedure described for the synthesis of (2S)-
1-(tert-butyldimethylsilyloxy)-2,3-epoxypropane (250) using (S)-(+)-glycidol 288 (9.93 g, 
134.0 mmol). This yielded (2R)-1-(tert-butyldimethylsilyloxy)-2,3-epoxypropane 289 
(22.9 g, 91%) as a colourless oil.193 [α]D24 +2.6 (c 1.0, CHCl3). All other spectroscopic 
data as previously reported for (2S)-1-(tert-butyldimethylsilyloxy)-2,3-epoxypropane 
(250). 
 
(2R)-1-(tert-Butyldimethylsilyloxy)undecan-2-ol (290) 
 
OTBDMS
OH
 
 
The reaction was carried out according to the procedure described for the synthesis of (2S)-
1-(tert-butyldimethylsilyloxy)heptan-2-ol (251) using (2R)-1-(tert butyldimethylsilyloxy)-
2,3-epoxypropane 289 (5.00 g, 26.6 mmol). This gave (2R)-1-(tert-
butyldimethylsilyloxy)undecan-2-ol (290) (8.1 g, 100%) as a colourless oil. [α]D23 +19.0 (c 
1.0, CHCl3). All other spectroscopic data as previously reported for (2S)-1-(tert-
butyldimethylsilyloxy)undecan-2-ol (280). 
 
(2R)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)undecane (291)  
 
OTBDMS
OMOM
 
 
The reaction was carried out according to the procedure described for the synthesis of (2S)-
1-(tert-butyldimethylsilyloxy)-2-(methoxymethoxy)heptane (252) using (2R)-1-(tert-
butyldimethylsilyloxy)undecan-2-ol (290) (5.00 g, 16.53 mmol). This gave (2R)-1-(tert-
butyldimethylsilyloxy)-2-(methoxymethoxy)undecane (291) (5.70 g, 100%) as a colourless 
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oil. [α]D23 –49.5 (c 1.4, CHCl3). All other spectroscopic data as previously reported for 
(2S)-1-(tert-butyldimethylsilyloxy)-2-(methoxymethoxy)undecane (279). 
 
(2R)-2-(Methoxymethoxy)undecan-1-ol (292)   
 
OH
OMOM
 
 
The reaction was carried out according to the procedure described for the synthesis of (2S)-
2-(methoxymethoxy)heptan-1-ol (248) using (2R)-1-(tert-butyldimethylsilyloxy)-2-
(methoxymethoxy)undecane (291) (0.50 g, 1.44 mmol). This gave (2R)-2-
methoxymethoxy)undecan-1-ol (292) (0.32 g, 100%) as a colourless oil. [α]D23 –7.1 (c 1.0, 
CHCl3). All other spectroscopic data as previously reported for (2S)-2-
(methoxymethoxy)undecan-1-ol (281). 
 
Ethyl (2E,4R)-4-(methoxymethoxy)tridecan-2-enoate (293) 
 
OMOM
CO2Et  
 
The reaction was carried out according to the procedure described for the synthesis of ethyl 
(2E)-2,8-nonadienoate (188) using (2R)-2-(methoxymethoxy)undecan-1-ol (292) (5.38 g, 
23.14 mmol). This gave ethyl (2E,4R)-4-(methoxymethoxy)tridecan-2-enoate (293) (7.10 
g, 100%) as a colourless oil. [α]D23 +63.2 (c 1.1, CHCl3). All other spectroscopic data as 
previously reported for ethyl (2E,4S)-4-(methoxymethoxy)tridecan-2-enoate (278). 
 
(2E,4R)-4-(Methoxymethoxy)tridecan-2-ene-1-ol (294) 
 
OMOM
OH  
 
The reaction was carried out according to the procedure described for the synthesis of 6-
hepten-1-ol (187) using ethyl (2E,4R)-4-(methoxymethoxy)tridecan-2-enoate (293) (4.80 
g, 16.0 mmol). This gave (2E,4R)-4-(methoxymethoxy)tridecan-2-ene-1-ol (294) (4.00 g, 
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97%) as a colourless oil. [α]D23 +87.6 (c 1.0, CHCl3). All other spectroscopic data as 
previously reported for (2E,4S)-4-(methoxymethoxy)tridecan-2-ene-1-ol (282). 
 
(3S,4R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-(methoxymethoxy)tridecan-1-
ene (296)   
 
OMOM
HN O
CCl3  
 
The reaction was carried out according to the procedure described for the synthesis of 3-
(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189) using (2E,4R)-4-
(methoxymethoxy)tridecan-2-ene-1-ol (294) (2.55 g, 9.90 mmol). This gave (3S,4R)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)tridecan-1-ene (296) (2.80 g, 
70%) as a colourless oil. [α]D23 –65.8 (c 1.0, CHCl3). All other spectroscopic data as 
previously reported for (3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)tridecan-1-ene (276a). 
 
(2S,3R)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol 
(297) 
 
OMOM
OH
HN O
CCl3  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol 
(283) using (3S,4R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)tridecan-1-ene (296) (0.50 g, 1.24 mmol). This gave (2S,3R)-2-
(2’,2’,2’-trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (297) (0.38 g, 
76%) as a colourless oil. [α]D23 –23.7 (c 1.3, CHCl3).  All other spectroscopic data as 
previously reported for (2R,3S)-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecan-1-ol (283). 
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(1R,4’S)-1-(Methoxymethoxy)-1-(2’-trichloromethyl-4’,5’-dihydrooxazo-4’-yl)]decane 
(299) 
OMOM
1
2
3
4
5
6
7
8
9
10
N
O
CCl3
2'
5'4'
1'
3'
 
To a solution of (2S,3R)-2-(2’,2’,2-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecan-1-ol (297) (0.10 g, 0.24 mmol) in dichloromethane (10 mL), 
methanesulfonyl chloride (0.04 mL, 0.37 mmol) and triethylamine (0.07 mL, 0.54 mmol) 
were added slowly at 0 °C and the solution stirred at room temperature for 24 h. Sodium 
borohydride (0.02 g, 0.50 mmol) was added in portions. The reaction mixture was heated 
at 35 °C for 48 h, acidified with 1 M hydrochloric acid, extracted with dichloromethane (3 
× 20 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (diethyl ether/petroleum ether, 1:9) gave (1R,4’S)-1-(methoxymethoxy)-1-
(2’-trichloromethyl-4’,5’-dihydrooxazo-4’-yl)]decane (299) (0.06 g, 60%) as a colourless 
oil. νmax/cm–1 (NaCl) 2926 (CH), 1665, 1466, 1234, 1036, 921, 794; [α]D23 –21.3 (c 0.8, 
CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.8 Hz, 10-H3), 1.26–1.59 (16H, m, 2-H2, 3-
H2, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, and 9-H2), 3.38 (3H, s, OCH3), 3.90–3.94 (1H, m, 4’-H), 
4.42 (1H, ddd, J 10.8, 8.0, 2.8 Hz, 5’-HH), 4.56–4.70 (4H, m, OCH2, 1-H and 5’-HH); δC 
(100 MHz, CDCl3) 14.1 (CH3), 22.7 (CH2), 25.4 (CH2), 29.3 (CH2), 29.5 (CH2), 29.6 (2 × 
CH2), 31.9 (CH2), 32.4 (CH2), 55.8 (CH3), 70.3 (CH2), 71.8 (CH), 77.5 (CH), 86.6 (C), 
96.5 (CH2), 163.2 (C); m/z (CI) 388.1219 (MH+. C16H2935Cl3NO3 requires 388.1213), 354 
(100%), 322 (45), 288 (8), 201 (13), 85 (20). 
 
(2S,3R)-1-Methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (300) 
 
OMOM
OMs
HN O
CCl3  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-1-methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
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(methoxymethoxy)dodecane (284) using (2S,3R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (297) (0.23 g, 0.56 
mmol). This gave (2S,3R)-1-methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-
3-(methoxymethoxy)dodecane (300) (0.23 g, 88%) as a colourless oil. [α]D23 –25.4 (c 1.0, 
CHCl3). All other spectroscopic data as previously reported for (2R,3S)-1-
methanesulfonate-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (284). 
 
(2S,3R)-1-Bromo-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (301) 
 
OMOM
Br
HN O
CCl3  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-1-bromo-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (285) using (2S,3R)-1-methanesulfonate-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecane (300) (0.41 g, 0.85 mmol). 
This gave (2S,3R)-1-bromo-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
(methoxymethoxy)dodecane (301) (0.31 g, 75%) as a colourless oil. [α]D23 –34.0 (c 1.0, 
CHCl3). All other spectroscopic data as previously reported for (2R,3S)-1-bromo-2-
(2’,2’,2’-trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecane  (285). 
 
(2S,3R)-2-Acetylamino-3-(methoxymethoxy)dodecane (302) 
 
OMOM
NHAc  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecane (286) using (2S,3R)-1-bromo-2-
(2’,2’,2’-trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecane (301) (0.05 g, 0.10 
mmol). This gave (2S,3R)-2-acetylamino-3-(methoxymethoxy)dodecane (302) (0.03 g, 
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100%) as a white solid. [α]D23 –45.7 (c 1.0, CHCl3). All other spectroscopic data as 
previously reported for (2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecane (286). 
 
(2S,3R)-2-Aminododecan-3-ol (274) 
 
OH
NH2  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-aminododecan-3-ol (270) using (2S,3R)-2-acetylamino-3-
(methoxymethoxy)dodecane (302) (0.015 g, 0.05 mmol). This gave (2S,3R)-2-
aminododecan-3-ol (274) (0.011 g, 100%) as a white solid. [α]D23 +5.4 (c 1.0, MeOH). All 
other spectroscopic data as reported above for (2R,3S)-2-aminododecan-3-ol (270).  
 
 (2S,3R)-2-Acetylaminododecan-3-ol (303) 
 
OH
NHAc  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylaminododecan-3-ol (271) using (2S,3R)-2-acetylamino-3-
(methoxymethoxy)dodecane (302) (0.027 g, 0.24 mmol). This gave (2S,3R)-2-
acetylaminododecan-3-ol (303) (0.018 g, 81%) as a white solid. [α]D23 –13.3 (c 1.0, 
MeOH). All other spectroscopic data as previously reported for (2R,3S)-2-
acetylaminododecan-3-ol (271). 
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(2S,3R)-2-(2’-Chloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (304) 
 
OMOM
12
3
4
5
6
7
8
9
10
11
12
OH
HN O
CH2Cl
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecane (286) using (2S,3R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (297) (0.10 g, 0.24 
mmol) and tributyltin hydride (0.83 mL, 2.95 mmol). The reaction mixture was heated for 
1 h. Flash column chromatography (diethyl ether/petroleum ether, 8:2) gave (2S,3R)-2-(2’-
chloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (304) (0.07 g, 84%) as a 
colourless oil. νmax/cm–1 (NaCl) 3308 (NH), 2925 (CH), 1656 (CO), 1541, 1465, 1034, 
919; [α]D23 –21.8 (c 1.7, CHCl3); δH (400 MHz, CDCl3) 0.88 (3H, t, J 6.4 Hz, 12-H3), 
1.26–1.65 (16H, m, 4-H2, 5-H2, 6-H2, 7-H2, 8-H2, 9-H2, 10-H2, and 11-H2), 2.91 (1H, dd, J 
6.4, 2.8 Hz, OH), 3.43 (3H, s, OCH3), 3.66–3.74 (2H, m, 1-H2), 3.94–4.00 (2H, m, 2-H and 
3-H), 4.10 (2H, d, J 3.2 Hz, ClCH2), 4.62 (1H, d, J 6.4 Hz, OCHHO), 4.67 (1H, d, J 6.4 
Hz, OCHHO), 7.66 (1H, br d, J 7.2 Hz, NH); δC (100 MHz, CDCl3) 14.1 (CH3), 22.7 
(CH2), 25.7 (CH2), 29.3 (CH2), 29.5 (2 × CH2), 29.7 (CH2), 31.9 (CH2), 32.7 (CH2), 42.7 
(CH2), 53.4 (CH), 56.1 (CH3), 62.0 (CH2), 82.2 (CH), 97.6 (CH2), 166.4 (C); m/z (CI) 
338.2095 (MH+. C16H3335ClNO4 requires 338.2098), 320 (88%), 306 (47), 288 (24), 254 
(4). 
 
(2S,3R)-2-Acetylamino-3-(methoxymethoxy)dodecan-1-ol (305) 
 
OMOM
OH
NHAc  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecane (286) using (2S,3R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (297) (0.10 g, 0.24 
mmol). This gave (2S,3R)-2-acetylamino-3-(methoxymethoxy)dodecan-1ol (305) as a 
colourless oil (0.07 g, 91%). [α]D23 –32.8 (c 1.0, CHCl3). All other spectroscopic data as 
previously reported for (2R,3S)-2-acetylamino-3-(methoxymethoxy)dodecan-1-ol (287).  
  
145 
(2S,3R)-2-Acetylaminododecan-1,3-diol (306) 
 
OH
OH
NHAc  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-acetylaminododecan-3-ol (271) using (2S,3R)-2-acetylamino-3-
(methoxymethoxy)dodecan-1-ol (305) (0.03 g, 0.08 mmol). This gave (2S,3R)-2-
acetylaminododecan-1,3-diol (306) (0.03 g, 100%) as a white solid. [α]D23 –4.1 (c 1.0, 
MeOH). All other spectroscopic data as previously reported for (2R,3S)-2-
acetylaminododecan-1,3-diol (272). 
 
(2S,3R)-2-Aminododecan-1,3-diol (307)167 
 
OH
OH
NH2  
 
The reaction was carried out according to the procedure described for the synthesis of 
(2R,3S)-2-aminododecan-3-ol (270) using (2S,3R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-(methoxymethoxy)dodecan-1-ol (297) (0.10 g, 0.24 
mmol). This gave (2S,3R)-2-aminododecan-1,3-diol (307) (0.05 g, 100%) as a colourless 
oil. [α]D23 –6.3 (c 1.0, MeOH), lit.167 [α]D20 –6.0 (c 0.1, MeOH). All other spectroscopic 
data as previously reported for (2R,3S)-2-aminododecan-1,3-diol (273). 
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3.8 Attempted Synthesis of NO-Inhibitor 
 
5,6-O-Isopropylidene-L-1,4-lactone (322)194 
O
HO OH
O
O
O H
6
2
7
4 3 15
 
 
A solution of L-gulono-1,4-lactone 321 (3.00 g, 16.84 mmol) in dimethylformamide (20 
mL) was cooled to 10 °C and p-toluenesulfonic acid (0.02 g, 0.14 mmol) was added 
dropwise followed by 2-methoxypropene (2.10 g, 21.90 mmol). The reaction mixture was 
warmed to room temperature and stirred overnight. The solution was treated with sodium 
carbonate decahydrate (3.0 g) and the suspension was vigorously stirred for 2 h. The 
solution was filtrered and the filtrate was concentrated in vacuo. The residue was washed 
with (hexane/ethanol, 9:1) gave 5,6-O-isopropylidene-L-1,4-lactone (322) (3.2 g, 88%) as  
white crystals. Mp 163–165 oC, lit.194 167–168 oC; [α]D25 +37.6 (c 1.0, MeOH), lit.194 
[α]D25 +38.3 (c 0.7, MeOH); Spectroscopic data in accordance with literature.194 δH (400 
MHz, CDCl3) 1.41 (3H, s, 6-H3), 1.47 (3H, s, 7-H3), 3.24 (2H, s, 2 × OH), 3.96 (1H, dd, J 
6.4, 2.4 Hz, 5-HH), 4.22 (1H, dd, J 6.4, 2.4 Hz, 5-HH), 4.38–4.44 (2H, m, 1-H and 2-H), 
4.49 (1H, dd, J 6.4, 2.4 Hz, 3-H), 4.54 (1H, q, J 6.4 Hz, 4-H); δC (100 MHz, CDCl3) 25.2 
(CH3), 26.5 (CH3), 64.3 (CH2), 69.1 (CH), 70.1 (CH), 75.0 (CH), 81.2 (CH), 109.0 (C), 
176.0 (C); m/z (CI) 219 (MH+. 16%), 203 (8), 137 (100), 121 (45), 69 (55). 
 
Ethyl (2E,4R)-4,5-(O-isopropylidene)-4,5-dihydroxypentan-2-enoate (320)195 
 
CO2Et
O
O
1
2
5
6
4
3
7
 
 
To a stirred suspension of 5,6-O-isopropylidene-L-1,4-lactone (322) (3.00 g, 13.74 mmol) 
in water (30 mL), sodium periodate (5.9 g, 27.5 mmol) was added dropwise at 0 °C. The 
reaction mixture was stirred for 2 h at room temperature. Triethyl phosphonoacetate (4.62 
mL, 20.60 mmol) and 6 M potassium carbonate solution (30 mL) were then added to the 
mixture, which was stirred overnight at room temperature. The reaction was extracted with 
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dichloromethane (4 × 40 mL), washed with brine (20 mL) and dried (MgSO4). 
Concentration under vacuum gave a clear oil. Purification by flash column 
chromatography (elution with petroleum ether/diethyl ether, 10:1) gave ethyl (2E,4R)-4,5-
(O-isopropylidene)-4,5-dihydroxypentan-2-enoate (320) (2.0 g, 71%) as a clear oil. 
Spectroscopic data in accordance with literature.195 [α]D25 –40.2 (c 2.2, CHCl3), lit.195 
[α]D25 –40.0 (c 1.096, CHCl3); δH (400 MHz, CDCl3) 1.30 (3H, t, J 7.2 Hz, OCH2CH3), 
1.41 (3H, s, 6-H3), 1.45 (3H, s, 7-H3), 3.67 (1H, dd, J 7.9, 7.5 Hz, 5-HH), 4.16–4.23 (3H, 
m, OCH2CH3 and 5-HH), 4.60–4.69 (1H, m, 4-H), 6.10 (1H, dd, J 15.6, 1.2 Hz, 2-H), 6.90 
(1H, dd, J 15.6, 5.6 Hz, 3-H); δC (100 MHz, CDCl3) 14.2 (CH3), 25.7 (CH3) 26.4 (CH3), 
60.6 (CH2), 68.8 (CH2), 75.0 (CH), 110.2 (C), 122.4 (CH), 144.6 (CH), 166.0 (C); m/z (CI) 
201 (MH+. 100%), 183 (20), 143 (14), 81 (7). 
 
(2E,4R)-4,5-(O-Isopropylidene)-4,5-dihydroxyprop-2-en-1-ol (323)196 
 
O
O
1
2
5
6
4
3
7
OH  
 
The reaction was carried out according to the procedure described for the synthesis of 6-
hepten-1-ol (187) using ethyl (2E,4R)-4,5-(O-isopropylidene)-4,5-dihydroxypentan-2-
enoate (320) (2.0 g, 10.0 mmol). Purification by flash column chromatography (eluting 
with petroleum ether/diethyl ether, 5:1), gave (2E,4R)-4,5-(O-isopropylidene)-4,5-
dihydroxyprop-2-en-1-ol (323) (1.20 g, 76%) as a colourless oil. Spectroscopic data in 
accordance with literature.196 [α]D25 –24.6 (c 1.6, CHCl3), lit.196 [α]D –27.6 (c 0.29, 
CHCl3); δH (400 MHz, CDCl3) 1.39 (3H, s, 6-H3), 1.42 (3H, s, 7-H3), 2.50 (1H, br s, OH), 
3.59 (1H, dd, J 8.0, 7.6 Hz, 5-HH), 4.10 (1H, dd, J 8.0, 7.6 Hz, 5-HH), 4.16 (2H, d, J 5.1 
Hz, 1-H2), 4.52 (1H, q, J 7.6 Hz, 4-H), 5.72 (1H, dd, J 15.6, 7.6 Hz, 3-H), 5.95 (1H, dt, J 
15.6, 5.1 Hz, 2-H); δC (100 MHz, CDCl3) 25.8 (CH3), 26.6 (CH3), 62.3 (CH2), 69.3 (CH2), 
76.2 (CH), 109.3 (C), 128.4 (CH), 133.5 (CH); m/z (CI) 159 (MH+. 100%), 141 (30), 83 
(35). 
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(3S,4S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-
dihydroxypenta-1-ene 317a, (3R,4R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4,5-
(O-isopropylidene)-4,5-dihydroxypenta-1-ene 317b and (2E,4R)-1-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene (317c) using thermal 
rearrangement55  
 
HN O
O
O
CCl3
2
3
14
7
6
5
HN O
O
O
CCl3
317b317a
O NH
CCl3
317c
OH
HO
 
   
Allylic alcohol (323) (0.10 g, 0.63 mmol) was dissolved in DCM (20 mL) and cooled to 0 
oC. 1,8-Diazabicyclo[5.4.0]undec-7-ene (0.02 mL, 0.15 mmol) was then added to the 
solution followed by trichloroacetonitrile (0.10 mL, 0.95 mmol). The reaction mixture was 
warmed to room temperature and stirred for 2 h under an argon atmosphere. The reaction 
mixture was then filtered through a short pad of silica gel and washed with diethyl ether 
(100 ml). The resulting filtrate was then concentrated to give the allylic 
trichloroacetimidate 319, which was used without further purification in the 
rearrangements that followed. The crude trichloroacetimidate 319 was dissolved in p-
xylene (20 mL) and heated to 140 oC until reaction was complete as observed by 1H NMR 
spectroscopy. The reaction mixture was concentrated in vacuo to give a brown oil. 
Purification by chromatography (elution with petroleum ether/diethyl ether, 9 : 1) gave the 
allylic trichloroacetamide products 317a and 317b as brown oils (0.05 g, 29% combined 
yield). Further elution (petroleum ether/diethyl ether, 1 : 9) gave 317c also as a brown oil 
(0.04 g, 27% yield). 317a: [α]D25 +36.7 (c 1.0, CHCl3), δH (400 MHz, CDCl3) 1.36 (3H, s, 
6-CH3), 1.47 (3H, s, 7-CH3), 3.70 (1H, dd, J 8.4, 6.4 Hz, 5-HH), 4.10 (1H, dd, J 8.4, 6.4 
Hz, 5-HH), 4.34 (1H, td, J 6.4, 2.4 Hz, 4-H), 4.47–4.52 (1H, m, 3-H), 5.29–5.37 (2H, m, 1-
H2), 5.88 (1H, ddd, J 17.2, 10.4, 6.0 Hz, 2-H), 7.05 (1H, br s, NH); δC (100 MHz, CDCl3) 
24.7 (CH3), 26.4 (CH3), 53.9 (CH), 66.3 (CH2), 76.6 (CH), 92.6 (C), 110.0 (C), 117.7 
(CH2), 133.9 (CH), 161.9 (C); m/z (CI) 302 (MH+. 53%), 268 (15), 244 (100), 210 (44), 
176 (12), 101 (12). 317b: δH (400 MHz, CDCl3) 1.35 (3H, s, CH3), 1.46 (3H, s, CH3), 3.84 
(1H, dd, J 9.1, 5.1 Hz, 5-HH), 4.10 (1H, dd, J 9.1, 5.1 Hz, 5-HH), 4.29–4.35 (1H, m, 4-H), 
4.47–4.52 (1H, m, 3-H), 5.33–5.38 (2H, m, 1-H2), 5.85 (1H, ddd, J 15.8, 10.3, 6.2 Hz, 2-
H), 7.01 (1H, br s, NH); δC (100 MHz, CDCl3) 24.7 (CH3), 26.1 (CH3), 55.8 (CH), 65.5 
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(CH2), 76.1 (CH), 92.5 (C), 110.2 (C), 119.3 (CH2), 131.6 (CH), 161.5 (C). 317c: υmax/cm-
1 (neat) 3512 (OH), 3420 (NH), 2986 (CH), 1723 (CO), 1512 (C=C), 1313, 1070; [α]D25 
+1.7 (c 1.0, CHCl3), δH (400 MHz, CDCl3) 1.90 (2H, br s, 2 × OH), 4.21 (2H, dd, J 5.0, 1.2 
Hz, 1-H2), 4.37 (1H, dd, J 8.6, 8.3 Hz, 5-HH), 4.77 (1H, dd, J 9.8, 8.3 Hz, 5-HH), 4.90–
4.97 (1H, m, 4-H), 5.78 (1H, ddt, J 15.5, 7.4, 1.2 Hz, 3-H), 5.96 (1H, dt, J 15.5, 5.0 Hz, 2-
H); δC (100 MHz, CDCl3) 62.4 (CH2), 67.9 (CH2), 76.2 (CH), 88.2 (C), 128.4 (CH), 133.3 
(CH), 163.5 (C); m/z (CI) 261.9725 (MH+, C7H11NO335Cl3 requires 261.9729), 242 
(100%), 226 (41), 210 (38), 193 (15), 118 (94). Spectroscopic data in accordance with 
literature.55 
 
(3S,4S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-
dihydroxypenta-1-ene (317a) using (R)-COP-Cl as catalyst55 
 
The reaction was carried out according to the procedure described for the synthesis of 3-
(2’,2’,2’-trichloromethylcarbonylamino)nona-1,8-diene (189) using (2E,4R)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol (323) (0.50 g, 3.16 mmol) and (R)-COP-Cl 
(0.31 g, 0.30 mmol). Purification by flash column chromatography (eluting with petroleum 
ether/diethyl ether, 20:1), gave (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene (317a) (0.70 g, 73%) as a brown oil. 
Spectroscopic data as reported above. 
 
1-(Benzyloxycarbonylamino)-3-butene (318)197 
 
NHCbz
24
13
 
 
To a suspension of 3-butenylamine hydrochloride salt 324 (5.50 g, 51.12 mmol) in 
dichloromethane (250 mL) was added a solution of sodium carbonate (16.80 g) in water 
(50 mL). The biphasic mixture was cooled to 0 oC and benzyl chloroformate (11.53 g, 
81.80 mmol) was added dropwise. The reaction mixture was stirred for 0.25 h at 0 oC, then 
warmed at room temperature for 14 h. The solution was diluted with dichloromethane (100 
mL) and water (50 mL) was added. The aqueous combined organic layers were washed 
with water, dried, filtered and concentrated in vacuo. Flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 1-(benzyloxycarbonylamino)-3-butene (318) 
(10.5 g, 100% yield) as a colourless oil. Spectroscopic data consistent with literature.197 δH 
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(400 MHz, CDCl3) 2.26 (2H, q, J 6.8 Hz, 2-H2), 3.28 (2H, q, J 6.8 Hz, 1-H2), 4.76 (1H, br 
s, NH), 5.06–5.12 (4H, m, 4-H2 and PhCH2), 5.69–5.80 (1H, m, 3-H), 7.29–7.38 (5H, m, 
Ph); δC (100 MHz, CDCl3) 34.1 (CH2), 40.1 (CH2), 66.6 (CH2), 117.4 (CH2), 127.9 (2 × 
CH) 128.5 (2 × CH), 131.4 (CH), 135.1 (C), 136.6 (CH), 156.3 (C); m/z (CI) 206 (MH+. 
100%), 181 (30), 145 (10), 91 (90). 
 
4-(N-Benzyloxycarbonylglycyl)morpholine (327)198 
 
O
N
NHCbz
O
1
2
4
5
3
6
 
To a solution of N-(benzyloxycarbonylamino)glycine (326) (3.00 g, 14.34 mmol) in 
dichloromethane (100 mL), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride 
(4.12 mL, 21.51 mmol) was added at 0 °C. Morpholine (1.50 mL, 17.21 mmol) was added 
to the reaction mixture followed by 4-dimethylaminopyridine (2.36 g, 20.00 mmol). The 
reaction mixture was stirred at room temperature overnight. The solution was quenched 
with ice cold water (50 mL). The mixture was separated and the aqueous layer was then 
extracted with dichloromethane (2 × 100 mL). The combined organic layers were washed 
with a saturated solution of ammonium chloride (50 mL) and brine (50 mL), then dried 
(Na2SO4) and concentrated in vacuo. Flash column chromatography (petroleum ether/ethyl 
acetate, 2:8) gave 4-(N-benzyloxycarbonylglycyl)morpholine (327) (3.50 g, 87%) as a 
white solid. Mp 142–144 oC (lit.198 mp 144–145 °C); Spectroscopic data consistent with 
literature.198 δH (400 MHz, CDCl3) 3.36 (2H, t, J 4.8 Hz, 2-HH and 6-HH), 3.59–3.66 (6H, 
m, 2-HH, 6-HH, 3-H2 and 5H2), 4.00 (2H, d, J 4.8 Hz, CH2NHCbz), 5.11 (2H, s, PhCH2), 
5.89 (1H, br s, NH), 7.29–7.35 (5H, m, Ph); δC (100 MHz, CDCl3) 34.8 (CH2), 42.5 (CH2), 
44.7 (2 × CH2), 66.6 (2 × CH2), 126.2 (CH), 128.1 (2 × CH), 128.5 (2 × CH), 136.4 (C), 
156.2 (C), 166.7 (C); m/z (CI) 279 (MH+. 60%), 235 (4), 171 (100), 147 (13), 91 (33), 71 
(20).  
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N-(Benzyloxycarbonylamino)butan-3-ene-2-one (328)199 
 
NHCbz
O
2
3 14
 
 
To a solution of 4-(N-benzyloxycarbonylglycyl)morpholine (327) (0.20 g, 0.71 mmol) in 
tetrahydrofuran (10 mL), was added vinylmagnesium bromide (2.15 mL, 2.15 mmol) 
dropwise. The reaction mixture was stirred at 0 °C for 1.5 h. The solution was quenched 
with 1 M hydrochloric acid, extracted with ethyl acetate (3 × 20 mL) and concentrated in 
vacuo. Purification by flash column chromatography (petroleum ether/ethyl acetate, 5:5) 
gave N-(benzyloxycarbonylamino)butan-3-ene-2-one (328) (0.069 g, 46%) as a clear oil. 
Spectroscopic data in accordance with literature.199 δH (400 MHz, CDCl3) 4.31 (2H, d, J 
4.8 Hz, 1-H2), 5.12 (2H, s, PhCH2), 5.62 (1H, br s, NH), 5.95 (1H, dd, J 7.6, 1.6 Hz, 3-H), 
6.35–6.38 (2H, m, 4-H2), 7.29–7.36 (5H, m, Ph); δC (100 MHz, CDCl3) 48.6 (CH2), 67.0 
(CH2), 128.1 (2 × CH), 128.2 (CH), 128.5 (2 × CH), 129.9 (C), 133.5 (CH2), 136.3 (CH), 
156.1 (C), 194.3 (C); m/z (CI) 220 (MH+. 100%), 176 (53), 147 (10), 91 (40).    
 
(5S,6S)-1-(Benzyloxycarbonylamino)-5-(2’,2’,2’-trichloromethylcarbonylamino)-6,7-
(O-isopropylidene)-6,7-dihydroxyhepta-3-ene-2-one (329) 
 
NHCbz
HN O
O
O
CCl3
O
3
2
1
6
45
7
8
9
 
 
The reaction was carried out according to the procedure described for the synthesis of 
(4R,5S)-3-(trichloromethylcarbonylamino)-5-(methoxymethoxy)-2-decen-1-al (257) using 
(3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-
dihydroxypenta-1-ene (317a) (0.10 g, 0.33 mmol), N-(benzyloxycarbonylamino)butan-3-
ene-2-one (328) (0.30 g, 1.32 mmol) and Hoveyda/Grubbs 2nd generation catalyst 114 
(0.05 g, 0.03 mmol). Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 5:5) gave (5S,6S)-1-(benzyloxycarbonylamino)-5-(2’,2’,2’-
trichloromethylcarbonylamino)-6,7-(O isopropylidene)-6,7-dihydroxyhepta-3-ene-2-one 
(329) (0.12 g, 68%) as a brown oil. νmax/cm–1 (NaCl) 3410 (NH), 2987 (CH), 1690 (CO), 
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1509, 1375, 1265, 1063, 821; [α]D23 +21.5 (c 2.0, CHCl3); δH (400 MHz, CDCl3) 1.36 (3H, 
s, 8-H3), 1.48 (3H, s, 9-H3), 3.75 (1H, dd, J 6.6, 2.4 Hz, 7-HH), 4.15 (1H, dd, J 6.6, 2.4 Hz, 
7-HH), 4.31 (2H, d, J 4.4 Hz, 1-H2), 4.40 (1H, td, J 6.6, 1.6 Hz, 6-H), 4.64–4.68 (1H, m, 5-
H), 5.12 (2H, s, PhCH2), 5.56 (1H, br s, Cl3CCONH), 6.33 (1H, d, J 16.0 Hz, 3-H), 6.90 
(1H, dd, J 16.0, 5.2 Hz, 4-H), 7.15 (1H, d, J 8.4 Hz, CbzNH), 7.31–7.39 (5H, m, Ph); δC 
(100 MHz, CDCl3) 24.4 (CH3), 26.3 (CH3), 49.5 (CH2), 53.1 (CH), 66.2 (CH2), 67.1 
(CH2), 75.6 (CH), 92.2 (C), 110.4 (C), 127.7 (C), 128.1 (2 × CH), 128.6 (2 × CH), 132.2 
(CH), 136.1 (CH), 142.5 (CH), 156.1 (C), 162.2  (C), 193.2 (C); m/z (CI) 493.0717 (MH+. 
C20H2435Cl3N2O6 requires 493.0700), 493 (8%), 459 (10), 218 (18), 152 (45), 107 (50), 91 
(100). 
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